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ABSTRACT 
It is accepted that CD4 T cells are required for the activation of naïve CD8 T cells. In this 
study, we have investigated the “reverse reaction” that of the effect of CD8 T cells have on 
the differentiation of CD4 T cells while present at the initiation of the immune response. 
Our experimental system consists of One Way Mixed Lymphocyte Reaction, MLR, where 
parental spleen cells homozygous at the Major Histocompatibility Complex, MHC, are 
activated by irradiated allogeneic spleen cells differing at the MHC loci. Differentiation of 
CD4 and CD8 T cells was assessed by their expression of distinct signature cytokines,  
IFN-γ and IL-4 by employing the single T cell ELISPOT assay. CD4 and CD8 T cell 
sorting and identification was achieved by Magnetically Activating Cell Sorting 
technology, MACs, and Flow-Cytometry, respectively. This methodology allowed us to 
explore the mechanism by which CD8 T cells regulate the differentiation of naïve CD4 T 
cells towards either a Th1(IFN-γ) or a Th2(IL-4) phenotype.  
 
We have found that distinct CD4:CD8 T cell ratios of the spleens of different strains of 
mice correlate with a Th1(IFN-γ), a Th2(IL-4) or a mixed Th1(IFN-γ)/Th2(IL-4) type 
immunity when these cells are stimulated with spleen cells from mice differing at the MHC 
loci. In contrast, similar cultures depleted of CD8 T cells, invariably generate Th2(IL-4), 
CD4 T cells in all mouse strains tested. Both, unprimed and effector CD8 T cells suppress 
the Th2(IL-4) development in an antigen specific manner. They do so by means of an allo-
antigen dependent secreted soluble factor. This factor is IFN-γ. Finally, the employment of 
the ELISPOT assay for enumerating and characterizing effector CD4 and CD8 T cells 
allowed us to verify, with contemporary methodology, the extraordinary high frequency of 
alloreactive T cells, a phenomenon described by Simonsen in 1957. 
 
Thus, in these studies we have revisited the mechanism by which CD8 T cells were known 
to “suppress” the antibody response. Our findings indicate that CD8 T cells inhibit in a 
cognate manner the CD4 Th2 (IL-4) differentiation, the subset required for antibody 
development. Further on, by extrapolation our data may explain the well-known in vivo 
phenomena in which distinct naturally occurring CD4:CD8 T cell ratios from two different 
parental mouse strains, promote either Th1 immunity and graft rejection, or a Th2-type 
 iii 
response ineffective at clearing the graft, upon allo-transplantation of parental spleen cells 
into F1 mice. Consequently, a persistent Th2 response results in time in antibody-mediated 
generalised autoimmunity resembling Systemic Lupus Erythematosus.    
 
   iv
ACKNOWLEDGEMENTS 
 
A heartfelt thank you and my sincere gratitude to my supervisor, Dr. Calliopi Havele for 
providing me with the amazing opportunity to work in your laboratory. Thank you for your 
guidance, patience and constant support throughout my Ph.D. thesis in both my academic 
and my personal life.  
 
Thank you, Dr. Peter Bretscher for nurturing in me an interest in the History of 
Immunology and always reminding me to look at the “big picture”. I cannot thank you 
enough for taking an interest in my education. I truly appreciate your invaluable 
discussions and encouragement, which helped to build my confidence as a scientist.  
  
I would like to thank the members of my advisory committee Dr. Sylvia van den Hurk, Dr. 
Linda Chelico and Dr. Volker Gerdts for generously giving of your time, guidance and 
support.  
 
I would like to thank Bryce Warner for your friendship during my studies. It was great to 
have someone to troubleshoot with. I would like to thank Ghassan Al-Yassin for the 
stimulating discussions we had, which I thoroughly enjoyed. 
 
I would like to thank Dr. Regan Arendse, my husband and my best friend. I cannot express 
my gratitude enough for your constant love and unwavering support and the complete 
confidence you had in my ability to succeed.   
 
All Glory, Honour, Praise and Thanks to God the Father, God the Son, and God the Holy 
Spirit. Honour and thank you to Mary Immaculate, My Queen, My Mistress and My 
Mother. 
   v 
TABLE OF CONTENTS 
           Page 
 PERMISSION TO USE……………………………………………… i 
 ABSTRACT…………………………………………………………. ii 
 ACKNOWLEDGEMENTS………………………………………….. iv 
 TABLE OF CONTENTS……………………………………………. v 
 LIST OF FIGURES………………………………………………….. xiii 
 LIST OF ABBREVIATIONS………………………………………... xvii 
   
 CHAPTER 1………………………………………………………….. 1 
 INTRODUCTION…………………………………………………... 1 
   
1.1 The foundations of Immunology are anchored in the early research of 
Allogeneic Tissue Transplantation…………………............................ 
 
1 
   
1.2 Allograft Rejection…………………………………………………… 3 
1.2.1 Historical Perspectives……………………………………………….. 3 
1.2.2 Immunological basis of allograft rejection…………………………… 5 
1.2.3 Linkage between allograft rejection and T cells……………………… 7 
 1.2.3.1 A historical perspective of the humoral and cell-mediated 
immune responses…………………………………………………. 
 
7 
 1.2.3.2 Humoral versus Cell-Mediated immune responses in allograft 
rejection……………………………………………………………… 
 
9 
1.2.4  Link between Immunological Tolerance and Transplantation………. 11 
1.2.5 Major Histocompatibility Locus and Histocompatibility Antigens….. 12 
 1.2.5.1 Contribution of the geneticists………………………………. 12 
 1.2.5.2 Passenger Leukocytes express allo-MHC initiating 
alloresponses………………………………………………………… 
 
15 
 1.2.5.3 T cells recognising MHC alloantigens………………………. 17 
 vi 
 1.2.5.4 Activation of CD4 T cells and CD8 T cells in response to allo-
MHC: direct and indirect allorecognition………………………... 
 
19 
   
1.3 Graft versus host reactions and graft versus host disease……………. 20 
1.3.1 Acute versus chronic graft versus host disease……………………...... 21 
 1.3.1.1 Acute graft versus host reaction……………………………… 21 
 1.3.1.2 Chronic graft versus host disease……………………………… 23 
1.3.2 Experimental avenues leading to the discovery of graft versus host 
disease………………………………………………………………... 
 
23 
 1.3.2.1 Induction of tolerance to skin allografts……………………... 23 
 1.3.2.2 Whole body irradiation and bone marrow transplantation…… 25 
1.3.3 Factors determining the development of an acute graft versus host 
reaction and a chronic graft versus host disease……………………… 
 
26 
 1.3.3.1 Different mouse strain combinations………………………… 26 
 1.3.3.2 T helper and T suppressor cells……………………………... 27 
 1.3.3.3 Major Histocompatibility Antigens…………………………. 29 
 1.3.3.4 Differences in CD8 T cells in the donor inoculum…………. 30 
1.3.4 Lymphocytes are implicated in graft versus host reactions………… 32 
1.3.5 Strategies to prevent graft versus host disease……………………… 33 
 1.3.5.1 The removal of T lymphocytes from a bone marrow graft: a 
potential prophylactic measure against the development of GVHD…. 
 
33 
 1.3.5.2 Predictors of the severity of GVHD after bone marrow 
transplantation……………………………………………………….. 
 
35 
1.3.6 Parabiosis of mice to F1 offspring…………………………………… 36 
1.3.7 Autoimmunity: a consequence of chronic graft versus host disease… 37 
1.3.8 Disease models related to CD4:CD8 T cell ratio…………………….. 38 
   
1.4 The Mixed Lymphocyte Reaction……………………………………. 38 
1.4.1 Principles of a Mixed Lymphocyte Reaction………………………… 38 
1.4.2 The Discovery of the Mixed Lymphocyte Reaction………………..... 39 
 1.4.2.1 Cell types implicated in the MLR…………………………..... 39 
 vii 
 1.4.2.2 Quantifying the proliferation of cells in the MLR…………… 40 
 1.4.2.3 The Mixed Lymphocyte Reaction: a consequence of MHC 
disparity…………………………………………………………….... 
 
40 
1.4.3 One-way Mixed Lymphocyte Reaction……………………………… 42 
1.4.4 The Effector arm of the MLR………………………………………… 43 
   
1.5 The Immunologically Competent Lymphocyte……………………… 44 
1.5.1 The role of lymphocytes in immunity………………………………… 44 
1.5.2 The thymus: the site of development for the immunologically active 
lymphocyte…………………………………………………………… 
 
46 
1.5.3 Functional differences between thymus-derived and bone marrow- 
derived lymphocytes in the production of antibodies………………… 
 
48 
1.5.4 A morphological difference between thymus-derived and bone 
marrow-derived lymphocytes………………………………………… 
 
50 
1.5.5 T cells as mediators of cytotoxicity………………………………….. 50 
1.5.6 Suppression and Promotion of the antibody response: the conflicting 
roles of T cells………………………………………………………... 
 
51 
1.5.7 The Discovery of Distinct T cell populations…………………………  52 
   
1.6 Immune regulation…………………………………………………… 53 
1.6.1 A historical perspective of Immune Regulation……………………… 53 
1.6.2 The current concept of immune class regulation…………………….. 54 
1.6.3 T helper subsets and their signature cytokines: IFN-γ and IL-4 56 
1.6.4 Factors that influence the Th1/Th2 phenotype of CD4 T cells………. 58 
 1.6.4.1 Antigen Dose………………………………………………..... 58 
 1.6.4.2 The number of responding CD4 T cells……………………… 59 
   
1.7 The interaction between the CD4 T cell and the CD8 T cell……. 59 
1.7.1 CD4 T cell help required for activation of naïve CD8 T cells……… 59 
1.7.2 Linked recognition of CD4 and CD8 T cells: a requirement for CD8 T 
cell activation…………………………………………………………. 
 
60 
 viii 
1.7.3 The role of CD8 T cells in suppressing the antibody response……..... 61 
   
1.8 The mechanism of antibody suppression by the CD8 T cell………… 65 
   
 CHAPTER 2…………………………………………………………. 68 
2.1 RATIONALE………………………………………………………… 68 
2.2 HYPOTHESIS……………………………………………………….. 70 
2.3 AIMS…………………………………………………………………. 72 
   
 CHAPTER 3…………………………………………………………. 73 
 MATERIALS AND METHODS……………………………………. 73 
   
3.1 Mice………………………………………………………………….. 73 
   
3.2 Media and Solutions…………………………………………………. 73 
 3.2.1 Roswell Park Memorial Institute Culture Medium…………….. 73 
 3.2.2 Phosphate Buffered Saline……………………………………… 73 
 3.2.3 Phosphate Buffered Saline-Tween……………………………...  73 
 3.2.4 Magnetic Activated Cell Sorting buffer………………………… 74 
 3.2.5 Fluorescence Activated Cell Sorting buffer…………………….. 74 
 3.2.6 Carbonate/Bicarbonate buffer for Coating ELISPOT plates…… 74 
 3.2.7 NBT/BCIP Developing Solution for ELISPOT assay…………. 74 
 3.2.8 Recombinant Interferon Gamma and Anti-Interferon Gamma 
Antibody……………………………………………………………… 
 
74 
   
3.3 Preparation of Spleen Single Cell Suspension……………………….. 75 
   
3.4 Mixed Lymphocyte Reaction………………………………………… 75 
 3.4.1 Control Cultures………………………………………………... 76 
 3.4.2 CD8 T cell Depleted Cultures………………………………….. 76 
 3.4.3 CD4 T cell Depleted Cultures………………………………….. 77 
 ix 
 3.4.4 Transwell Membrane Cultures…………………………………. 77 
   
3.5 Irradiation of Stimulator Spleen Cells……………………………….. 77 
   
3.6 Sorting out of unprimed CD8 T cells from the spleens of mice for use 
in Reconstruction assays……………………………………………… 
 
77 
 3.6.1 T cell enrichment of the spleen cells using Nylon wool……….. 77 
 3.6.2 Magnetic Activated Cell Sorting……………………………….. 78 
   
3.7 Assessment of the Immune Responses by ELISPOT assay………….. 78 
   
3.8 Flow Cytometric Analysis……………………………………………. 80 
   
3.9 Statistical Analysis…………………………………………………… 80 
   
 RESULTS……………………………………………………………. 81 
   
 CHAPTER 4………………………………………………………….. 81 
 Analysis of the role of the naturally occurring CD4:CD8 T cell ratios 
at day 0 in the spleens of adult BALB/c, C57BL/6, C3H, CBA/J, 
DBA/1 and DBA/2, mice in determining the Th1 (IFN-γ) /Th2 (IL-4) 
phenotype of the immune response when stimulated with allo-MHC as 
assessed at day 5 of culture………………………………………… 
 
 
 
 
81 
   
 Preamble……………………………………………………………… 81 
   
4.1 Correlation between the CD4:CD8 T cell ratio and the phenotype of 
the immune response, Th1 or Th2, generated by the spleen cells of 
different strains of adult mice upon allo-MHC stimulation ……………  
 
 
82 
4.1.1 The naturally occurring CD4:CD8 T cell ratio of the spleens of adult 
BALB/c and C57BL/6 are different………………………………… 
 
82 
 x 
4.1.2 The CD4:CD8 T cell ratio are similar among the spleen cells and the 
cells of the inguinal lymph nodes ……………………………………. 
 
  87 
4.1.3 Expansion of CD4 T cells and CD8 T cells of the spleens of adult 
BALB/c and C57BL/6 mice assessed at day 5 of culture…………….. 
 
89 
4.1.4 The naturally occurring CD4:CD8 T cell ratio of the spleens of 
BALB/c and C57BL/6 mice is associated with a particular type of 
immune response, Th1/IFN-γ or Th2/IL-4, generated upon stimulation 
with allo-MHC……………………………………………………….. 
 
 
 
93 
4.1.5 The CD4:CD8 T cell ratio of the spleens of the CBA/J, C3H, DBA/2 
and DBA/1 strains of mice is associated with a particular the type of 
immune response, Th1/IFN-γ or Th2/ IL-4, generated upon stimulation 
with allo-MHC. 
 
 
98 
4.1.6 Characterization of the Phenotype of Effector T cells of the spleens of 
BALB/c mice producing IFN-γ and IL-4 Cytokines: IL-4 is produced 
exclusively by CD4 T cells…………………………………………… 
 
 
106 
4.1.7 The production of IFN-γ and IL-4 cytokines by Effector T cells is 
antigen-dependent and antigen specific………………………………. 
 
109 
4.1.8 Individual spleen cells versus pooled spleen cells……………………. 112 
 (I) No difference was observed in the percentages of CD4 T cells and 
CD8 T cells of individual spleens and pooled spleen cells of BALB/c 
and C57BL/6 mice…………………………………………………… 
 
 
112 
 (II) The production of IFN-γ and IL-4 by the cells of individual spleens 
of BALB/c and C57BL/6 mice is equivalent to the IFN-γ and IL-4 
production of pooled spleen cells upon restimulation with fresh 
irradiated F1 (BALB/c x C57BL/6) spleen cells…………………….. 
 
 
 
112 
   
   
 CHAPTER 5………………………………………………………….. 116 
 The role of CD8 T cells in promoting the differentiation of naive CD4 
T cells towards a Th1 (IFN-γ) mode and the concomitant inhibition of 
the CD4 Th2 (IL-4) subset……………………………………………. 
 
 
116 
 xi 
   
 Preamble……………………………………………………………… 116 
   
5.1 CD8 T cells regulate the differentiation of the CD4 T cell to either a 
Th1(IFN-γ) or a mixed Th1/Th2 (IFN-γ/IL-4) immune response……. 
117 
5.1.1 The absence of CD8 T cells at the initiation of the immune response to 
allo-MHC results in the CD4 T cells displaying a Th2 (IL-4) phenotype  
(Indirect Approach)……………………………………………………	
 
 
117 
5.1.2 The reconstruction of the CD4:CD8 T cell ratio in CD8 T cell depleted 
cultures with sorted unprimed CD8 T cells switches the immune 
response from a Th2 to a Th1 mode in C57BL/6 mice or to a mixed 
Th1/Th2 phenotype in BALB/c mice 
(Direct Approach)…………………………………………………….	
 
 
 
 
128 
5.1.3 The reconstruction of the CD4:CD8 T cell ratio in CD8 T cell depleted 
cultures with sorted unprimed CD8 T cells switches the CD4 Th2    
(IL-4) immune response to a mixed Th1(IFN-γ)/Th2(IL-4) phenotype.. 
 
 
133 
   
 CHAPTER 6………………………………………………………….. 136 
 Revisiting the mechanism by which CD8 T cells exert their regulatory 
role on the differentiation of naïve CD4 T cells by employing the 
transwell membrane plate……………………………………………. 
 
 
136 
   
 Preamble……………………………………………………………… 136 
   
6.1 The effect of the addition of IFN-γ on the production of cytokines by 
CD8 T cell depleted cultures…………………………………………. 
 
137 
6.2 The effect of the CD4 and CD8 T cells in control cultures in switching 
the CD4 Th2 (IL-4) immune response to a mixed Th1 (IFN-γ)/Th2  
(IL-4) immune response in CD8 T cell depleted cultures……………. 
 
 
141 
6.3 CD8 T cells require CD4 T cell help to differentiate into IFN-γ 
producing Effector cells……………………………………………… 
 
144 
 xii 
6.4 Effector CD8 T cells switch the CD4 Th2 (IL-4) immune response to 
a mixed Th1(IFN-γ)/Th2 (IL-4) immune response…………………… 
 
147 
6.5 Identification of IFN-γ as an essential factor produced by CD8 T cells 
that is required to switch a predominant Th2 (IL-4) response to a Th1 
(IFN-γ) immune response……………………………………………. 
 
 
150 
   
 CHAPTER 7………………………………………………………….. 153 
 DISCUSSION………………………………………………………… 153 
 Preamble……………………………………………………………… 153 
   
7.1 The relationship between the CD4:CD8 T cell ratio of spleens of 
various mouse strains and the tendency of CD4 T cells to differentiate 
to either a Th1 (IFN-γ) or a Th2 (IL-4) subset in response to allo-MHC 
 
 
154 
7.2 The role of CD8 T cells in promoting the differentiation of naive CD4 
T cells to a Th1 (IFN-γ) subset and the concomitant inhibition of a 
CD4 Th2 (IL-4) antibody response…………………………………… 
 
 
159 
7.3 The mechanism by which the CD8 T cells promotes the differentiation 
of the CD4 T cell into a Th1 (IFN-γ) phenotype and suppresses a Th2 
(IL-4) immune response against allo-MHC…………………………… 
 
 
161 
7.4 Implications for Transplantation Immunity: Graft Rejection or 
Antibody-Mediated Autoimmune Diseases…………………………... 
 
164 
7.5 Conclusion……………………………………………………………. 165 
   
 CHAPTER 8………………………………………………………….. 167 
 REFERENCES……………………………………………………….. 167 
 
   xiii 
LIST OF FIGURES 
                                    Page 
Figure 2.1 A Three-Cell Model of Antigen Specific Regulation of Immune 
Responses to Alloantigens by CD8 T cells…………………… 
 
71 
   
Figure 4.1 Characterization of the CD4 T cell and the CD8 T cell 
percentages of the spleens of unprimed, adult BALB/c and 
C57BL/6 mice………………………………………………… 
 
 
84 
   
Figure 4.2 Significant difference between the naturally occurring 
CD4:CD8 T cell ratio among spleen cells of adult BALB/c and 
C57BL/6 mice………………………………………………… 
 
 
86 
   
Figure 4.3 The CD4:CD8 T cell ratio are similar among the spleen cells 
and the cells of the inguinal lymph nodes …………………….. 
 
88 
   
Figure 4.4 Expansion of CD4 T cells and CD8 T cells of the spleens of 
adult BALB/c and C57BL/6 mice upon allo-MHC stimulation 
assessed at day 5 of culture…………………………………. 
 
 
90 
   
Figure 4.5 Significant difference in the CD4:CD8 T cell ratio of the spleen 
cells of the adult BALB/c and C57BL/6 mice assessed at day 5 
of culture……………………………………………………… 
 
 
92 
   
Figure 4.6 The IFN-γ and IL-4 production of the Effector T cells of 
spleens of adult BALB/c and C57BL/6 mice assessed at day 5 
of culture…………………………………………………….. 
 
 
95 
   
Figure 4.7 Significant difference between the ratio of IFN-γ:IL-4 
producing cells of spleens of adult BALB/c and C57BL/6 
mice………………………………………………………….. 
 
 
97 
 xiv 
   
Figure 4.8 Variations in the CD4:CD8 T cell ratio of the spleens of 
individual, adult CBA/J, C3H, DBA/2 and DBA/1 mice……… 
 
99 
   
Figure 4.9 Comparison of the naturally occurring CD4:CD8 T cell ratios 
of different strains of mice…………………………………... 
 
100 
   
Figure 4.10 The IFN-γ and IL-4 production of the Effector T cells of 
spleens of individual, adult CBA/J, C3H, DBA/2 and DBA/1 
mice were assessed at day 5 of culture………………………. 
 
 
101 
   
Figure 4.11 Comparison of the ratio of IFN-γ:IL-4 producing cells in 
different strains of mice………………………………………. 
 
105 
   
Figure 4.12 Characterization of the phenotype of Effector T cells of 
BALB/c mice producing IFN-γ and IL-4 cytokines: IL-4 is 
produced exclusively by CD4 T cells……………………….. 
 
 
107 
   
Figure 4.13 The production of IFN-γ and IL-4 in response to allo-MHC 
stimulation is antigen-dependent and antigen-specific……… 
 
110 
   
Figure 4.14 No difference in the percentages of CD4 T cells and CD8 T 
cells of individual spleens and pooled spleen cells of BALB/c 
and C57BL/6 mice…………………………………………… 
 
 
113 
   
Figure 4.15 The production of IFN-γ and IL-4 by the cells of individual 
spleens of BALB/c and C57BL/6 mice is equivalent to the    
IFN-γ and IL-4 production of pooled spleen cells at day 5 of 
culture upon restimulation with F1 (BALB/c x C57BL/6) 
spleen cells …………………………………………………… 
 
 
 
 
114 
   
 xv 
Figure 5.1 CD8 T cells regulate the immune response of the spleen cells 
of BALB/c mice away from a Th2 mode towards a mixed 
Th1/Th2 mode……………………………………………….. 
 
 
119 
   
Figure 5.2 CD8 T cells regulate the immune response of the spleen cells 
of C57BL/6 mice towards a Th1 mode………………………. 
 
121 
   
Figure 5.3 Significant difference in the ratio of IFN-γ:IL-4 producing 
spleen cells in the control cultures and the CD8 T cell depleted 
cultures of BALB/c and C57BL/6 mice………………………. 
 
 
123 
   
Figure 5.4 CD8 T cells regulate the immune response towards a Th1 mode 
and away from a Th2 phenotype in the CBA/J, C3H, DBA/2 
and DBA/1 strains of mice…………………………………… 
 
 
124 
   
Figure 5.5 The production of IFN-γ and IL-4 by Effector T cells in CD8 T 
cell depleted cultures is alloantigen-dependent and alloantigen-
specific………………………………………………………. 
 
 
126 
   
Figure 5.6 The presence of CD8 T cells results in a switch from a Th2 to 
a mixed Th1/Th2 immune response in reconstructed CD8 T cell 
depleted cultures of the BALB/c mice………………………… 
 
 
129 
   
Figure 5.7 The presence of CD8 T cells results in a switch from a Th2 to 
a Th1 immune response in reconstructed CD8 T cell depleted 
cultures of the C57BL/6 mice………………………………… 
 
 
131 
   
Figure 5.8 The presence of CD8 T cells switches the CD4 Th2 (IL-4) 
response to a mixed Th1 (IFN-γ)/Th2 (IL-4) immune response 
in reconstructed CD8 T cell depleted cultures in BALB/c 
mice…………………………………………………………… 
 
 
 
134 
 xvi 
   
Figure 5.9 The presence of CD8 T cells switches the CD4 Th2 (IL-4) 
response to a mixed Th1 (IFN-γ)/Th2 (IL-4) in reconstructed 
CD8 T cell depleted cultures in C57BL/6 mice……………… 
 
 
135 
   
Figure 6.1 IFN-γ switches the CD4 Th2 (IL-4) immune response to a Th1 
(IFN-γ) immune response in CD8 T cell depleted cultures…… 
 
139 
   
Figure 6.2 The effect of the control culture in switching the CD4 Th2    
(IL-4) immune response to a mixed Th1(IFN-γ)/Th2(IL-4) 
immune response in CD8 T cell depleted cultures…………… 
 
 
142 
   
Figure 6.3 CD8 T cells require CD4 T cell help in order to produce IFN-γ 
upon stimulation with allo-MHC……………………………… 
 
145 
   
Figure 6.4 Effector CD8 T cells switch the CD4 Th2 immune response to 
a Th1 immune response in an antigen specific manner……… 
 
148 
   
Figure 6.5 Effector CD8 T cells switch CD4 Th2 (IL-4) immune response 
to a Th1 (IFN-γ) phenotype by producing IFN-γ ……………… 
 
151 
 
 
 
   xvii 
LIST OF ABBREVIATIONS 
 
AFC    Antibody Forming Cells 
aGVHD    Acute Graft Versus Host Disease 
ALS    Anti-Lymphocytic Serum 
ANOVA   Analysis of Variance 
APCs    Antigen Presenting Cells 
cGVHD    Chronic Graft Versus Host Disease 
BCR     B Cell Receptor 
BMT    Bone Marrow Transplants 
51Cr    Chromium-51 
CTL     Cytotoxic T Lymphocyte 
DAMPs   Danger Associated Molecular Patterns  
DCs    Dendritic Cells 
DRBC    Donkey Red Blood Cells 
ELISPOT    Enzyme-linked Immunospot Assay 
FACS     Fluorescence-Activated Cell Sorting 
FasL    Fas Ligand 
FBS     Fetal Bovine Serum 
FITC     Fluorescein Isothiocyanate 
GM-CSF   Granulocyte Macrophage Colony Stimulating Factor 
GVHD    Graft Versus Host Disease 
GVHR    Graft Versus Host Reaction 
HIV    Human Immunodeficiency Virus 
HLA    Human Leukocyte Antigen 
IFN-γ     Interferon Gamma 
Ig     Immunoglobulin 
IL     Interleukin 
JAKs    Janus Kinases 
LASU    Laboratory and Animal Services Unit 
LCMV    Lymphocytic Choriomeningitis Virus 
 xviii 
L major   Leishmania major 
mAB    Monoclonal Antibody 
MACS    Magnetic-Activated Cell Sorting 
MHC     Major Histocompatibility Complex 
MLC    Mixed Lymphocyte Culture 
MLR     Mixed Lymphocyte Reaction 
NO    Nitric Oxide 
PBS     Phosphate-Buffered Saline 
PBS-T    Phosphate-Buffered Saline with Tween 20 
PE     Phycoerythrin 
PFC    Plaque Forming Colonies 
PHA    Phytohemagglutinin 
r    Recombinant  
TCR    T Cell Receptor 
TNF    Tumour Necrosis Factor   
RPMI     Roswell Park Memorial Institute 
SCID    Severe Combined Immunodeficiency 
SD     Standard Deviation 
SLE    Systemic Lupus Erythematosus 
SRBC    Sheep Red Blood Cells 
ssDNA   Single Stranded Deoxyribose Nucleic Acid 
STATs    Signal Transducer and Activator of Transcription 
Th    T helper 
TCR     T cell receptor 
WBI    Whole Body Irradiation 
 
   1 
CHAPTER 1 
INTRODUCTION 
1.1 The foundations of Immunology are anchored in the early research of Allogeneic 
Tissue Transplantation 
At the beginning of the twentieth century, transplantation surgeons and tumour biologists 
working independently of each other began to lay the foundations of transplantation 
immunology and contributed significantly to immunology. Tumour biologists were 
attempting to understand the pathophysiology of tumours and thus transplanted allogeneic 
tumours into different hosts. E.E. Tyzzer and C.C. Little, two American geneticists, 
reported the reasons for the rejection of the transplanted tumours in 1916. They observed 
that tumours obtained from the Japanese waltzing mice, an inbred mouse strain, were 
accepted by all mice from that strain but regressed in mice from an unrelated strain. This 
observation prompted Tyzzer and Little to explore the role that genetic differences played 
in the regression of the tumour. Extensive research in this field eventually led to one of the 
most significant contributions of transplantation immunology to basic immunology: the 
discovery of the histocompatibility antigens, which were initially referred to as the 
transplantation antigens. Originally the major histocompatibility complex (MHC) locus 
was described in detail in mice as the H-2 locus (Gorer et al., 1948). Shortly after, a similar 
locus was described in humans as the human leukocyte antigens (HLA). In 1980, the Nobel 
Prize in Physiology or Medicine was given to Jean Dausset, George Snell and Baruj 
Benacerraf for their contributions to the discovery of the major histocompatibility system 
(Raju, 1999).  
 
Knowledge of the existence of the MHC led to the discovery of major phenomena central 
to immunity: T cell recognition of MHC; the realisation of the existence of different T cell 
subsets, CD4 and CD8 T cells, recognising distinct MHC antigens; the role of class II MHC 
antigens in the generation of the antibody response originally described as immune 
response (Ir) genes; distinct pathways of antigen processing and presentation by either class 
I and class II MHC molecules and finally to the realisation that immune responses to 
foreign antigens are self MHC restricted. 
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The goal of the transplantation surgeons was to successfully transplant solid organs such 
as the kidney into genetically different recipients. During these early years of attempts at 
transplantation, an explanation as to why autografts were accepted, and allografts were 
rejected was a mystery to transplantation surgeons and tumour biologists alike. Peter 
Medawar, a zoologist at the time, was made aware of a British pilot who had crashed an 
aeroplane near Medawar’s home during the early part of World War II (reviewed in Brent, 
1997). The extensive burns of the pilot awoke in Medawar an appreciation for the potential 
lifesaving effect a successful skin allograft could have on the survival of a burn victim. 
This is particularly pertinent, as some burn victims may not necessarily have sufficient 
healthy skin available to undertake an autologous skin graft. Thus, began his interest in 
trying to understand the mechanisms behind the rejection of a skin allograft. Subsequently, 
his work on skin allografts in rabbits provided evidence of the immunologic nature of the 
rejection of allografts. Continued research into skin allografts by Medawar and his student   
Mitchison in 1953, demonstrated that immunity to tumour and skin allografts were 
transferrable. The idea that immunity could be transferred increased the knowledge of the 
cellular arm of the immune system and the critical role played by lymphocytes in immunity. 
 
The concept of immunological tolerance made its appearance through the observations of 
R.D. Owen in 1945. He demonstrated that cattle dizygotic twins possessed both their own 
red blood cells and that of their twin. The cattle shared the same placenta allowing for the 
exchange of blood resulting in cellular chimerism. As a result, the cattle twins remained 
tolerant of each other’s cells throughout their lives. A chance meeting between Medawar 
and H. P Donald, who was Director of the Agriculture Research Council’s Animal 
Breeding and Genetics Research Organisation in Edinburgh, expanded of the concept of 
immunological tolerance. Donald had hoped to find a means to distinguish between 
monozygotic and dizygotic twins in cattle. Collaboration between Medawar and Donald 
led to a series of experimental skin grafts in cattle. Medawar hypothesised that if the cattle 
accepted the skin grafts from their twins they would be monozygotic while those that 
rejected the skin grafts from their twins would be dizygotic. The dizygotic twins however, 
were shown to accept each other’s skin grafts initially despite their genetic differences but 
eventually rejected them over time. In contrast, the dizygotic twins rejected skin grafts 
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rapidly from parents and from siblings from a separate birth. Thus, the earlier findings of 
Owen (1945) and the findings of Medawar contributed to the recognition of the concept of 
immunologic tolerance.  
 
Immunological reactivity of cells was found under a variety of experimental conditions. 
One such experiment was the inoculation of allogeneic lymphoid cells onto the 
chorioallantoic membranes of chick embryos. The unfortunate outcome of these 
experiments was the development of a graft versus host disease (GVHD), which occurs 
when the host cells inoculated into an immunocompromised recipient, mounts an immune 
response against the cells of the recipient. Burnet observed in 1959 that during a graft 
versus host reaction (GVHR) the proliferating cells tended to group together. This 
observation initiated his clonal selection theory, which has stood the test of time. This 
theory states that a single B cell specific for an antigen will proliferate and produce 
antibody exhibiting the same specificity. However, credit should be given to David 
Talmage who first reported on the specificity of antibodies (Talmage, 1957). Nossal and 
Lederberg successfully proved that the antibodies were specific in their action in 1958, 
which was eventually shown to be applicable to the T lymphocytes. 
 
A selection of the phenomena mentioned above will be discussed in greater detail below. 
 
1.2 Allograft rejection 
1.2.1 Historical Perspectives 
During the early years of the twentieth century transplantation was not as rigorously 
controlled as it is today. Numerous attempts were made to transplant a variety of organs 
and tissues some of which included spurs of young cocks and even a human tooth (Brent, 
1997). Some researchers reported that their transplants were successful although no 
distinction was made between the different types of grafts undertaken. In addition, the use 
of inbred strains of mice had not yet made its appearance with the exception of the Japanese 
waltzing mice (Gates, 1925).  
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Grafts are classified as follows: autografts, are grafts transplanted into the same individual, 
such as a skin autograft from an unharmed portion of a burn victim’s body to a burnt area 
of the same individual; allografts refer to grafts between different individuals of the same 
species while syngeneic grafts refer to grafts between animals of an inbred strain and of 
the same sex.  
 
In 1908, Alexis Carrel, (reviewed in Brent, 1997) a surgeon, who had a keen interest in the 
transplantation of kidneys into dogs and cats, observed that autografts survived while the 
allografts invariably failed. He was highly perplexed by the short survival of the allografts. 
He believed that the recipients were responding to the donor organ and surmised that the 
use of sibling dogs and cats may prove successful. He, however, obtained results similar to 
his previous experiments.  
 
At the time that normal tissue transplants were undertaken, tumour biologists were also 
performing tumour transplants in the hope of finding a cure for cancer. There are numerous 
tumour biologists that have contributed to this body of work. However, I wish to discuss 
the significant contributions made by J.B. Murphy at the Rockefeller Institute, New York. 
Murphy’s initial attempts at the transfer of adult chicken tumours into different adult 
chicken hosts were not successful. However, he demonstrated in a series of experiments 
that rat tumours that were inoculated into chick embryos before day eight of incubation 
could establish themselves unhindered up until day eighteen. Interestingly, the rat tumours 
that were transplanted at day 15, began to regress between days 19 and 21 of development, 
which coincided with the development of the spleen (Murphy, 1913 and 1914a). In 
contrast, rat tumours that were inoculated into chicken embryos together with either the 
spleen or bone marrow of adult chickens at day 7 of embryogenesis regressed soon after 
inoculation. An influx of lymphocytes was observed around the tumour. Notably the 
chicken spleens rather than the bone marrow elicited a more rapid destruction of the rat 
tumours. Murphy surmised that the spleen and bone marrow of the adult chickens provided 
some form of defense against the rat tumour that was similar to that observed in the adult 
chickens inoculated with rat tumours (Murphy, 1914b). The finding that the spleen played 
a role in the regression of the tumours was augmented by the findings of Apolant (Brent, 
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1997) who showed that the life span of transplantable tumours increased if the spleen of 
the recipient was removed.   
 
Murphy drew a general conclusion that the rejection or failure of the growth of the tumour 
allograft coincided with an increase in lymphocytes into the tumour area. He, however, did 
not conclude definitively that the lymphoid cells were the cause of the destruction of the 
rat tumour. Despite the lack of conviction on the role of the lymphocytes in tumour 
regression, the author wanted to determine what effect the removal of the lymphoid cells 
would have on the growth of the transplanted tumour (Murphy and Taylor, 1918). The 
authors subjected immunized ‘white’ mice to different doses of x-rays, which is known to 
reduce the number of circulating lymphocytes (Murphy and Norton, 1915). Briefly, mice 
were first immunized with allogeneic defibrinated blood beneath the skin. Ten days later 
both the immunized group of mice and a non-immunized group were inoculated with a 
mouse tumour from the same species as the donor of the defibrinated blood. Three weeks 
thereafter, they noticed that the transplanted tumours in 80% of the immunized mice had 
regressed while 90% of the non-immunized group developed tumours. These findings 
suggested that previous immunization provided immunity against a subsequent inoculation 
from the original donor.  The mice in which the tumours had regressed were further divided 
into two groups, one receiving x-rays for seven days and a control group that did not receive 
x-rays. Both groups were again inoculated with the tumour. Tumours developed in mice 
that received x-rays. Murphy and Taylor thus, had demonstrated that the induced resistance 
to tumours could be ablated by the use of x-rays. These findings highlighted the importance 
of the lymphocytes in resisting tumour growth by depleting them using x-rays. Despite the 
thought-provoking findings of Murphy, his work remained largely unappreciated until the 
1950’s. 
 
1.2.2 Immunological basis of allograft rejection 
A brief note on why Medawar became involved in skin transplantation was given in 1.1 of 
the introduction. Collaboration between Gibson and Medawar resulted in what is 
considered today to be the first scientific report on human skin allografts (Gibson and 
Medawar, 1943). A series of skin grafts were undertaken on a burn victim using both 
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autografts, and allografts obtained from the patient’s brother. Gibson did the surgeries 
while Medawar provided a histological description of the autografts and allografts over a 
period of 36 days after which the patient was discharged. The autografts were fully 
accepted with the innervation of blood and lymphatic vessels into the graft evident by day 
four. In contrast, the allografts that initially displayed epidermal outgrowths eventually 
showed signs of breakdown by day 15 and were completely rejected by day 23. In addition, 
the authors transplanted a second set of allografts, obtained from the brother, 15 days after 
the first allograft transplant. Notably the rejection of the second set allografts was more 
rapid than the first and did not display any epidermal outgrowths. This was a significant 
finding and illustrated one of the signatures of adaptive immunity, namely memory.  
 
Subsequently, these findings were reproduced in outbred rabbits (Medawar, 1944). 
Medawar observed in rabbit skin autografts that although vascularization was accompanied 
by mild inflammation the grafts were always accepted. In contrast, he found that most of 
the rabbit skin allografts were rejected. A considerable influx of recipient lymphocytes and 
monocytes into the graft area was accompanied by intense inflammation. The rejection of 
the graft was usually complete within four days post transplantation. Medawar therefore 
concluded that rabbit skin allografts could not be successfully achieved. The influx of 
lymphocytes into the graft area was consistent with the earlier findings of Murphy 
(Murphy, 1914a and b). In these experiments Medawar’s meticulous recording provided 
the first evidence of the ‘mean survival times’ of allografts, which refers to the period 
between the transplantation of the allograft to its complete destruction. The first set 
allografts had a mean survival time of 10 days while the second set allografts survived for 
only 6 days. Furthermore, the vigour with which the second set allografts were rejected 
was not observed when a second set allograft from a different donor was transplanted. This 
provided evidence for the specificity of allograft rejection. Notably, Medawar found that 
differences in sex had no significant effect on the survival times of the allografts. He did, 
however conclude that several differences in antigens between the recipient and the donor 
played a role in the rejection of the skin transplants in the rabbits. Medawar believed at the 
time that rejection of an allograft was due to an actively acquired immunity in which 
antibodies were the sole mediators of rejection. Notwithstanding, this partially correct 
 7 
conclusion, it is now recognised that Medawar has made a significant contribution to 
understanding the immunologic basis for allograft rejection. 
  
1.2.3 Linkage between allograft rejection and T cells 
1.2.3.1 A historical perspective of the humoral and cell-mediated immune responses 
To understand the controversy behind the humoral and cell-mediated immune responses, 
one needs to look at how researchers were influenced by the scientific concepts that were 
in vogue at the time. Eli Metchnikoff, led the charge for a cell as opposed to an antibody 
as the protector against pathogens. During his studies in 1884, on the digestive function of 
simple organisms he observed that amoeboid cells within these organisms engulfed foreign 
organisms using pseudopodia (Metchnikoff, 1905). He referred to these cells as phagocytes 
and questioned whether they also played a role in the protection of more complex 
organisms against pathogens. This led him to undertake experiments with this aim in mind. 
In one such experiment he inserted a thorn into a transparent starfish larva. The thorn was, 
subsequently surrounded by amoeboid cells. Consequently, he proposed his phagocytic 
theory, which suggested that phagocytes were important in the defense of an organism. 
This theory proved to be a catalyst for great objection by the humoralists who believed at 
the time that antibodies within the blood were the only means of defense against pathogens. 
They believed that leukocytes were only important for assisting in the circulation of 
bacteria around the body rather than playing any role in defense. In order to determine if 
phagocytes did indeed provide a defense mechanism against pathogens Metchnikoff turned 
to experiments with the water flea. The phagocytes proved essential for the survival of the 
water flea during feeding. They engulfed ingested spores that had pointed ends which could 
have ruptured the digestive tract causing water to enter. This would have resulted in the 
water flea bursting. This provided evidence of a non-specific defense mechanism for 
phagocytes. Thereafter, Metchnikoff wanted to determine if the phagocytes were important 
for actively acquired immunity. Robert Koch had earlier determined that the anthrax 
bacillus was responsible for anthrax. Metchnikoff vaccinated a group of rabbits against the 
anthrax bacillus. Thereafter he infected vaccinated and naïve rabbits. He reported the 
presence of the bacillus in the phagocytes in vaccinated animals while in the naïve rabbits 
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the bacillus remained in the fluid. He thus concluded that acquired immunity to anthrax 
was due to the phagocytes ingesting the bacteria. 
 
The humoralists believed that humoral factors were the mediators of the immune response. 
This viewpoint stemmed from the centuries old belief by the Greeks who associated disease 
with changes in the four humours, namely blood, phlegm, yellow bile and black bile 
(Silverstein, 2003). Based on the findings of Von Behring and Kitasato in 1890, the 
humoralists believed that antitoxins in the serum of immune individuals were the main 
protectors against pathogens. The findings of experiments that were undertaken by Von 
Behring and Kitasato were reported in 1890. They demonstrated that animals could be 
immunized against tetanus toxin. If serum, from an animal that had recovered from the 
infection were inoculated into a non-infected animal, the non-infected animal would 
become resistant to a subsequent tetanus toxin exposure. The antitoxins, as they were 
referred to then, neutralized the tetanus toxins. Further studies by these authors using 
immune serum in children, stricken with diphtheria also proved successful. These findings 
constituted a large body of research citing antibodies as the only means by which acquired 
immunity was expressed.  
 
Notably at the time, researchers who accepted the cell-mediated hypothesis used anthrax 
bacillus that was effectively cleared by the phagocytic cells. In contrast, the humoralists 
used serum which was successful in removing bacterial toxins. This clearly suggested that 
both the humoral and cell mediated responses could be important in mediating active 
immunity. However, it appeared inconceivable to either group that there may be some form 
of collaboration between the cellular and humoral-mediated immune responses. In 1903, 
Wright and Douglas tried to span the bridge in thinking between the humoral and cell-
mediated response camps. They demonstrated that both antibodies and phagocytes played 
a role in the defense against bacteria. Their findings suggested that bacteria coated with 
serum factors (opsonised) were more effectively phagocytized (Wright and Douglas, 
1903).  
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However, it was at this time that Paul Erlich’s side-chain theory of antibody formation and 
function made its appearance. His findings augmented the argument in favour of the 
humoralists whose ideas proved dominant in the first half of the twentieth century. As a 
result of these two schools of thought it was to be expected that this would also extend to 
the mechanism by which allograft rejection occurred. 
 
1.2.3.2 Humoral versus Cell-Mediated immune responses in allograft rejection 
The tumour biologists in the early twentieth century did not attribute the rejection of 
allografts to antibodies. Their main observation was the influx of lymphocytes at the site 
of the graft. It was the work of Gorer who in 1942, revealed a role for antibodies in the 
destruction of malignant tissue transplants. His efforts were based on the hope of producing 
anticancer sera. He immunised resistant C57 black mice with leukemic cells. Thereafter, 
albino mice who were highly susceptible to the leukemic cells were inoculated with 
leukemic cells suspended in the sera from the immunised C57 black mice. The tumour cells 
were unable to establish themselves in the albino mice. Gorer demonstrated using 
agglutination assays that antibodies in the sera of the C57 black mice bound to the leukemic 
cells and this prevented the tumour cells from establishing themselves in the albino mice. 
Gorer further demonstrated that the protective effect against the leukemic cells was only 
achievable if serum was isolated from a donor that was previously immunized with 
leukemic cells (Gorer, 1942).  
 
Amos and colleagues obtained similar findings in 1954 using normal tissue transplants 
(Amos et al., 1954). Inbred strains of mice received allogeneic skin grafts. After the 
complete regression of the grafts the sera of the mice that had received the allografts were 
tested for the presence of antibodies. With the aid of agglutination assays they observed 
the production of antibodies to both the red blood cells and the leukocytes of the donor 
strain.  
 
While it was evident that antibodies were produced against both malignant and normal 
tissue transplants, the antibodies appeared to have a different effect on transplanted 
tumours and normal tissue transplants. The presence of antibodies against leukemic cells 
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appeared to be directly responsible in preventing the cancer from establishing in the host 
(Gorer, 1942). In contrast, antibody production observed after the transplantation of normal 
tissue did not appear to be associated with allograft rejection. This was reported by 
Medawar in 1948. Medawar demonstrated that adult skin epithelium could grow in serum 
that was not primed to contain antibodies to epithelial cells. He, however, observed that 
the survival of the skin of adult rabbits, placed in serum, which was specifically immunized 
against it, was not compromised. This finding suggested that antibodies in the serum did 
not retard the growth of the epithelium (Medawar, 1948). The finding, however, was not 
profound enough to change the thinking of the humoralists who believed that antibodies 
were important for the destruction of transplanted tissues.   
 
Acknowledgement of the significance of the cell-mediated route of allograft rejection 
originated from the findings of N.A. Mitchison in 1953. Earlier experimental work used 
outbred strains of mice to demonstrate the passive transfer of immunity to tumours. 
Invariably, this led to contradictory results. Mitchison decided to revisit the passive transfer 
of transplantation immunity to a tumour using inbred strains of mice (Mitchison, 1953). 
With his initial experiments he showed that the rejection of a mouse lymphosarcoma 
occurred more rapidly in a non-susceptible mouse, when that mouse was previously 
exposed to the tumour, which it had rejected. This result was also observed in mice that 
were first immunized with tissue from an animal that had been exposed to the tumour. 
Subsequently, when the immunized mice received a tumour from the donor strain it 
rejected it much faster. These findings are consistent with the results Medawar obtained 
with his second set skin allografts, which were rejected faster than the first set allografts 
(Medawar, 1944). In addition, Mitchison observed that the transfer of the draining lymph 
nodes of immunised mice into normal syngeneic mice resulted in a more rapid rejection of 
the tumour. In contrast, the transfer of serum, peritoneal exudate and non-draining lymph 
nodes did not prove successful in increasing the speed at which the tumour was rejected. 
Thus, he concluded that transplantation immunity was transferred more efficiently with 
cells rather than with antibodies in serum. 
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Consequently, in 1953 Billingham, Brent and Medawar wanted to ascertain whether the 
above findings of Mitchison in 1953 also applied to normal tissue transplants. They once 
again used skin allografts and inbred strains of mice. The authors undertook a variety of 
experiments, which allowed them to make a distinction between actively acquired 
immunity and adoptively acquired immunity. In their first set of experiments mice received 
a skin allograft that completely disintegrated by the eleventh day. These mice subsequently 
received a second skin allograft on the opposite side of their bodies. The authors 
demonstrated that the second graft disintegrated faster than the first allograft. The authors 
referred to this type of response as an actively acquired immunity. In the second set of 
experiments, they transferred into a secondary host, various tissues and cells obtained from 
a primary host that had been actively immunized. The primary and secondary hosts were 
always from the same inbred strain. They found that the transfer of only the living draining 
lymph node tissue and to a lesser extent the spleen initiated the rapid disintegration of the 
skin allografts in the secondary host as observed in second set allografts. They referred to 
this type of immunity as being adoptively transferred. The immunity of the primary host 
was maintained for 30 days during which time it could still be transferred and affect a 
response. In contrast, large doses of blood, blood leukocytes and serum were ineffective in 
initiating a secondary response. Thus, the authors reported that the passive transfer of 
antibodies (which would confer passive immunity) was less likely to be associated with 
the rejection of skin allografts. 
 
1.2.4 Link between Immunological Tolerance and Transplantation 
In early studies, Billingham, Brent and Medawar had linked immunological tolerance to 
transplantation. They infected an embryo of a CBA/J mouse with lymphocytes from an 
adult A strain mouse. They did find that early exposure to alloantigens during 
embryogenesis made the offspring of the CBA/J mouse tolerant to a subsequent skin graft 
from an A mouse for the duration of their lives (Billingham, Brent and Medawar, 1953 and 
1954). Thereafter, the tolerant mice were inoculated with serum from an animal immunised 
against A strain antigens in order to determine if antibodies in the serum would result in 
the rejection of allograft. The graft remained intact, demonstrating that the antibodies in 
the serum were ineffective in eliciting graft rejection.  
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Despite these findings there was still no consensus as to whether allograft rejection was 
due to cells or antibodies. It was in these circumstances that Billingham and Brent, in 1954 
decided to further investigate the role of antibodies in allograft rejection in a more rigorous 
manner. In these experiments they tried to determine whether the dose of the serum and 
the mode of transmission of the serum had any effect on the outcome of allograft rejection. 
Secondary hosts were inoculated with serum from primary hosts that were immunized three 
times for maximal response. The serum in some cases was given to the secondary hosts 
before the transplantation of the allografts. These rigorous experiments failed to 
demonstrate a role for antibodies in graft rejection. These findings led them to argue 
strongly in favour of a cell-mediated response against allografts. 
 
It was reported by Gorer in 1942, that leukemic cells in suspension required specific 
antibodies for clearance. It seems that host complement was activated, and the membrane 
attack complex of complement activation lysed the leukemic cells. In contrast, skin 
allografts and solid tumours required the action of lymphoid cells. These types of 
experiments shed light on the role of antibodies and /or cell-mediated immunity against 
allografts. 
 
1.2.5 Major Histocompatibility Locus and Histocompatibility Antigens 
Graft rejection has been shown to occur between individuals that are genetically different. 
Geneticists played a crucial role in determining which antigens present in the allograft were 
responsible for eliciting a humoral and/or a cell-mediated immune response in the recipient, 
which ultimately led to its rejection. Since these antigens were initially associated with the 
rejection of transplants they were referred to as the transplantation antigens. Currently they 
are referred to as the histocompatibility antigens. Below is a description of how the concept 
of histocompatibility antigens evolved. 
 
1.2.5.1 The contributions of the geneticists 
The work of C.C Little and E.E Tyzzer paved the way for the discovery of the genetic 
factors that elicited an immune response to allografts. The authors noted that tumours 
originating in an inbred strain of mice, the Japanese waltzing mouse was accepted in all 
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mice from that strain. However, the same tumour would regress in mice from a different 
strain. In 1916, Tyzzer and Little hypothesised that a ‘large number of independently 
inherited factors’ determined tumour susceptibility. Intrinsic to their analysis was the idea 
that there were multiple histocompatibility loci, which has subsequently been proven. 
Rejection occurred if there are any foreign histocompatibility antigens on the tumour. 
 
In 1953, Snell and colleagues demonstrated that a difference in the H-2 alleles of the donor 
and host was the critical factor that determined susceptibility or resistance to an allogeneic 
tumour. They used 15 mouse strains, some of which were closely related and others that 
were not related. They first demonstrated that all mice from the same strain would accept 
a tumour from a donor of the same strain. The authors further demonstrated that the 
rejection of the tumour was shown to be less vigorous when the mouse strains were closely 
related than when they were distantly related. For example, BALB/c and the DBA/2 mice 
both exhibiting a H-2d haplotype took a much longer time to reject a tumour from the other. 
In contrast, the C57BL/6, H-2b, mice consistently rejected a tumour from the BALB/c,       
H-2d, donor much more vigorously. Billingham, Brent and Medawar, demonstrated in 1953 
the importance of H-2 in skin allograft rejection. Skin grafts between individuals of the 
same mouse strain were accepted while grafts between different strains of mice were 
rejected.  
 
Interest in research into the MHC waned. However, after the discovery of the human MHC, 
referred to as the human leukocyte antigen (HLA) and evidence that the human HLA and 
the mouse MHC were strikingly similar, renewed interest in the MHC was generated. The 
significance of having all the HLA loci matching prior to a transplant have been 
demonstrated with grafts between monozygotic twins that are invariably accepted and 
grafts between unrelated individuals that are generally rejected (Kortholm, 1968).  
 
As the mouse model is being used in this thesis only the H-2 of the mouse will be discussed 
in greater detail. The rejection of a tumour allograft (Snell, 1953) and a normal tissue 
allograft (Billingham, Brent and Medawar, 1953) has been shown to be due to differences 
in MHC antigens between donor and host. The expression of these antigens is controlled 
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by the MHC loci, which map in the H-2K, H-2I, H-2D and H-2L regions of chromosome 
17. The I region is further divided into the I-A and I-E as well as the I-B and I-C regions 
which will not be discussed further. The products of the MHC loci can be identified 
serologically or by T cell reactivity. The H-2K and H-2D are specifically associated with 
acute graft rejection and the cytotoxic activity of T lymphocytes. They are important for 
the expression of MHC Class I molecules. These molecules are expressed on all nucleated 
cells of the body. Variations in the level of antibody production by different strains of mice 
are controlled by the immune response (Ir) loci. The Ir loci are critical for the expression 
of the MHC class II antigens, which are expressed on the antigen presenting cells (Klein, 
1979 and Klein et al., 1981).  
 
The MHC class I molecules are composed of a polymorphic a chain and non-polymorphic 
b2 microglobulin. The MHC class II molecules are composed of a polymorphic a chain 
and a polymorphic b chain. The peptide binding regions of the MHC involve the a1 and 
a2 domains of the class I molecules and the a1 and b1 domains of the class II molecules.  
 
One of the most striking characteristics of the H-2 loci is their genetic polymorphism 
particularly in the peptide binding regions. Several alleles exist at a single H-2 locus within 
a given population (Klein, 1979). One possible explanation for this polymorphism of the 
H-2 loci is to ensure the survival of a species. It is suggested that the polymorphic nature 
of the MHC is essential in order to counteract the evasive techniques of pathogens. The 
polymorphism of the MHC in a population increases the number of antigenic determinants 
against which the immune system can respond. Pathogens must be presented to the T cells 
in order to elicit an immune response against them. The peptide binding site of the MHC 
molecule is specific for particular antigenic determinants of a pathogen. The MHC-peptide 
complex is presented to the T cells in order for an immune response to be generated against 
them. The resulting immune response may lead to the destruction and elimination of the 
pathogen. However, pathogens are able to mutate, thus eliminating the dominant antigenic 
determinants that are recognised by the MHC molecule. Therefore, if all the individuals 
within a species displayed the same MHC binding sites, then only specific antigenic 
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determinants can bind to the MHC molecule. The pathogen would be able to avoid 
detection, which could lead to the demise of that species.  
 
1.2.5.2 Passenger Leukocytes express allo-MHC initiating alloresponses 
Rapid allograft rejection is due to differences in MHC. Several studies were undertaken to 
determine the cells that were expressing the MHC molecules that initiated graft rejection. 
The concept of passenger leukocytes first made its appearance in Snell’s review of 1957.  
Several studies reported a difference in immunogenicity between tissues that were taken 
from rats treated with cortisone and tissues taken from untreated rats when transplanted 
into allogeneic recipients. The cortisone treated tissue was far less immunogenic. It was 
suggested that the cortisone had reduced the number of leukocytes in the donor tissues, 
which implied that leukocytes were important for sensitising the recipient’s T cells.  
 
However, it was ten years later in 1967 that Steinmuller revisited this concept. The author 
found that skin grafts, obtained from mice that were made tolerant to allogeneic spleen 
cells, could immunize syngeneic recipients, allowing for a second set rejection of an 
allograft. Mice of the A strain were made tolerant by the injection of allogeneic spleens 
cells, (A x C3H) within 24 hours of birth. The authors believed the mice to be leukocyte 
chimaeras. The inoculation of the F1 cells into the neonatal mice reduced the risk of GVHD 
in the neonatal mice. Two months later the tolerized mice received a skin allograft from a 
C3H strain and syngeneic skin graft from an A strain on either side of the abdomen. Both 
grafts were fully accepted. The C3H and the A strain grafts were removed and transferred 
separately to non-tolerant A strain mice. The C3H skin allograft was destroyed within 15 
days whereas, the A skin syngeneic graft was accepted. Both groups of mice then received 
a C3H skin allograft. As was expected the A strain group that had initially rejected the first 
C3H skin allograft rejected the second skin allograft more rapidly that the first transplant. 
However, the A strain that had received the isograft from the tolerant mice also rejected 
the C3H allograft with the same vigour as those that had received the second C3H skin 
allograft. This finding suggested to the author that the allogeneic cells in the tolerant A 
strain mice were transferred with the isografts in sufficient numbers to generate an immune 
response. A control group of A strain mice that received only one C3H allograft rejected 
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the graft much slower. These findings are consistent with the findings of Medawar who 
reported in 1944 that second set rejections occurred much faster than first set rejections. 
Steimuller surmised that since the neonatal mice were leukocyte chimaeras, the leukocytes 
from the original donor strain had migrated into the skin and had initiated an immune 
response in the syngeneic recipients.  
 
In 1968, the work of Elkins and Guttmann contributed to the concept of the passenger 
leukocyte. Parental rat kidneys were transplanted into F1 hybrids that were tolerant to the 
parental kidneys. However, when parental lymphocytes were inoculated under the kidney 
capsule the destructive lesions of the kidney were observed. This was characteristic of a 
graft versus host reaction, which is discussed in greater detail in 1.3 of the introduction. 
However, when the recipient of the kidney had been irradiated prior to receiving the 
allogeneic kidney, the severity of the destructive lesions correlated with the dose of 
irradiation. The authors surmised that the circulating host leukocytes activated the donor 
spleen cells, which resulted in non-specific damage of the kidney parenchyma. When the 
host was irradiated prior to receiving an allogeneic kidney their leukocytes were destroyed 
and no longer provided the stimulus for the donor lymphocytes. The authors thus concluded 
that the circulating host leukocytes could provide the stimulus to activate the donor cells 
either in the donor organ or in the regional lymph nodes. They further suggested that 
removal of such leukocytes by irradiation could prove advantageous for transplantations.  
 
Lafferty and colleagues expanded upon the concept of passenger leukocytes in 1975. They 
proposed that H-2 antigens expressed on the surface of cells are not strongly immunogenic 
on their own and additional stimuli are required from metabolically active and 
immunocompetent cells. In order to test their hypothesis, they cultured mouse thyroid lobes 
in medium for 12 days. Thereafter, the lobes were transplanted under the kidney capsule 
of allogeneic recipients in which the thyroid had been removed. Even though the thyroid 
cells of the donor expressed different H-2 antigens, the thyroid thrived in the recipient 
suggesting that parking the allograft in medium for a few days removes the metabolically 
active and immunocompetent cells that provided other stimuli required for activation.  
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Once it was determined that leukocytes expressing MHC antigens elicited an immune 
response, several studies were undertaken to search for the specific leukocyte expressing 
the MHC antigens. Lechler and Batchelor demonstrated using in vivo experiments that the 
dendritic cells of the donor expressed MHC molecules, which provided the trigger for 
allograft rejection (Lechler and Batchelor, 1982). Kidneys from F1 rats (As x Aug) that 
survived for a long period in the primary As host were transplanted into secondary As rat 
hosts. They continued to thrive in their secondary hosts. All nucleated cells express MHC 
class I molecules on their surfaces. Thus, the kidney cells with their MHC molecules should 
have elicited an immune response. The authors surmised that the cells that expressed both 
the incompatible MHC molecules and other stimulatory signals were absent reducing 
immunogenicity. In order to rescue the immune response, the authors inoculated small 
numbers of dendritic cells obtained from the donor at the time of retransplantation. The 
kidney allografts were subsequently rejected. This finding suggested that the dendritic cells 
expressed incompatible MHC molecules and other costimulatory signals, which led to the 
activation of the T cells.  
 
1.2.5.3 T cells recognising MHC alloantigens 
Although research had discovered the MHC antigens that elicited a rejection of a 
transplanted tumour or normal tissue transplants, the cells that were responding to these 
antigens had not yet being discovered. The importance of T lymphocytes in the production 
of antibodies and the killing of target cells was initiated with the work of Gowans in 1962. 
Following the discovery of the MHC antigens a series of experiments provided evidence 
that these transplantation antigens, served an additional role other than determining 
susceptibility or resistance to tumour and tissue transplants. Thus, follows below a 
discussion on the work of numerous researchers who demonstrated the association of T 
cell responses to MHC antigens in general and the recognition of different classes of MHC 
by two different subsets of T cells namely the CD4 and CD8 T cells. 
 
Experiments undertaken by Kindred and Shreffler, tested the putative link between 
antibody production and H-2 antigens (Kindred and Shreffler, 1972). Their approach was 
to determine if the immune response to sheep red blood cells (SRBC) in nude mice could 
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be rescued by the inoculation of H-2 compatible thymus cells. Nude mice at the time had 
an H-2d haplotype with a mutation at the Foxn1 gene which results in a genetic defect that 
prevents the development of a mature thymus. The lack of a functioning thymus, the site 
of T lymphocyte maturation (Miller, 1961), prevents these mice from mounting an immune 
response against foreign antigens. Furthermore, both thymus-derived and bone marrow-
derived lymphocytes were known to be required for antibody production (Claman, 1966, 
Miller and Mitchell, 1968). Kindred and Shreffler backcrossed nude mice with BALB/c 
mice which have a H-2d haplotype resulting in them displaying between 70 and 90% of the 
genes of the BALB/c strain. A suspension of 4 x 107 thymus cells was inoculated into the 
nude mice. There were three sets of donors of the thymus cells: the first set displayed an 
H-2d haplotype and was derived from the BALB/c, DBA/2, and BALB/c x DBA/2 strains.  
The C57BL strain displaying an H-2b haplotype and the CBA mice exhibiting a H-2k 
haplotype were the other two thymus cell donors. After inoculation with the thymus cells 
the authors used haemagglutination assays to test the ability of the nude mice to produce 
antibodies against SRBC. The nude mice that had received thymus cells from the BALB/c, 
DBA/2 and the BALB/c x DBA/2 were able to produce antibodies against the SRBC. 
However, the mice that received thymus cells from the C57BL and CBA mice were unable 
to generate anti-SRBC antibodies. These findings demonstrated that H-2 compatibility was 
needed for thymocytes to rescue the immune response to SRBC in nude mice. Antibody 
production by the nude mice required that the H-2d antigens recognised by the T cells were 
also expressed by the B cells. Thus, Kindred and Shreffler provided the first evidence of 
MHC restriction in B-T cell cooperation in 1972. 
 
The findings reported by Kindred and Shreffler in 1972 demonstrated that antibody 
production required that the B cells express the same MHC molecules that T cells recognise 
as foreign. Work undertaken by Shearer in 1974 as well as the work of Zinkernagel and 
Doherty in 1974 provided evidence that the recognition of antigen by CTL, that we now 
know to be largely CD8 T cells, are restricted to a particular allele of MHC. Shearer 
cultured mouse spleen cells with trinitrophenyl-modified syngeneic spleen cells. Cytotoxic 
T cell activity was observed only against the trinitrophenyl-modified target cells and not 
against unmodified cells (Shearer, 1974). Zinkernagel and Doherty observed that cytotoxic 
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T cell activity against virus infected fibroblasts were MHC restricted (Zinkernagel and 
Doherty, 1974). Soon after Miller and colleagues demonstrated in 1975 that CD4 T cells 
that were responsible for antibody production and delayed-type hypersensitivity, 
responded to antigen in association with MHC class II encoded I-A and I-E gene products 
(Miller et al., 1975). However, the interaction between the T cell and the MHC-peptide 
complex was insufficient to activate the cells and required a second signal, as proposed by 
Lafferty and Cunningham in 1975. The second signal was later discovered to be the 
interaction between various costimulatory molecules.  
 
1.2.5.4 Activation of CD4 T cells and CD8 T cells in response to allo-MHC: direct and 
indirect allorecognition 
Nevertheless, there were instances when, despite the absence of passenger leukocytes, 
allografts were rejected. Thus, in 1982, Lechler and Batchelor proposed two distinct 
pathways for the activation of the T cells upon stimulation with allo-MHC, which did not 
necessarily occur independent of each other. The direct pathway occurred when the 
recipient’s T cells recognized the intact MHC on the surface of the donor antigen 
presenting cells (APCs). There is no need for antigen processing and presentation by the 
host’s APCs during this pathway. In contrast, the indirect pathway involved the processing 
and presentation of the alloantigens by the host’s own APCs. It has been suggested that 
acute allorejection is due to the direct pathway (Lechler and Batchelor, 1982).  
 
The robust response elicited by direct allo-recognition has been attributed to a high 
frequency of T cells specific for allo-MHC. The frequency of T cells specific for 
alloantigens, which is approximately 1 in 102, has been shown to be much higher than the 
frequency of T cells specific for a typical foreign antigen, which is of the order of 1 in 105 
(Wilson, 1968). T cell activation is generally self-MHC restricted (Zinkernagel and 
Doherty, 1974). The T cell receptor (TCR) genes that encode the TCR that recognises 
MHC-peptide complex, involves random events resulting in an extensive range of 
specificities. Consequently, this results in a low frequency of T cells recognising a foreign 
peptide in the context of a given self-MHC. A model for the high frequency of T cells 
specific for allo-MHC and the way in which self-restricted T cells recognise allo-MHC-
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peptide complexes have been described by Matzinger and Bevan in 1977. 
 
It is suggested that the self-MHC and allo-MHC have specific structural similarities. T cells 
are positively selected in thymus based on their ability to recognise self-MHC. Therefore, 
self-restricted T cells, which have an inherent ability to recognise MHC molecules 
recognise allo-MHC in the same way they would recognise self-MHC. Thus, donor APCs 
express allo-MHC with a large variety of peptides to the T cells of the recipient. The 
peptides may have originated from proteins similar between for example different strains 
of mice. However, the interaction of these peptides with the allo-MHC appear foreign to 
the TCR of the recipient. Thus, T cells with different specificities would recognise the 
many different allo-MHC-peptide complexes eliciting a robust immune response.  
 
The significance of the peptide in the context of MHC in eliciting a robust T cell immune 
response was reported by Heath and colleagues in 1991. The authors used a mutant T cell 
line, T2Kb, that expressed MHC class I molecules on the surface of cells, which were 
devoid of peptides processed endogenously. Alloreactive T cells specific for Kb did not 
display any cytotoxic activity in the 51Cr release assay. However, MHC class I molecules 
of the T2Kb cell line were able to bind with peptides that were added to the culture. 
Subsequently cytotoxic activity of the alloreactive T cells specific for Kb was observed. 
This finding suggested that peptide-MHC complex expressed on the surface of the cells 
were important for activation of T cells (Heath et al., 1991). 
 
1.3 Graft versus host reactions and graft versus host disease 
Bone marrow transplants (BMT) have proven to be beneficial in the treatment of 
haematological malignancies and more recently in the treatment of autoimmune diseases 
such as scleroderma (Sullivan et al., 2016). However, BMT are not without associated 
risks. Graft versus host disease (GVHD) occurs in 30-65% of allogeneic bone marrow 
recipients and is associated with a mortality of approximately 15% (Blazar et al., 2012). A 
GVHR is induced after the transfer of histoincompatible cells of a donor into an 
immunocompromised recipient (Champlin et al., 2000) or a recipient that cannot react to 
the donor cells for genetic reasons (Via et al., 1987). The latter case may occur when 
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parental cells are inoculated into the F1 offspring. The F1 offspring do not recognise the 
parental cells as being foreign (Via et al., 1987). In a GVHR the CD4 T cells and CD8 T 
cells of the donor recognise the genetically different MHC molecules on the recipient’s 
APCs and are activated. Therefore, considerable effort is made to ensure that the recipient 
and the possible donors are screened and matched for HLA to decrease the risk of a GVHR 
after a BMT. In the ideal situation, a bone marrow transplant would occur between HLA 
genetically identical siblings. However, this occurs only in 30% of patients. Most transplant 
recipients receive bone marrow cells from either an HLA matched unrelated donor, a 
haploidentical donor or cord blood unit. The haploidentical donor is a family member with 
6 to 8 HLA matches. The cord blood unit is the blood isolated from the umbilical cord and 
the placenta. However, despite rigorous HLA typing, bone marrow recipients may still 
develop GVHD (Blazar et al., 2013). 
 
A GVHR may progress into either a lethal form known as the acute (a) GVHR or the 
chronic (c) form. These classifications are based on the pathology of the disease. A 
description of aGVHR and cGVHD and the factors determining the disease outcomes 
follow below.  
 
1.3.1 Acute versus chronic graft versus host disease 
1.3.1.1 Acute graft versus host reaction 
In humans, the following clinical features characterize aGVHR: skin rashes, hepatitis and 
jaundice associated with the liver, as well as abdominal pain and diarrhoea (Jacobson and 
Vogelsang, 2007). Numerous mouse models have been utilised to demonstrate GVHD. In 
mice, aGVHR is characterised by cell engraftment of the donor cells, severe depletion of 
the host’s lymphoid cells, in particular B cells, and extreme anemia, which may result in 
rapid death. Thus, aGVHR is often referred to as lethal GVHD (Pals et al., 1982). The 
aGVHR displays a highly inflammatory phenotype that has been likened to a cytokine 
storm (Ferrara et al., 2003). A cytokine storm is the dysregulation of the immune response 
resulting in extensive Th1 mediated cytokine production that causes tissue damage. Ferrara 
suggested that the aGVHR occurs in 3 phases: (1) tissue damage from conditioning, (2) 
donor T-cell activation and (3) inflammatory effectors.  
 22 
Phase I: The first phase of aGVHR is tissue damage. Prior to a patient undergoing a tissue 
transplant, the patient undergoes a conditioning regimen. The conditioning regimen causes 
tissue damage that initiates the inflammatory response. The inflammatory response is 
characterized by the production of tumour necrosis factor (TNF)α, IL-1 and IL-6. The 
effects of the conditioning regimen in initiating the cytokine storm were demonstrated in 
mice (Xun et al., 1994). The authors used a severe combined immunodeficiency (SCID) 
mouse model to demonstrate the detrimental effects of radiation that was part of the 
conditioning regimen. The group of mice that underwent this regimen had increased levels 
of TNFα, IL-1 and IL-6 in their serum and colon compared to the group did not receive 
radiation. The authors surmised that the presence of cytokines was due to the release of 
danger associated molecular patterns (DAMPS) by cells during radiation that activated 
antigen-presenting cells (APC’s) such as the dendritic cells (DCs) of the recipient. The 
TNFα and IL-6 resulted in colon tissue damage. Furthermore, the role of TNF in tissue 
damage was verified with the use of a human TNF receptor that antagonized the binding 
of TNF resulting in reduced tissue damage. In addition, they found that damage to the 
gastrointestinal tract triggered microbial invasion that further stimulated the APCs to 
produce TNFα, IL-1 and IL-6. The increase in TNFα and IL-1 leads to epithelial damage 
while the excessive amounts of IL-6 was associated with liver damage, a feature of 
aGVHR.  
 
Phase II: The second phase of the cytokine storm that leads to aGVHR is the activation of 
donor CD4 and CD8 T cells through the recognition of host MHC molecules. This results 
in further production of cytokines such as interferon gamma (IFN-γ) and IL-2 by the donor 
T cells, which are evidence of a cell-mediated immune response. The increased production 
of IFN-γ has been shown to be an early indicator of aGVHR (Rus et al., 1995).  
 
Phase III: The third phase involves the effects of the cytokines produced. The IFN-γ has 
numerous functions that further enhance the inflammatory response. The lytic activity of 
the CD8 T cells is augmented, which results in the depletion of the host cells. The IFN-γ 
enhances the microbicidal activities of macrophages that are associated with the first step 
as described above. Activated macrophages produce IL-12 that promotes a Th1 
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inflammatory response. Moreover, the IL-3 and GM-CSF produced by the T cells increases 
the macrophages in circulation. The macrophages in turn produce nitric oxide (NO) that 
damages target tissue. Furthermore, the NO inhibits target tissue repair by inhibiting 
proliferation of epithelial stem cells in the gut and skin (Nestel et al., 2000). The array of 
cytokines and their effects eventually leads to tissue damage associated with aGVHR.  
 
1.3.1.2 Chronic graft versus host disease 
In contrast, the clinical features of chronic GVHD in humans include lichenoid-oral or 
vaginal changes, dry eye syndrome, skin-discolouring, scleroderma-like disease, 
bronchiolitis obliterans and esophageal web formation (Lee et al., 2003). The clinical 
features of chronic GVHD abnormalities in mice include persistent lymphoid hyperplasia, 
and hypergammaglobulinaemia (Rolink et al., 1983). The persistent B cell stimulation 
eventually leads to the production of autoantibodies, which may manifest as autoimmune 
diseases such as sclerodermatous or the lupus-like autoantibody mediated disease 
depending on the murine model used (Blazar et al., 2012). The production of IL-4 by the 
alloreactive CD4 T cells which promotes B cell stimulation has been shown to be a 
signature cytokine of the development of cGVHD (Rus et al., 1995). 
 
1.3.2 Experimental avenues leading to the discovery of graft versus host disease 
1.3.2.1 Induction of tolerance to skin allografts 
Murphy’s interest in tumour transplants in chicken embryos provided early evidence of 
GVHD. In his experiments, as described earlier in the introduction, he observed that after 
transplanting the spleen cells of adult chickens onto the chorioallantoic membrane of 
chicken embryos, the spleens of these chicken embryos became enlarged. He further 
noticed the development of nodules on the chorioallantoic membrane. However, he 
suggested that growth factors were responsible for the formation of these nodules. 
 
It was only in 1957 that Simonsen first recorded the enlargement of the spleen in chicken 
embryos as a consequence of a GVHR (Simonsen, 1957). Simonsen inoculated chicken 
embryos with adult spleen cells three days before hatching in the hope of tolerizing the 
chicks to the adult spleen cells. However, soon after hatching the chicks developed severe 
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haemolytic anemia and died. Simonsen believed that the chicks were tolerant to the donor 
cells as there was no evidence of antibodies against the donor cells. Further investigation 
revealed the enlarged spleens of the chicks. He reported that the donor cells had been 
activated by host antigens and proliferated, destroying and replacing the host lymphocyte 
population. He postulated that the recipient had to be young enough to be unable to respond 
to the donor cells and that the donor cells had to be mature enough to form antibodies in 
order for this phenomenon to occur. A cell-mediated immune response by the donor cells 
is currently known as the leading cause for a GVHR. A cell-mediated immune response by 
the donor cells, however, was not considered by Simonsen at the time. 
 
In the same year that Simonsen reported his findings on GVHR in chicken embryos, 
Billingham and Brent reported similar findings using two inbred strains of mice. In his 
attempt to induce tolerance to allogeneic skin grafts he injected immunologically 
competent cells of adult mice into histoincompatible newborn mice. The newborn mice 
developed runt disease and eventually died two to three weeks later. Exfoliation of the skin 
and reduced flexibility were marked features of these mice, with considerable weight loss 
and the eventual enlargement of all lymph nodes as well as the spleen. They further 
observed that the donor cells persisted in the recipient. Notably the runt disease only arose 
with cells from adult spleens and not cells from the kidney or the skin. The fact that only 
spleen cells were effective provided evidence of the role of the lymphocytes on the 
development of runt disease in mice. The authors initially thought that the presence of a 
pathogen in the adult inoculum could have resulted in an infection, which led to death. 
However, they favoured the idea that the immunologically competent cells in the adult 
spleens mounted an immune response against the host’s cells. In fact, they observed that 
the tissues that were most affected during runt disease were those to which the lymphocytes 
migrated. The migration of the lymphocytes through the lymphoid tissue was later 
demonstrated by Gowans and Knight in 1964 as described later in the introduction. 
 
In a paper by Billingham and Brent in 1959, they provided conclusive evidence that runt 
disease in newborn mice was due to a GVHR. They inoculated newborn mice with cells 
from different histoincompatible donors with varying results. Spleen cells from adult F1, 
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(AxB) mice inoculated into parental (A) newborn mice did not result in runt disease. 
However, the inoculation of the spleen cells from the parental strain (A) into F1, (AxB) 
newborn mice induced runt disease. Furthermore, they noted that the inoculation of bone 
marrow, which contains fewer immunologically competent cells than spleen, resulted in a 
less severe form of runt disease in the newborn mice. The authors came to two conclusions: 
the first is that the donor cells that were inoculated were responsible for the runt disease 
that developed in the newborn mice and secondly that there was a dose effect between the 
number of immunologically competent cells and the severity of the disease. 
 
GVHD was not only a phenomenon that occurred in mice and chickens but also in non-
human primates such as the rhesus monkey. In 1961 Crouch and colleagues reported that 
monkeys receiving allogeneic bone marrow with critical contaminating T cells after 
irradiation also developed GVHD. Thus, it was that the phenomenon of GVHR was firmly 
demonstrated in a number of different animal species. Furthermore, this response of the 
donor cells against the host cells eventually leads to GVHD and potentially the death of 
the host. 
 
1.3.2.2 Whole body irradiation and bone marrow transplantations 
As early as 1915 Hektoen noted that with an unknown dose of irradiation, administered 
over several days, rats were unable to produce antibodies to SRBCs (Hektoen, 1915). This 
provided early evidence of the effects of irradiation on the immunological competent cells 
of the body. However, it was much later, after the atom bomb was deployed at the end of 
World War II that active investigation into the effects of radiation on the hematopoietic 
cells was undertaken at the Radiobiological Research Unit of the Atomic Energy Research 
Establishment in Harwell (United Kingdom) and the Radiobiologic Institute in Rijswijk 
(The Netherlands) (Brent, 1997). During these investigations the lethal dose for mice that 
resulted in the destruction of the bone marrow was determined. In order to counteract the 
effects of irradiation they transferred bone marrow from mice that differed at their major 
histocompatibility antigens into the irradiated mice. Although the transplant appeared 
initially to be protective, the mice developed extreme diarrhoea and weight loss and 
eventually died. Since allogeneic bone marrow was used in the transplant, the disease 
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manifestation was referred to as homologous disease. Homologous grafts were originally 
grafts transplanted from one individual to another of the same species. However, the 
homologous graft subsequently became known as the allograft.  
 
The work on GVHD resulting in runt disease in mice, prompted Barnes and Loutit to 
undertake a series of studies, the findings of which were reported in 1958 (Barnes and 
Loutit, 1958). They explored the potential relationship between the runt disease observed 
in neonatal mice and the development of the homologous disease after bone marrow 
transplants in irradiated recipients. The transplanted cells were implicated in the 
development of runt disease. Barnes and colleagues inoculated irradiated adult mice with 
either allogeneic neonatal spleen cells or with adult bone marrow. The mortality rate was 
much higher when adult bone marrow cells were administered. Moreover, they found that 
bone marrow from an F1 into an irradiated parental strain increased the survival rate 
compared to the transfer of bone marrow from the parent into irradiated F1. These findings 
suggested that the inoculated cells were responsible for the development of the homologous 
disease in irradiated recipients as were they in neonatal mice and chicken embryos. 
Therefore, homologous disease was considered to be the same as the runt disease observed 
in mice and the GVHR observed in the chickens.  
 
1.3.3 Factors determining the development of an acute graft versus host reaction and 
a chronic graft versus host disease 
1.3.3.1 Different mouse strain combinations 
In the GVHD murine model, the type of GVHD observed is greatly influenced by the 
combination of donor and recipient mouse strains used in the experiments. The early 
experiments undertaken by Billingham and Brent as reported in 1959, provided evidence 
of this in neonatal mice. They demonstrated that the type of GVHD was dependent on the 
degree of genetic differences between the donor and the recipients mouse strains. They first 
injected newborn mice of strain A (H-2a) with spleen cells from adult C57 mice, (H-2b), 
which were distant relatives of strain A. The newborn mice initially appeared normal but 
soon afterwards developed extreme diarrhoea with the cessation of their growth and died 
within two to three weeks of birth. In contrast, when the newborn mice of strain A were 
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injected with the spleen cells of adult C3H mice, (H-2k), which were more closely related 
to strain A than the C57 mice, the newborn strain A mice survived for more than two 
months. During this time, however, they developed chronic GVHD. The authors suggested 
that the more distantly related the donor and host strains were, the more aggressive the 
response of the donor cells against the host cells.  
 
The effect of the spleen cells of different combinations of mouse strains on the type of 
GVHD elicited, was further demonstrated in adult mice (Pals et al., 1982). A GVHR was 
induced when the spleen cells of adult C57BL/10 mice were injected into non-irradiated 
F1 (C57BL/10 x DBA/2) mice, (H-2b/d). These F1 mice developed a lethal GVHR with a 
rapid decrease in the number of cells in the spleen, lymph nodes and thymus. Extreme 
anemia and excessive weight loss, features of aGVHR, were also evident in these mice. 
However, the mice did not die and two weeks later the lymphoid tissue of the F1 mice 
began to be repopulated by the donor cells. In contrast, the GVHR induced in F1 mice 
following the inoculation of spleen cells from adult DBA/2 mice, (H-2d) was characterized 
by a slight initial cellular reduction followed by increased cell proliferation in the lymphoid 
tissue and specifically in the region in which the B cells were found. As the GVHR 
progressed an increase in B cell numbers correlated with an increase in IgG antibodies to 
nuclear antigens and double stranded DNA (dsDNA), which was absent in the F1 mice 
receiving the spleen cells of C57BL/10 mice. The spleens of the C57BL/10 mice, (H-2b) 
and the DBA/2 mice (H-2d) had an entirely different effect on the F1 recipient mice. It 
appeared that the T lymphocytes of the spleens of C57BL/10 mice were able to induce an 
acute GHVR resulting in the suppression of antibodies while the T lymphocytes in the 
spleens of the DBA/2 mice induced a chronic GVHD when inoculated into the same F1 
mouse strain. The difference in T lymphocytes of these mouse strains is elaborated upon 
below.  
 
1.3.3.2 T helper and T suppressor cells  
From the above discussion it is clear that the T lymphocytes of the C57BL/10 mouse strain 
induce a different disease in the F1 mouse from that of the DBA/2 mouse strain. It was 
known at that time that T lymphocytes were subdivided into T helper (CD4 T cells) and T 
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suppressor cells (CD8 T cells) based on their Ly surface markers (Cantor and Boyse, 1975; 
Cantor et al., 1976). Furthermore, suppressor T cells and helper T cells reciprocally 
regulate the antibody and the cell-mediated immune responses, respectively, which is 
discussed in greater detail below (Ramshaw et al., 1977). Thus, the question arose as to 
whether the T suppressor cells in the C57BL/10 mouse were responsible for the 
development of the aGVHR in the F1 mouse strain while inhibiting the production of 
antibodies (Rolink et al., 1982). In order to explore this question, the authors inoculated 
the spleen cells from C57BL/10 mice into non-irradiated F1, (C57BL/10 x DBA/2) mice. 
the spleen cells of the F1 mice were removed at either day five or six and inoculated into 
non-irradiated secondary F1 recipients. The non-irradiated syngeneic F1 hosts receiving 
the day five T cells displayed a reduced number of cells in their lymphoid tissue, in 
particular, plasma cells and plasma cell precursors, which is a feature of aGVHR. All of 
these mice died within three weeks upon receiving the day five T cells. In contrast, all the 
F1 mice receiving the day six T cells developed cGVHD displaying excessive proliferation 
of their lymphoid tissue, which persisted for three months.  
 
The authors then proceeded to evaluate the antibody promoting ability of the day five and 
day six T cells. Irradiated F1 mice received spleen cells depleted of T cells with varying 
numbers of either day five or day six T cells. Thereafter, they were injected with levan. 
Five days later the spleens of these mice were removed and their ability to generate plaque 
forming colonies (PFC) and antibodies against levan were determined. The spleen cells of 
irradiated syngeneic F1 mice receiving day five T cells were unable to generate PFC or 
mount an antibody response, which was indicated by the inability to produce of IgG 
antibodies. In contrast, the spleen cells of the F1 mice receiving T cells cultured for 6 days 
displayed a considerable increase in IgG antibodies when stimulated with levan. The 
authors concluded that the day five T cells were able to suppress the antibody response and 
were responsible for aGHVR while the day six T cells facilitated the antibody response 
and induced a cGHVD. Thus, day six cells were designated T helper cells that promoted 
cGVHD characterized by the robust antibody response while the day five cells were 
designated T suppressor cells that promoted the aGVHR that was characterized by the lysis 
of host cells and the absence of an antibody response. This is consistent with the findings 
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of Salvin who reported that the immune response to antigens evolves from an initial Th1 
phenotype to a Th2 phenotype (Salvin, 1958).  
 
1.3.3.3 Major Histocompatibility Antigens 
Besides the contribution of the donor CD4 T cells and CD8 T cells in the induction of the 
different types of GVHD, the alloantigens of the host against which the donor T cells 
respond should also be considered. Differences in the MHC molecules between the donor 
and recipient are known triggers for activating the CD4 T and CD8 T cells. In vitro studies 
demonstrated that differences in MHC class II (I-A and /or I-E) antigens activated the 
alloreactive CD4 T cells. Similarly, the alloreactive CD8 T cells were activated by the 
recognition of differences in the MHC class I antigens, (K and D) (Rolink et al., 1983). 
Thus, the expression of the different MHC class I and class II molecules on the cells of the 
host can influence the activation of the alloreactive CD4 and CD8 T cells of the donor. In 
1983, using these findings Rolink and colleagues undertook in vivo experiments to explore 
the genetic basis for the different disease outcomes. The authors used congenic C57BL/6 
mice that differed at either the MHC class I and/or at the MHC class II loci. The mice used 
were the C57BL/6 wild type mouse, the B6 (bm1) mouse with a mutation at only the K 
locus and the B6 (bm12) mouse with a mutation at the I-A locus. The F1 strains prepared 
were F1 (bm1 x bm12) and the F1 (B6 x bm1) mice. Unfractionated spleen cells from the 
C57BL/6 mice were injected into the two different F1 mouse strains. A difference at both 
the K locus and the I-A locus was a requirement for the development of aGVHD while a 
difference at only the I-A locus was a requirement for the development of cGVHD.  
 
An earlier experiment was undertaken with C57BL/10 mice and F1 mice that differed only 
across the I-E region. The recognition of only the I-E antigens on the surface of the F1 B 
cells and APC’s by the B10.A(4R) mice was sufficient to generate a cGVHD characterized 
by autoantibodies (van Rappard-van Der Veen et al., 1982). These findings implied that 
the activation of both CD4 T cells and CD8 T cells were required for the development of 
aGVHD while activation of only CD4 T cells were a requirement for cGVHD.  
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1.3.3.4 Differences in CD8 T cells in the donor inoculum 
From the above experiments the absence of alloreactive CD8 T cells gave rise to cGVHD. 
Thus, Via and Shearer, in 1987 undertook experiments to examine the effect of the CD8 T 
cells on inhibiting the development of cGVHD and ultimately preventing the development 
of the lupus-like disease, a consequence of cGVHD (Via et al., 1987). The authors 
inoculated F1 (C57BL/6 x DBA/2) mice with either the spleen cells of C57BL/6 mice or 
those of the DBA/2 mice. The spleens of the F1 mice that received the DBA/2 inoculum 
was found to have predominantly donor CD4 helper T cells and a near absence of donor 
CD8 T cells.  In contrast the spleens of the F1 mice that received the C57BL/6 inoculum 
were found to have a predominance of the donor CD8 CTLs. The difference in the CD8 T 
cells in the donor inoculum of the two parental strains gave rise to different GVHD 
phenotypes in the F1 mice. The F1 mice receiving spleen cells from the DBA/2 mice 
displayed increased host cell proliferation and low numbers of the donor cells.  The spleen 
cells in these F1 mice were devoid of CTL activity in vitro. The production of anti-DNA 
antibodies was also characteristic of these mice. The F1 mice that received spleen cells 
from the C57BL/6 mouse displayed a higher degree of chimerism with an increase in donor 
T cell that was predominantly of the CD8 T cell type. Furthermore, there was considerable 
reduction in the host lymphoid cells, specifically the B cells. The anti-F1 CTL activity of 
the spleen cells of the F1 mice that received the C57BL/6 spleen cells suggested that the 
reduction of the host’s cells was due to the CTL activity. This result provided evidence of 
an aGVHR. The authors surmised that the lysis of the B cells would lead to a decrease in 
antibody production and that this may ultimately be a mechanism to prevent the 
development of the lupus-like autoimmune disease.  
 
To further demonstrate the effects of the alloreactive CD8 T cells, the C57BL/6 inoculum 
was depleted of CD8 T cells using anti-Ly-2 antibody and complement prior to inoculation 
into the F1 mice. The F1 mice that received the CD8 T cell depleted C57BL/6 inoculum 
developed a similar GVH phenotype to the F1 mice that received the DBA/2 inoculum. 
Notably the inoculum of the parental strains contained comparable absolute numbers of 
CD4 T cells. Altogether these findings imply that the number of the CD4 T cells to that of 
the CD8 T cells may determine the type of GVHD that may develop in an allogeneic host 
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receiving donor T cells. Interestingly though, Tschetter demonstrated in 2000 that the 
aGVHR may evolve into a cGVHD that was characterized by antibodies to single stranded 
deoxyribose nucleic acid (ssDNA) and double stranded (ds) DNA antigens (Tschetter et 
al., 2000). 
 
The findings of Via in 1987 was expanded upon by Tschetter in 2000. Tschetter 
demonstrated that there is a higher frequency of CD8 T cells specific for the F1 alloantigen 
in the C57BL/6 mouse strain than either in the BALB/c or the DBA/2 mouse strains by 
employing limiting dilution CTL assays. The C57BL/6 mouse strain had a CTL frequency 
of 1/1000 while the BALB/c and DBA/2 mouse strains both had a CTL frequency of 
1/20,000 for their respective F1 cells in an in vivo mouse model. These findings further 
emphasize that the frequency of the CD8 T cells in the donor inoculum plays a pivotal role 
in the type of GHVD generated in a F1 recipient.  
 
Thus, it was with this knowledge that we set out to determine the effects of varying 
numbers of the CD4 T cells relative to that of the CD8 T cells in the spleens of different 
mouse strains on the type of immune response generated against the same alloantigen. 
 
In the above experiments genetic differences in C57BL/6 and DBA/2 mouse strains, 
unknown at the time, contributed to the different disease pathologies. It is now known that 
the mice with the H-2b haplotype have a defective I-Eα gene and thus are unable to express 
the I-E molecule in the thymus (Flavell et al., 1985). The CD4 T cells are positively 
selected in the thymus based on their recognition of MHC class II, I-E or I-A molecules on 
the surface of the thymic epithelial cells. The lack of expression of I-E molecules results 
in a reduction in the positive selection of CD4 T cells. Consequently, a reduced number of 
CD4 T cells would migrate to the periphery. The expression of the MHC molecules in the 
thymus are important in determining the number of CD4 and CD8 T cells circulating in the 
periphery. Thus, the number of CD4 T cells to that of the CD8 T cells in the periphery in 
the C57BL/6 mouse strain would be anticipated to be lower than that of a mouse strain that 
does not have this defect. However, the CBA/J mouse strain that have intact I-A and I-E 
genes behave as a C57BL/6 mouse strain. 
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1.3.4 Lymphocytes are implicated in graft versus host reactions 
Lymphocytes were demonstrated to play a key role in allograft rejection (Mitchison, 1953). 
It soon became apparent through a series of experiments that lymphocytes were also linked 
to the induction of a GVHR. The inoculation of histoincompatible spleen cells and not 
kidney cells into embryonic chickens and newborn mice resulted in splenomegaly and runt 
disease, respectively. These findings suggested that cells within the donor spleens could be 
responsible for the development of GVHD. Murphy observed both an enlarged spleen of 
the chicken embryo and an influx of lymphocytes after inoculation with adult chicken 
spleen cells.  
 
However, it was Terasaki, a fellow in Medawar’s laboratory who demonstrated that the 
lymphocytes were responsible for GVHR in chickens (Terasaki, 1959). In an effort to 
determine the type of cells in the donor inoculum responsible for the development of 
GHVR in chickens, he prepared a sample of lymphocytes with 95% purity as well as a 
monocyte population with 100% purity from the blood of adult chickens. Inoculating these 
two populations into separate chicken embryos resulted in a considerable increase in spleen 
size only when the lymphocytes were inoculated into the embryos. Thus, he was able to 
demonstrate that the lymphocytes rather than the monocytes were responsible for the 
development of GVHR in chickens.  
 
Soon after the findings of Terasaki were reported in 1959, Billingham and colleagues 
reported in 1960 that cells in the thoracic duct lymph or lymphocytes from lymph nodes 
were also capable of inducing GVHR in rats. Moreover, since the findings of Gowans 
demonstrated in 1959 that thoracic duct cells were composed of 95% small lymphocytes it 
was assumed that small lymphocytes rather than large lymphocytes were responsible for 
GVHR. There remained, however, some disagreement in this regard, as some researchers 
believed that large lymphocytes were responsible for GVHR, since they were shown to 
proliferate in culture. Gowans and colleagues in 1962 took on the task of determining 
whether it was the large or small lymphocytes that were associated with the development 
of GVHD. The first step in this investigation was to tolerize newborn albino parental rats 
by injecting them with splenocytes from F1 rats. At age 6 weeks, the albino rats were 
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tolerant to a skin graft from the F1 rats. The authors were able to break the tolerance of the 
albino rats by inoculating them with small lymphocytes from syngeneic non-tolerant 
donors. These findings provided evidence that small lymphocytes were responsible for 
immune rejection and by inference for GVHR in rats. Further studies by Gowans in 1962 
demonstrated that the small lymphocytes that caused the GVHR in the rats migrated to the 
spleens and subsequently developed into larger cells. This finding suggested that the large 
lymphocytes played a role in the immune response (Gowans, 1962). 
 
1.3.5 Strategies to prevent Graft versus Host Disease 
1.3.5.1 The removal of T lymphocytes from a bone marrow graft: a potential 
prophylactic measure against the development of GVHD 
The profound clinical consequences of acute GVHR and chronic GVHD have motivated 
clinicians and researchers to find ways to prevent the development of these potential 
complications of BMT.  T cells were identified as critical role players in the induction of a 
GVHR (Terasaki, 1959, Billingham et al., 1960). It was therefore hypothesised, that 
depletion of the T cells from allogeneic bone marrow, prior to inoculation into a host, may 
be a potential prophylactic measure against the development of GVHD. A series of 
investigations were conducted to test this hypothesis. In the first series of experiments, the 
T lymphocytes were depleted from the bone marrow of the donor mice using anti-theta 
antiserum and complement (Sprent et al., 1975). The development of GVHD was 
considerably reduced in these mice. The authors further, determined that the T lymphocytes 
circulating in the chimeras six months later were mainly of donor origin. In a second series 
of experiments, T lymphocytes were depleted in the donor using anti-lymphocytic serum 
(ALS) prior to whole body irradiation (WBI) (Norin et al., 1981). A control group of mice 
that underwent WBI only, prior to receiving allogeneic bone marrow developed GVHD 
and died within 45 days. In contrast, mice that received ALS before undergoing WBI and 
then receiving allogeneic bone marrow survived for more than 200 days (Norin et al., 
1981). These findings provided evidence that T cell depletion from the bone marrow of a 
donor reduced the risk of GVHD in the recipient. However, despite the success in 
preventing GVHD, T cell depletion did not necessarily lead to successful engraftment of 
the allogeneic bone marrow. 
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Further research expanded on the data above. The effects of the removal of T cells from 
allogeneic bone marrow prior to inoculation on skin graft tolerance in the bone marrow 
recipient were determined. Lethally irradiated mice received allogeneic bone marrow either 
with or without T lymphocytes (Vallera et al., 1981). The depletion of T cells from the 
allogeneic bone marrow inoculum prevented the development of GVHD in the irradiated 
host. Furthermore, the recipients of the allogeneic bone marrow were able to accept skin 
grafts from the bone marrow donor. This phenomenon was also demonstrated in humans. 
Leukemic patients underwent radiation prior to receiving bone marrow depleted of T cells 
from HLA-identical siblings. They did not develop GVHD. However, their risk of graft 
failure increased considerably compared to those that received bone marrow containing T 
lymphocytes (Champlin et al., 2000; Marmont et al., 1991). Thus, it appeared that the T 
lymphocytes responsible for the development of GVHD were somehow also important for 
bone marrow maturation.  
 
Studies emerged that demonstrated that T lymphocytes produced IL-3 and granulocyte-
macrophage colony stimulating factor (GM-CSF) that were essential for bone marrow 
growth (Aversa et al., 1994). In these studies recombinant (r) GM-CSF was added to bone 
marrow depleted of T lymphocytes prior to injection into patients. The patients that 
received the rGM-CSF together with the bone marrow depleted of T lymphocytes had a 
significantly higher graft survival rate than patients that did not receive the rGM-CSF and 
had a lower risk of developing GVHD. It was thus suggested that the allogeneic bone 
marrow depleted of T cells should be supplemented with the specific cytokines required 
for successful engraftment. 
 
The negative effects of the development of GVHD after BMT has been discussed above. 
However, there is a positive effect of GVHD. BMT are usually a last course of action for 
patients with leukemia. The main defence against the cancer cells is CTL activity. An acute 
GVHR in these patients is characterized by strong CTL activity. Therefore, depletion of T 
cells from the donor bone marrow inoculum may result in a relapse of the leukemia (Blazar 
et al., 2012). Therefore, total T cell depletion from the bone marrow inoculum may not be 
a viable strategy to prevent GVHD.  
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1.3.5.2 Predictors of the severity of GVHD after bone marrow transplantations 
Although HLA-typing is mandatory in BMT, studies are undertaken to find ways to predict 
whether GVHD will occur and the severity of the manifestation. Early studies utilised the 
mixed lymphocyte reaction (MLR) to determine T cell alloreactivity. In a study undertaken 
by Bach and Kisken in 1967 the alloreactivity of the T cells of the different recipients were 
determined when stimulated with different donor T cells. The donor T cells were treated 
with mitomycin C and thus were unable to respond. The lymphocytes of a single donor and 
a single recipient were mixed and cultured for 4-5 days, after which tritiated thymidine, a 
radioactive labeled nucleoside was added. The incorporation of the tritiated thymidine into 
the dividing cells was measured by the precipitate that formed. The precipitate was counted 
with a scintillation counter and expressed as counts per minute. A high stimulation index 
indicated a high degree of alloreactivity between the cells of the donor and the recipient.  
Skin grafts were undertaken in varying combinations to determine if the stimulation index 
obtained in the mixed lymphocyte culture corresponded to the acceptance or rejection of 
the allografts.  
 
Since the CTL response has been associated with acute GVHR, studies were undertaken to 
determine the effect of CTL frequency of donor bone marrow on the severity of GVHR. 
Thus, studies using the parent-into-F1 mouse model (Via et al., 1987) have suggested that 
the number of CTL precursors could be used to predict whether either an acute or a chronic 
GVHD develops. The cytotoxicity of the responder cells was determined by the 
Chromium-51 (51Cr) release assay. In this assay 51Cr is incorporated into target cells during 
incubation. Effector cells are subsequently added, and the chromium released is determined 
after a period of 4 hours using a gamma counter. Limiting dilution analysis was used to 
determine the frequency of CTL. A high number of CTL in the parental inoculum correlates 
with acute GVHR in the F1 mouse, while a low frequency correlates with chronic GVHD.  
 
In human studies, conflicting evidence exists as to whether the number of CTL precursors 
can be used as a predictor of the severity of the GVHD. Some studies demonstrated that a 
high frequency of CTLp correlated with acute GVHR (Affaticati et al., 2000; Batchelor et 
al., 1990), while other studies suggested that the frequency of CTLp is not a good predictor 
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of the severity of the GVHD that developed after BMT (Wang et al., 2000). All the above 
human studies used limiting dilutions analysis to determine the frequency of the cytotoxic 
T precursor cells. Thus, it appears that a predictor for the development of GVHR and the 
severity of GVHD needs further investigation.  
 
1.3.6 Parabiosis of parental mice to F1 offspring 
The intense investigation into GVHD led some researchers to undertake interesting 
experiments involving the parabiosis of mouse strains that differed at the H-2. Parabiosis 
is the process of joining two individuals together to allow sharing of the blood supply. 
Suturing the skin of the individuals together promotes the formation of blood capillaries. 
Parabiosis provides an alternate method to the inoculation of allogeneic donor cells to an 
immunocompromised recipient for the study of GVHD. The blood chimerism in the 
parabionts permits the analysis of the effects of the circulating cells between the two 
animals.  
 
In an early study, mice that originated from different strains formed parabiont pairs 
(Eichwald et al., 1959). When two genetically identical mice were joined they remained 
tolerant. However, a union between mouse strains that were completely H-2 incompatible 
led to the separation of the two mice. A third group of parabionts constituted a union 
between a parent and F1. Initially it was demonstrated that the GVHR induced in these 
mice would invariably lead to the death of both animals two to three weeks after the union. 
The death of the animals was referred to as parabiosis intoxication disease (Eichwald et al., 
1959). However, later research provided evidence contrary to this. Not all H-2 
incompatible unions end in death (Shaw et al., 1974). The parabiosis of the F1 (DBA/2 x 
C3H) with the parental DBA/2 mouse resulted in long-term survival of the pair despite H-
2 incompatibility. The parental DBA/2 cells populated the entire lymphoid system of the 
F1 mouse. Furthermore, the F1 mouse displayed circulating red blood cells that were 
mainly of DBA/2 origin. Interestingly, the F1 were tolerant to a C3H and a DBA/2 skin 
graft, while the DBA/2 mouse showed no sign of rejecting the C3H skin allograft, although 
an antibody response against the C3H skin graft could have occurred. Despite the 
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unresponsiveness observed by the pair to a C3H skin graft, the cells of the pair were fully 
reactive against cells of the C3H mouse in a mixed lymphocyte reaction. 
 
1.3.7 Autoimmunity: a consequence of chronic graft versus host disease 
Chronic GVHD in the murine model resembles the antibody-mediated autoimmune 
disease, SLE in humans and is characterised by the presence of a number of different 
autoantibodies. These findings suggest that autoreactive B cells have been activated and 
produce antibodies to self-antigens. Several mouse models have been described in which 
the spontaneous development of SLE occurs such as the New Zealand strains and the 
Murphy Roths Large (MRL) strain (Borchers et al., 2000). GVHD can be induced in mouse 
models such as the parent-into-F1 model. In the latter model the donor CD4 T cells 
recognise allo-MHC class II, I-A and I-E, molecules on the B cells of the host. The immune 
response that is generated is a Th2 antibody response that is unable to eliminate host cells. 
The continuous presence of the host cells results in the persistent Th2 antibody response, 
which ultimately leads to the chronic form of the disease. The high frequency of the CD4 
T cell repertoire, specific for allo-MHC (Wilson et al., 1968) results in the activation of a 
large number of CD4 T cells. As the host is not irradiated and the lymphocytes are still 
viable, the autoreactive B cells of the host can be activated. The B cells require two signals 
in order to differentiate into antibody producing cells. The first signal received by the 
autoreactive B cell is the binding of its B cell receptor (BCR) with its cognate ligand, a 
self-antigen. The alloreactive CD4 T cells of the donor interact with the MHC class II 
molecules expressed on the surface of the autoreactive B cells of the host thus providing 
the B cells with a second signal (Bretscher, 1973). A study undertaken by Morris and 
colleagues in 1990 demonstrated that the autoantibodies produced by the host B cells are 
from cognate T-B interactions (Morris et al., 1990). The activated B cells differentiate into 
plasma cells producing antibodies against the self-antigens. IgG anti-ssDNA antibodies are 
known to appear approximately 10 days after the induction of GVHR in the mouse. The 
lupus-specific autoantibodies such as the anti-dsDNA, and anti-Smith antibodies appear a 
month later (Puliaeva et al., 2009). The high frequency of alloreactive CD4 T cells may 
activate a large number of autoreactive B cells. This is evident by the presence of several 
different antibodies to self-antigens. 
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The presence of CD8 T cells was shown to inhibit the development of cGVHD and 
indirectly the autoimmune disease. The lysis of the host B cells appears to be one 
mechanism demonstrating how the CD8 T cells are able to accomplish this (Via et al., 
1987).  
 
1.3.8 Disease models related to CD4:CD8 T cell ratio 
The CD4:CD8 T cell ratio has been shown to have practical applications in the treatment 
of human subjects with a variety of infective and oncological illnesses. One of the first 
observations of the importance of the CD4:CD8 T cell ratio in humans relates to humans 
infected with human immunodeficiency virus (HIV). In HIV, the CD4 T cell is 
preferentially infected and depleted by the HIV, which leads to an imbalance of the 
naturally occurring CD4:CD8 T cell ratio. The disturbance of the naturally occurring 
CD4:CD8 T cell ratio may lead to non-HIV related mortality and morbidity and other 
immune dysfunctions (Holmes et al., 2006). The non-HIV outcomes relates to greater risk 
of malignancy, cardiovascular and renal diseases. A low CD4:CD8 T cell ratio has been 
associated with a poor response to antiretroviral therapy (Rosado-Sanchez et al., 2017). In 
contrast, correction of the profoundly low CD4:CD8 T cell ratio may lead to an 
immunological disease called the immune reconstitution inflammatory syndrome (IRIS) 
(Smith et al., 2009). Research into ovarian cancer (Sato et al., 2005) and colorectal cancer 
(Diederichsen et al., 2003) in humans has explored the role of the CD4:CD8 T cell ratio as 
a prognostic indicator. A low CD4:CD8 T cell ratio in these individuals has been associated 
with a good clinical outcome. This suggests that a Th1 cell mediated response is generated 
which would be effective in killing the cancer cells.  
 
1.4 The Mixed Lymphocyte Reaction 
1.4.1 Principles of a Mixed Lymphocyte Reaction 
The experimental system we use in our study is a one-way mixed lymphocyte reaction 
(MLR). The reaction occurs when lymphocytes from individuals that differ at their MHC 
are cultured together. Both sets of lymphocytes are activated when they recognise the 
opposing foreign MHC. The activated lymphocytes differentiate into large effector cells. 
In a one-way MLR only the responder lymphocytes are activated and differentiate into 
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effector cells. Different methods can be used to incapacitate the stimulator cells. Irradiation 
inactivates the stimulator cells while mitomycin C kills the stimulator cells.  
 
1.4.2 The Discovery of the Mixed Lymphocyte Reaction 
1.4.2.1 Cell types implicated in the MLR 
The basis for the MLR originates from a technique developed by Nowel in 1960 that was 
subsequently used to culture lymphocytes. This technique involved the preparation of a 
culture of human blood leukocytes with a plant extract called phytohemagglutinin (PHA). 
Upon exposure of the leukocytes to the PHA, the leukocytes began to undergo mitosis, 
which was evident from the developing mitotic bodies. The general consensus was that the 
small lymphocytes in the leukocyte population were responding to the PHA and this 
method was subsequently used as a technique to culture lymphocytes. This technique 
prompted the development of the concept of the mixed lymphocyte reaction (MLR). 
 
A year after the work by Nowel in 1960, Shrek and Donnelly embarked on an investigation 
of the morphology of the lymphocytes of patients with leukemia, without the use of PHA 
(Shrek and Donnelly, 1961). They observed the presence of “large cells with large nuclei 
and prominent nucleoli” in a single blood smear prepared five days after culture. The 
authors reported that this blood smear was derived from an in vitro culture that contained 
a mixture of blood from two different individuals. This report prompted Bain, Vas and 
Lowenstein to explore in 1964 whether they could reproduce the results obtained by Shrek 
and Donnelly with the in vitro mixing of leukocytes from unrelated pairs of human 
individuals in the absence of PHA. After five days of culturing the leukocytes from 
unrelated individuals the authors prepared stained blood smears of the cultures. They 
noticed that some of the leukocytes developed into large basophilic cells, which were at 
different stages of mitosis. The authors suggested that these large cells that were observed 
in vitro resembled cells that “developed in vivo in lymph nodes and spleens in response to 
the injection of soluble antigens and following skin homografts” (Bain et al., 1964). This 
suggestion provided the first evidence of the link between the mechanism of allograft 
rejection and the MLR. The authors noted that the large cells only appeared when 
leukocytes from one individual were cultured with the leukocytes from another individual. 
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There was no effect when leukocytes were cultured with the either the plasma, erythrocytes 
or platelets from another individual. Thus, it was that Bain and colleagues coined the 
phrases mixed leukocyte culture and mixed leukocyte reaction since only the mixing of the 
leukocytes could initiate this reaction. In 1967 Wilson obtained a similar result using the 
lymphocytes of rats, which is explained further below. Thus, the mixed leukocyte culture 
and the mixed leukocyte reaction soon became known as the mixed lymphocyte culture 
(MLC) and the mixed lymphocyte reaction (MLR) 
 
1.4.2.2 Quantifying the proliferation of cells in the MLR 
The effect of mixing the leukocytes of unrelated individuals in culture was evident by the 
increase in the size of cells observed in the blood smears (Bain, Vas and Lowenstein, 1964). 
In addition to the observation of the increase in cell size as an indicator of the MLR the 
authors quantified the effects by determining cell proliferation. Cell proliferation was 
visualised through the use of tritiated (3H)-thymidime autoradiographs. As the proliferating 
cells were undergoing mitosis the radioactive thymidine was incorporated into the DNA of 
these cells. The authors found that the appearance of the large cells correlated with the 
uptake of radioactive thymidine. Notably they showed that the proliferation of the cells 
occurred only when leukocytes from different individuals were cultured together and not 
when leukocytes from one individual were cultured with the plasma, erythrocytes or 
platelets from another individual. However, there was some degree of variation in the 
leukocyte responses between the individual experiments. The reason for this observation 
became clearer with later studies from animal models discussed below (Wilson et al., 
1967). 
 
1.4.2.3 The Mixed Lymphocyte Reaction: a consequence of MHC disparity 
A second important observation made by Bain, Vas and Lowenstein in 1964, was that a 
response only occurred when the leukocytes of unrelated individuals were cultured together 
and not when the leukocytes of monozygotic twins were cultured together. The results they 
observed by mixing the lymphocytes from dizygotic twins were variable. These findings 
implied that genetic differences between the individuals from whom the blood leukocytes 
were taken were partly responsible for the leukocyte reaction. The different responses 
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generated in the in vitro MLC appeared to reflect the results obtained in the in vivo skin 
transplantation experiments undertaken by Medawar in 1944. The lack of response 
observed when the lymphocytes of monozygotic twins were mixed together (Bain, Vas and 
Lowenstein, 1964) mirrored the acceptance of skin autografts in rabbits (Medawar, 1944).  
In contrast, the reaction observed when the lymphocytes of unrelated individuals were 
mixed together in the MLC reflected the rejection of allografts by a heterogeneous 
population of rabbits as described by Medawar in 1944. Based on their observations Bain, 
Vas and Lowenstein cautiously suggested that the MLR could be used to determine 
alloreactivity between donor and host and a lack of response may indicate 
histocompatibility between donor and host. 
 
In the same year, 1964, that Bain, Vas and Lowenstein published their paper, Bach and 
Hirschhorn published their work on the culture of blood lymphocytes from three different 
individuals (Bach and Hirschhorn, 1964). The authors knew the immunological cross 
reactivity of the individuals beforehand. Their colleagues in the surgery department who 
were trying to determine donor and recipient combinations for kidney allografts provided 
this information. The surgeons had sensitised recipients with white cells from the three 
donors. Thereafter, the recipients received skin transplants from the other two donors. Two 
of the donors proved to be strongly cross-reactive. It was suggested at the time that these 
two individuals shared histocompatibility antigens. Thus, in 1964, Bach and Hirschhorn 
cultured the lymphocytes of the three donors in pairs, in all combinations. They compared 
the presence of large cells and the mitotic bodies in the blood smears of each combination. 
They found that the lymphocyte combination from the pair that was most cross-reactive 
displayed the lowest in vitro percentage of large cells and mitosis. The authors made a 
similar suggestion to that made by Bain and colleagues that the reaction of mixed cultures 
might be used to determine potential recipients of kidney allografts.  
 
Numerous animal models were subsequently used to further explore the concept of the 
MLR. Using the lymphocytes of inbred strains of rats Wilson reported in 1967 that the 
vigour of the MLR was dependent on the degree of the MHC disparity. By this time, it was 
well appreciated that inbred strains of animals were homozygous and displayed a distinct 
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haplotype. Thus, the response of their lymphocytes to antigens would be uniform. The 
results Wilson obtained, attested to this. The rejection or acceptance of an allograft in rats 
is determined by the Ag-B histocompatibility gene locus. The authors first demonstrated 
that the response of the lymphocytes of individual rats from a single inbred strain mixed 
with the lymphocytes of the same F1 hybrid rats was consistent. However, the mixing of 
lymphocytes from individual rats from different strains that differed at the Ag-B locus, 
with the lymphocytes from the same F1-hybrid rats resulted in varying degrees of 
responsiveness. The combination of blood lymphocytes from rats that were more distantly 
related exhibited a stronger proliferative response, which was indicated by an increase in 
large cells and a higher level of thymidine incorporation. The conclusion from this study 
was that the greater the disparity of the MHC between the individuals from whom the 
lymphocytes were obtained the greater the number of large cells observed. The earlier 
studies of Bain reported in 1964, in which the mixing of human leukocytes produced 
varying degrees of responsiveness could thus be associated with the degree of MHC 
disparity between the human donors. 
 
Secondary to the results obtained above, Wilson, as reported in 1967, examined the kinetics 
of the MLR. In the early stages of the MLR up until day four the reaction between the 
lymphocytes was minimal as observed by the low numbers of large cells. Thereafter, the 
response increased significantly peaking at day seven. 
 
1.4.3 One-way Mixed Lymphocyte Reaction 
At that time the authors were aware that F1-hybrid strains of animals did not mount an 
immune response against an allograft from the parental strains (Medawar, 1944). In 1967 
Wilson and colleagues observed a similar unidirectional response in the MLR when the 
lymphocytes from DA male rats were cultured with the lymphocytes of F1, DA/BN male 
rats. All the lymphocytes undergoing mitosis were from the DA male rats and not from the 
F1 hybrid rats. This became a means to investigate the activity of just the responders within 
the mixed culture. The lymphocytes of the F1 hybrid rats were regarded as the stimulators. 
Subsequently this unidirectional reaction soon became known as a one-way MLR. There 
are other methods besides the use of F1 hybrids as stimulators that can be used to render 
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the stimulators incapable of activation and proliferation or kill the cells. These include the 
use of irradiation as well as the use of mitomycin C (Bach and Voynow, 1966), which binds 
to DNA by alkylation and interferes with mitosis (Verwij and Pinedo, 1990).  
 
1.4.4 The Effector arm of the MLR 
The role of lymphocytes in allograft rejection was extensively investigated in the 1950’s 
and led to the idea that lymphocytes could be cytotoxic in vitro. This was demonstrated 
when blood lymphocytes from dogs that had received kidney allografts exerted a cytotoxic 
effect on the renal cells of the donors (Govaerts, 1960). Further evidence of the cytotoxic 
effect of lymphocytes was demonstrated in mice. Mouse lymphocytes sensitized with 
allogeneic cells surrounded their target cells with subsequent cytopathic changes and cell 
death (Rosenau and Moon, 1961). 
 
Thus, by the time that the concept of the MLR emerged it was known that lymphocytes 
were responsible for rejecting allografts in vivo and that they were able to exert cytotoxic 
activity in vitro. Thus, research was undertaken to determine if the large cells produced in 
the MLR exerted an effector function. It was purported that if the cells generated in the 
MLR were functionally capable then the link between the MLR and the in vivo rejection 
of an allograft would be indisputable. Thus, in 1970 Hayry and Defendi reported their 
findings on the function of the large cells observed in the MLR. In order to determine this, 
the authors cultured the peripheral blood lymphocytes of either DBA/2 or C3H mice with 
the peripheral leukocytes of F1, DBA/2 x C3H mice. The lymphocytes sensitised in vitro 
were then incubated on day 6 with 51Cr-labelled target cells. The lymphocytes killed the 
target cells, which was evident by the release of chromium. In addition to the effector 
function of the cells produced in the MLR, they also displayed specificity and memory in 
their function. Only target cells that displayed the priming antigen were destroyed. 
 
Thus, the in vitro alloreactivity in the MLR became fully identified with in vivo allograft 
rejection. The MLR was synonymous with the immune reaction and the cytotoxic activity 
of the cells of the MLR was seen as the cellular effector arm of allograft rejection.  
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1.5 The Immunologically Competent Lymphocyte 
1.5.1 The role of lymphocytes in immunity 
In the early twentieth century tumour transplantation and healthy tissue transplantation 
were separate fields with little to no collaboration between investigators in these fields. In 
retrospect, had the researchers collaborated earlier, it is possible that they would have 
gained rapid understanding.  
 
It was under these circumstances that Murphy undertook tumour transplantation 
experiments that implicated a role of lymphocytes in allograft rejection (Murphy, 1913). 
Murphy initially tried, albeit unsuccessfully, to transfer adult chicken tumours into adult 
chicken hosts. He did, however, demonstrate in a series of experiments that rat tumours 
inoculated into chick embryos before day eight of gestation could establish themselves 
unhindered. The chicken embryos appeared to be tolerant to the rat tumours. However, 
when the rat tumours were grown in chicken embryos in close proximity to secondary 
lymphoid tissue such as the spleen or bone marrow from adult chickens, their survival rate 
was considerably reduced. Although both the adult chicken spleens and bone marrow 
elicited a rapid influx of lymphocytes around the tumour, the adult chicken spleens resulted 
in a more rapid destruction of the rat tumours than the bone marrow grafts. Murphy 
surmised that the adult chicken spleens and bone marrow provided some type of defense 
against the rat tumour. Moreover, this defense appeared to be similar to that generated in 
adult chickens against adult chicken tumours. He drew the general conclusion that the 
rejection of the tumour allograft coincided with an increase in lymphocytes into the tumour 
area. He however, did not conclude that the lymphoid cells were the cause of the regression 
of the rat tumour.  
 
Murphy’s contemporary Apolant (Brent, 1997) provided further evidence of the role of the 
spleen cells in tumour regression by demonstrating that transplantable tumours survived if 
the spleen was removed. Furthermore, white mice that were initially resistant to a 
transplanted tumour became susceptible to it after exposure to radiation. The radiation 
depleted the circulating lymphocytes thereby rendering the mice susceptible. These 
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observations led Murphy to surmise that lymphocytes may have a role in preventing tumor 
growth.  
 
Despite Murphy’s findings there was a 50-year hiatus before lymphocytes became the 
subject of interest in graft rejection. One reason for this void in lymphocyte research was 
that most immunologists at that time believed that antibodies were the primary mediators 
of the acquired immune response. As late as the early 1960’s lymphocytes were still 
regarded as hematopoietic stem cells. It was believed at the time that the lymphocytes 
entered the bone marrow and became the stem cells from which the erythrocytes and 
granulocytes originated.  
 
Gesner and Gowans, undertook a series of experiments the findings of which were reported 
in 1962, to investigate this theory (Gesner and Gowans, 1962). It was known at the time 
that the transfer of bone marrow could rescue lethally irradiated animals. Thus, the authors 
surmised that if lymphocytes gave rise to bone marrow, then the inoculation of the 
lymphocytes into lethally irradiated animals should give rise to new bone marrow which 
would lead to the survival of the animal. Subsequently, they inoculated lethally irradiated 
CBA mice with either isologous thoracic duct cells or with isologous bone marrow cells. 
Thoracic duct cells contained lymphocytes that re-entered the blood stream. Only the mice 
that received the bone marrow cells survived and displayed extensive hematopoiesis in the 
red pulp of the spleen and the bone marrow. The mice that received isologous thoracic duct 
cells showed considerable increase in large lymphocytes particularly in the white pulp of 
the spleen but no evidence of hematopoiesis in bone marrow. These mice died within 9 to 
12 days. The findings of this study suggested that thoracic duct cells or lymphocytes were 
not associated with hematopoiesis but may have some other yet to be determined role. 
 
Gesner and Gowans thus wanted to determine the immunological function of the thoracic 
duct cells or the lymphocytes. They wanted to determine if the ability of lethally irradiated 
mice to reject an allograft can be restored by the inoculation of thoracic duct cells. Thus, 
the authors inoculated lethally irradiated mice with either rat bone marrow cells, or with 
rat bone marrow cells and isologous thoracic duct cells. The mice that received only rat 
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bone marrow cells showed signs of hematopoiesis and survived. In contrast, the mice that 
received both bone marrow and thoracic duct cells did not survive. The thoracic duct cells 
destroyed the allogeneic bone marrow cells. The inoculated thoracic duct cells were able 
to restore the ability of the lymphoid tissue to reject an allograft. 
 
The work of Gowans and Knight proved to be critical in cementing the importance of the 
lymphocyte in graft rejection (Gowans and Knight, 1964). They used inbred strains of rats 
to demonstrate that “small” lymphocytes circulate from the blood to the lymph and back 
to the blood. In order to demonstrate this thoracic duct cells were obtained from rats and 
labelled with tritiated compounds. The large lymphocytes were labelled with tritiated 
thymidine while both the large and small lymphocytes were labelled with tritiated 
adenosine. Two groups of rats from the same inbred strain as the donors of the thoracic 
duct cells were transfused with labelled thoracic duct cells. At various time points the rats 
from one group were killed and with the aid of autoradiographs, the position of the labelled 
lymphocytes was determined. The thoracic ducts of the second group of rats were 
cannulated to determine if the labelled thoracic ducts cells injected into the blood stream 
entered the lymph nodes. The authors found that the small lymphocytes preferably 
trafficked from the blood through secondary lymphoid tissue such as the lymph nodes, the 
white pulp of the spleen and the Peyers’s patches of the intestine. The preferential 
migration of the small lymphocytes through the spleens and the lymph nodes made it easier 
for researches to obtain large numbers of these cells to further investigate their role in 
immunity.   
 
1.5.2 The thymus: the site of development for the immunologically active lymphocyte  
Although a number of researchers were exploring the function of the thymus at the same 
time it was the work of J.F.A.P. Miller that provided the most notable contributions to the 
discovery of the importance of the thymus as a site for the development of the 
immunologically active lymphocyte. In his initial experiments in 1959, Miller embarked 
on a series of investigations to determine whether leukemia would develop in a low 
leukemic mouse strain such as the C3H mouse by the inoculation of leukemic tissue 
obtained from the high-leukemic mouse strain, the AK mouse. The results he obtained were 
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consistent with the original findings of Ludwik Gross in that the C3H strain developed 
leukemia. Miller was aware that lymphocyte leukemia occurred in the thymus and that 
adult thymectomy prevented the development of the cancer in both the low and the high 
leukemic strains of mice. These findings led him to explore the role of the thymus in the 
development of the virus-induced cancer (Miller, 1959). He undertook experiments in 
which low leukemic mice, C3Hf/G mice, were inoculated with leukemic tissue extracts at 
birth and then thymectomised three to four weeks later. None of these mice developed 
leukemia. However, grafting these thymectomised mice with syngeneic thymus tissue up 
to six months later lead to the development of leukemia. Miller postulated that the virus 
initially replicated in the thymus and then remained dormant post thymectomy in other 
tissues. Although this proved not to be the case, it became clear to Miller that the thymus 
played a role in the development of an immune response. A chance meeting with Medawar 
provided Miller with the insight to undertake neonatal thymectomies. Thus, neonatal mice 
were thymectomised and inoculated with the virus and the effect of the absence of a thymus 
at birth was assessed on the development of leukemia. An important finding from these 
experiments was the wasting disease observed in the thymectomised neonatal mice, which 
was accompanied by a considerable reduction in lymphocytes. Of critical importance was 
the finding that the mice thymectomised at birth and who received skin allografts at six 
weeks of age did not reject grafts. The grafts in fact, exhibited “luxuriant crops of hair”. In 
stark contrast, mice that were thymectomised at three weeks of age did not show any 
impairment of the immune response to allografts. Thus in 1961 (Lancet) Miller 
hypothesised: “and, contrary to the prevailing opinion, I postulated that during 
embryogenesis the thymus would produce the originators of immunologically competent 
cells many of which would have migrated to other sites at about the time of birth. This 
would suggest that lymphocytes leaving the thymus are specially selected cells”.  
 
A series of experiments followed to test experimentally his hypothesis (Miller, 1962) and 
to confirm his original findings on the acceptance of the allografts by the mice 
thymectomised at birth. Based on the findings of Gowans in 1962 who demonstrated that 
lymphocytes were critical role players in the rejection of allografts, Miller surmised that 
his thymectomised neonatal mice with their reduced lymphocyte population would accept 
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an allograft. He thus transplanted skin grafts from a variety of mouse strains with different 
degrees of histoincompatibility onto his thymectomised neonatal mice six weeks after 
birth. The mice accepted the allografts. The removal of the thymus soon after birth greatly 
impaired the immune response to the allograft. However, neonatal mice that were 
thymectomized at birth and then received syngeneic fetal thymuses two weeks later 
rejected skin allografts within fifteen days.  
 
Independent work by Good and colleagues on the role of the thymus in immunity was 
published in the same year as the initial work described by Miller in 1962. The former 
group of authors thymectomized rabbits five days after birth and challenged them with 
BSA seven weeks later. The control group of rabbits that were not thymectomized readily 
produced antibodies to the BSA while none of the thymectomized rabbits produced 
antibodies (Good et al., 1962). The cumulative findings of Miller and Good provided 
evidence of the importance of the thymus in immunity. 
 
1.5.3 Functional differences between thymus-derived and bone marrow-derived 
lymphocytes in the production of antibodies 
Once the significance of lymphocytes in immunity became apparent cellular immunology 
advanced rapidly. Extensive research was undertaken to further the understanding of the 
role of these lymphocytes. During this time, it was initially thought that the thymus-derived 
lymphocytes were responsible for both cell mediated immunity and antibody production.  
This assumption was made when neonatally thymectomized mice were neither able to 
reject skin allografts or produce antibodies to Salmonella typhi H antigen. However, a 
series of experiments, as described below, thwarted this hypothesis that the thymus-derived 
lymphocytes were able to produce antibodies. Hereafter, thymus-derived lymphocytes will 
be referred to as T cells. In 1966 Claman and colleagues embarked on an investigation to 
determine if the thymus contained immunologically competent antibody forming cells 
(Claman et al., 1966). In their first set of experiments the authors inoculated thymocytes 
together with SRBC into irradiated syngeneic mice. The production of antibodies against 
the SRBC was not observed and the authors believed that more time was required for the 
thymocytes to reach maturity. Increasing the time unfortunately led to the demise of the 
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mice. The authors were aware that radiation sickness was common in individuals that were 
irradiated and that the transfer of bone marrow may prolong their lives. Thus, they 
inoculated the mice with thymocytes, SRBC and syngeneic bone marrow. What ensued 
was a robust anti-SRBC antibody response. As a result, the authors demonstrated that both 
the bone marrow and the thymus-derived lymphocytes were required for the development 
of an antibody response.  
 
The findings of Claman in 1966 led Miller to revisit his initial hypothesis that the 
thymocytes were responsible for producing antibodies. Thus, followed a series of 
experiments by Miller and Mitchell in 1968 in this regard. The authors began by 
thymectomising newborn CBA mice, which were inoculated with either SRBC only, or a 
combination of SRBC and syngeneic thymocytes or thoracic duct cells three to five weeks 
later. They demonstrated that both syngeneic thymocytes and thoracic duct cells rescued 
the antibody response to SRBC. Furthermore, they were able to demonstrate that semi-
allogeneic thymocytes and thoracic duct cells produced a similar result to that of the 
inoculum containing the syngeneic cells. The use of semi-allogeneic thymocytes and 
thoracic duct lymphocytes allowed the authors to determine the origin of the cells 
responsible for the production of antibodies. The neonatally thymectomised CBA mice 
were thus inoculated with thymocytes or thoracic duct cells from C57BL or F1 (CBA x 
C57BL) mice. The number of antibody producing cells was assessed by an in vitro plaque-
forming cell (PFC) assay. The single cell suspension of the spleen cells of the neonatally 
thymectomised CBA mice was layered onto an agar plate together with SRBC and 
complement. Antibody producing cells specific for SRBC in the spleens of the CBA mice 
would produce antibody that bound to the SRBC, which would subsequently be lysed by 
complement. A clear zone or a plaque would form in the area of the lysed cell. Thus, using 
anti-H-2 isoantisera they were able to identify that the cells responsible for the formation 
of the PFC originated within the recipient. The anti-CBA serum reduced the number of 
PFC by 98-100% in comparison to the anti-C57BL serum that showed no reduction in PFC. 
The authors, surmised that the semi-allogeneic cells provided a helper function in the 
production of antibodies. Following on these experiments the authors then set out to 
determine the cell population responsible for the production of antibody to SRBC in the 
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CBA mice. Lethally irradiated thymectomised mice were inoculated with syngeneic bone 
marrow. Two weeks later the mice received F1, (CBA x C57BL) thoracic duct lymphocytes 
and SRBC. This resulted in the formation of anti-SRBC PFC. After their series of 
experiments Miller and Mitchell concluded that the thymocytes co-operated with the bone 
marrow in the production of antibodies and that the bone marrow contained cells 
responsible for the production of antibodies. 
 
1.5.4 A morphological difference between thymus-derived and bone marrow 
lymphocytes 
Clear evidence emerged that the thymocytes and bone marrow derived lymphocytes were 
functionally different, and this led Roitt in 1969 to designate the thymus-derived cells as T 
cells and the bone marrow derived lymphocytes as B cells (Roitt et al., 1969). Thus, it 
became essential to find a marker that could distinguish the T cells from the B cells. The 
theta (θ) antigen, which was initially described by Reiff and Allen, (1966) was found 
exclusively on thymocytes and the brain and also to a lesser extent expressed by peripheral 
lymphocytes. Subsequently Raff suggested in 1969 that θ could be used as a possible 
surface marker that could distinguish the T and B cells. Thymocytes were known to 
circulate through the lymph nodes and the spleen. Raff demonstrated that 80-90% of the 
lymphocytes from the lymph nodes and 30-50% of the spleen expressed the θ marker. A 
year later Raff (1970) was able to distinguish T cells from B cells using indirect 
immunofluorescence. He accomplished this by confirming the expression of θ on the 
surfaces of T cells only and the immunoglobulin expression on the surfaces of B cells only. 
 
1.5.5 T cells as mediators of cytotoxicity 
The cytotoxic role of the T cells was highlighted by the work of Cerottini and colleagues 
in 1970. At this time the GVHR was well described demonstrating an influx into and the 
repopulation of the spleens of the recipients by the donor cells which led to the destruction 
of the recipient’s cells. Thus, the authors injected lethally irradiated DBA/2 mice with 
spleen cells from C57BL/6 mice. The cytotoxic T cells of the C57Bl/6 mice that had 
repopulated the spleens of the DBA/2 mice were able to lyse 51Cr-labelled DBA/2 target 
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cells. The cytotoxic effect of the recipient spleen cells was abrogated when mixed with 
AKR anti-theta serum and complement. Theta is a marker expressed by T cells. 
 
Thus, the cumulative work of many researches provided clear evidence that the bone 
marrow contained cells responsible for the production of antibodies while the thymus 
contained cells that assisted the bone marrow cells in the antibody production. 
Furthermore, the activated T cells could be cytotoxic. 
 
1.5.6 Suppression and Promotion of the antibody response: the conflicting roles of T 
cells 
Before the discovery that two distinct T cell subsets existed, the CD4 T cells and CD8 T 
cells (Cantor and Boyse, 1975), research emerged of the discordant roles of T cells in the 
production of antibodies. In their first set of experiments Gershon and Kondo used 
thymectomised, lethally irradiated and bone marrow reconstituted mice that received 
SRBC for 30 days. These mice were unable to produce antibody to SRBC during the 30 
days and were considered tolerant. This finding suggested that the absence of thymocytes 
prevented the production of antibody by the bone marrow cells. Four days after the end of 
treatment the mice received thymocytes that reversed the initial effects. They were able to 
produce anti-SRBC antibodies (Gershon and Kondo, 1970). This result confirmed the 
earlier findings of Claman in 1966 and Mitchell and Miller in 1968 that both bone marrow 
cells and thymus cells are required for antibody production.  
 
The authors undertook further experiments utilising the same protocol as above but with 
the addition of thymocytes at the initiation of the experiment (Gershon and Kondo, 1971). 
In this instance the mice were unable to produce antibodies even after receiving the second 
dose of thymocytes. The potential inhibition of the antibody response provided an alternate 
function for the thymocytes. They thus displayed a dual role; one of promoting the antibody 
response and one in suppressing the antibody response. The same authors in 1971 further 
cemented the idea that thymocytes were able to inhibit antibody production. They tolerized 
mice to SRBC and then adoptively transferred the spleen cells of the tolerized mice into 
syngeneic mice. The adoptively transferred lymphocytes prevented the production of 
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antibody in these mice. It was suggested that the adoptively transferred lymphocytes 
prevented the interaction between the recipient’s thymocytes and their bone marrow cells. 
It was however only in their third paper in 1972 that Gershon used the term suppressor cell 
for the T cells suppressing the antibody response. Furthermore, they concluded that two 
populations of T cells might exist, one that suppresses the antibody response and one that 
enhances the antibody response.  
 
1.5.7 The Discovery of Distinct T cell populations 
T lymphocytes are composed of two distinct subsets, the CD4 T cell and CD8 T cell subsets 
that display a helper and a cytotoxic phenotype, respectively. This idea evolved during the 
early 1970’s with the identification of the surface marker, Ly. The Ly antigens are 
expressed by T cells only and not by non-lymphoid cells. The Ly antigens are divided into 
three types, namely Ly-1, Ly-2 and Ly-3. Experiments with neonatally thymectomised 
mice showed a reduction in peripheral lymphocytes expressing the Ly antigens confirming 
that the expression of the Ly antigens are restricted to the thymus-derived cells.  
 
T lymphocytes were known to be instrumental in different immune responses upon 
recognition of antigen such as the production of antibody and the rejection of allografts. In 
1975 Cantor and Boyse wanted to determine if the different functions exhibited by T cells 
was reflective of the presence of different T cell subsets before exposure to antigen. Thus, 
using the surface marker Ly they explored if a single T lymphocyte population was 
heterogenous before stimulation. Using Ly antisera, they were able to show the existence 
of different T lymphocyte populations based on the expression of these Ly antigens. 
Depletion of Ly-2+3+ cells from the spleens of B6 mice inoculated into B6 x BALB/c mice, 
failed to generate cytotoxic T cells against BALB/c targets, while they produced PFCs to 
SRBCs upon immunisation with SRBCs. In contrast, depletion of Ly-1+ cells from the 
spleen cells of B6 mice generated cytotoxic T cells against BALB/c targets, while they 
failed to produce PFCs to SRBCs upon immunisation with SRBCs. Thus, it was 
demonstrated that the Ly-1+ T lymphocytes exhibited primarily a helper phenotype before 
antigen exposure whereas the Ly-2+ T lymphocytes had a reduced helper phenotype with 
a dominant cytotoxic phenotype (Cantor and Boyse, 1975). The new nomenclature used 
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today denotes the Ly-1+ cells as being the CD4 T cells while the Ly-2+3+ cells are 
considered to be the CD8 T cells. Thus, Cantor and Boyse demonstrated on the basis of the 
Ly-surface markers that T lymphocytes were grouped into two subsets with distinct 
functions. The Ly-1+, Ly-2+ and Ly3+ surface markers which are denoted as CD5, CD8α 
and CD8β by the current nomenclature of cluster differentiation. The CD5 marker is 
expressed by both CD4 and CD8 T cells but at a higher level of expression by the CD4 T 
cells. This would seem to clarify the findings of Cantor and Boyse that the Ly-1+ cell is the 
CD4 T cell. 
 
1.6 Immune Regulation 
1.6.1 A historical perspective of Immune Regulation 
The ability to modulate the immune response without any adverse effects has been 
extensively investigated in numerous situations such as in the hope of inducing tolerance 
to allografts. The benefits thereof are huge and ultimately would lead to improved quality 
of life and increased life expectancy. Some researchers believe that the concept of 
modulating the immune response dates as far back as the tenth century. The Chinese 
inhaled smallpox crusts from the lesions of infected individuals as a form of vaccination 
thereby, as we know it today, generating a primed state. 
 
Despite the advancements made in establishing the dual roles of T lymphocytes in 
immunity there was limited research undertaken on the cell-mediated immune response of 
these lymphocytes. It was during this period that Parish and Liew undertook a series of 
experiments in 1972 to determine the relationship between the humoral (antibody) response 
and the cell mediated immune response of the T lymphocytes to the same antigen (Parish 
and Liew, 1972). They inoculated adult rats with different doses of cyanogen bromide 
digest of flagellin over a 28-day period. On day 28 the rats were challenged with 100µg of 
flagellin in saline which is considered an antibody-inducing dose. The cell-mediated 
immune response was determined by means of delayed type hypersensitivity (DTH) 
reactions. The reaction was observed when the footpads of the rats were injected with the 
antigen, which subsequently became swollen. Antibody production was determined by 
hemagglutination assays using SRBC coupled with flagellin. A low and a high dose of 
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antigen resulted in a DTH reaction upon challenge with the antibody-inducing dose of 
flagellin at day 28. During the DTH reaction a lack of antibody production was observed, 
while in contrast, a DTH reaction was absent during the antibody response that was 
generated with an intermediate dose. The authors thus concluded, that the generation of the 
cell-mediated and the antibody responses tended to be mutually exclusive. These findings 
expanded upon the original findings of Asherson and Stone who, in 1965 demonstrated 
that a DTH reaction could be prevented by first inoculating an animal with an antigen 
precipitated in alum or in a soluble form known to produce antibodies. Two weeks 
thereafter the animal was inoculated with the antigen in Freund’s complete adjuvant known 
to induce DTH reaction. The secondary response was characterized as an antibody 
response. Asherson and Stone regarded this observation as the immune response deviating 
away from the DTH reaction (Asherson and Stone, 1965). 
 
The above findings led to the hypothesis of immune class regulation, which proposed that 
the cell mediated and antibody responses to the same antigen were reciprocally regulated 
(Bretscher, 1974), which was subsequently successfully demonstrated by the work of 
Ramshaw and colleagues (Ramshaw et al., 1977). Based on the work of Cantor and Boyse 
in 1975, Ramshaw and colleagues used the anti-Ly and the anti-Ia sera to determine 
whether the T cells that suppressed the antibody response displayed a different phenotype 
from those that suppressed the cell-mediated response. Using the mouse model, they 
confirmed the presence of two distinct suppressor T cell subsets. They demonstrated that 
the suppressor T cell of the antibody response was Ly-1-, Ly-2+ and Ia+. We now know that 
the T cell expressing Ly-2+ is the CD8 T cell. In contrast, the T cells suppressing DTH or 
the cell-mediated immune response were Ly-1+, Ly-2- and Ia-, which are currently 
considered to be the CD4 T cells associated with an antibody response. Thus, it was shown 
that CD4 T cells and CD8 T cells reciprocally regulated the mutually exclusive cell-
mediated and antibody responses of T lymphocytes, respectively. 
 
1.6.2. The current concept of immune class regulation 
The Th1/Th2 concept of reciprocal regulation of distinct classes of immunity by T cells 
and their cytokines is our contemporary explanation of immune class regulation. In 1986, 
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Mosmann and colleagues decided to further analyse the CD4 T cell subset using a panel of 
Ly1+, L3T4+, Ly2-, Ia restricted T cell clones. They demonstrated by the stimulation with 
Concanavalin A (Con A) that T helper cells could be divided into two distinct subsets based 
on their expression of specific cytokines. The Th1 subset produced IL-2, IFN-γ, 
granulocyte macrophage colony stimulating factor (GM-CSF) and IL-3 while the Th2 
subset produced IL-3, B cell stimulating factor 1 (IL-4) and IL-10. Different sources 
provide evidence of distinct functions exhibited by these two subsets. The Th1 group and 
not the Th2 subset have been shown to express delayed type hypersensitivity (DTH) upon 
transfer to naïve recipients (Cher et al., 1987). The Th2 subset, in contrast, is the dominant 
facilitator of B cell antibody production; facilitating the production of IgG1 (Isakson 1982) 
and IgE (Coffman 1986). Several articles demonstrate the Th1 subset’s inability to provide 
help to B cell for antibody production. However, there is evidence of its role in the 
production of IgG2a (Snapper and Paul, 1987). Consequently, the Th1 subset is associated 
with DTH response while the Th2 subset is the main facilitator of antibody production. 
Furthermore, these functions tend to be mutually exclusive.  
 
The Th1 and Th2 subsets and their unique pattern of cytokines displaying distinct functions 
are associated with reciprocal regulation of immunity. Evidence of this is through the 
antagonistic action of their signature cytokines, IFN-γ (TH1) and IL-4 (Th2). Gajewski and 
Fitch noted that the supernatants from cultures of Th1 clones would inhibit the proliferation 
of Th2 and not Th1 clones (Gajewski and Fitch, 1988). In contrast, Susan Swain and 
colleagues reported in 1990 that the addition of IL-4 to CD4 T cells stimulated with 
Concanavalin A (ConA) suppressed the generation of Th1 cells but enhanced the 
generation of Th2 cells in vitro (Swain et al., 1990).  
 
IL-4 is essential for the activation and proliferation of B cells and was initially referred to 
as the B cell growth factor, (BCGF) (Howard, et al., 1982). The IL-4 stimulates the B cells 
to produce IgM and IgG1 antibodies (Boom et al., 1988). In contrast, a study undertaken 
by Snapper and Paul demonstrated the effects of IFN-γ on the production of murine IgG 
antibodies (Snapper and Paul, 1987). The authors demonstrated that the B cells from the 
spleens of DBA/2 mice stimulated with LPS produced large amounts of IgM and IgG2b 
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and low amounts of IgG1 and IgG2a. However, the addition of high concentrations of 
rIFN-γ inhibited the production of IgG1, IgG2b and IgE hallmarks of a Th2 immune 
response. In contrast, rIFN-γ stimulated the expression of IgG2a which has been associated 
with a Th1 immune response. The inhibitory effect of the rIFN-γ on the production of Th2 
antibodies was abrogated by the addition of anti-rIFN-γ antibody.  Thus, the cytokines 
produced by the Th1 and Th2 subsets suppressed the development of the opposing T helper 
phenotype while enhancing their own.  
 
1.6.3. T helper subsets, their signature cytokines and transcription factors 
The transcription factors, T-bet and GATA 3 have been identified as the signature 
transcription factors of the Th1 and Th2 subsets, respectively. Interaction of cytokines with 
their respective receptors on the surface of T cells initiates a signalling pathway that 
involves non-receptor tyrosine kinases called Janus kinases (JAKs) and transcription 
factors called signal transducers and activators of transcription (STATs). Before we 
describe the effects of the induction of the transcription factors, T-bet and GATA3 we will 
briefly discuss the signalling pathways initiated by the IFN-γ and IL-4.  
 
The Th2 cytokines, IL-4 and IL-5 amongst others, bind to the type I cytokine receptors on 
the T cells while the type II cytokine receptors interact with type I and II interferons and 
IL-10 as well. The associated JAK tyrosine kinases are activated upon ligation of the 
receptors with the cytokines.  Phosphorylation of the receptor chains occurs resulting in 
the recruitment of specific STAT proteins to the cytokine receptor. The STAT proteins are 
phosphorylated, and the dimers formed migrate to the nucleus binding to specific DNA 
sequences in the promoter regions of cytokine responsive genes and activate transcription 
factors such as the T-bet and GATA3 (Darnell, 1997).  STAT 1 is associated with IFN-γ 
expression, while signalling through STAT 6 mediates IL-4 expression. 
 
T-bet was isolated by Szabo and colleagues and its importance in the induction of the Th1 
phenotype was revealed while searching for the transcription factors involved in the 
expression of the Th1 cytokines, IFN-γ, TNFβ and IL-2 (Szabo et al., 2000). At that time 
the region of the IL-2 promoter was characterized. Thus, using a yeast one-hybrid assay 
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the authors integrated the EGY48 yeast strain with the IL-2-promoter/HIS3 construct, 
which they had developed earlier. The yeast cells were then transfected with a library of 
Th1 cDNA fused to an activation domain. A novel protein was identified which they 
subsequently termed T-bet. The significant link between T-bet and the induction of the Th1 
phenotype became apparent when the transcription factor was primarily expressed in Th1 
cells and not Th2 cells. This link was further emphasized when naïve transgenic T cells 
cultures prepared under Th2 polarizing conditions switched to a Th1 phenotype in the 
presence of overexpressed T-bet. This was evident by the simultaneous loss of IL-4 and 
IL-5 expression and the activation of the expression of IFN-γ. To determine whether T-bet 
actually exerted an effect on the IFNG gene, EL4 cells, a murine tumour cell line, were 
transfected with T-bet and stimulated with PMA/ionomycin. The ensuing results led to the 
hypothesis that T-bet is a potent transactivator of IFN-γ. Many researchers argued that      
IL-12, a Th1 cytokine was responsible for the induction of T-bet. However, Zhu and 
colleagues demonstrated in 2000, using a mouse reporter strain for T-bet, that both IFN-γ 
and IL-12, which signals through STAT 4, were able to induce the expression of T-bet. 
Thus, T-bet the Th1 signature transcription factor is induced by both IFN-γ and IL-12 and 
in turn induces the expression of IFN-γ. Thus, IFN-γ has the ability of enhancing a Th1 
response.  
 
The signature transcription factor for the induction of a Th2 phenotype is GATA 3 as 
reported by Zheng and Flavell in 1997. Firstly, the authors observed a high level of 
expression of GATA3 in the naïve CD4 T cells at the periphery, which is probably due to 
its requirement in T cell development within the thymus. This contrasts greatly to the 
expression of T-bet which is inducible in newly activated CD4 T cells primed towards a 
Th1 phenotype. Furthermore, they noted differences in the level of expression of GATA 3 
in naïve CD4 T cells primed towards either a Th1 or a Th2 phenotype. The level of the 
transcription factor remained high as the cells differentiated towards a Th2 phenotype 
whereas it decreased considerably in the Th1 cells. Moreover, GATA 3 was shown to 
promote the Th2 phenotype by being a potent transactivator of the IL-4 promoter. 
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What then is the regulatory role of the transcription factors in the current thinking on 
immune class regulation? One-way in which the concept of immune class regulation can 
be reconciled, is through the mutual antagonistic action of GATA 3 and IL-12. This would 
occur if GATA3 inhibits the expression of the IL-12 receptor, independent of the presence 
of IL-4, preventing the development of a Th1 phenotype. On the other hand, IL-12 
signalling through STAT4 inhibits the expression of GATA3, a critical component of Th2 
development. However, the introduction of GATA 3 after the development to a Th1 
phenotype is unable to prevent the expression of IFN-γ in these cells (Ouyang et al., 1998). 
The T-bet repression of IL-4 expression was found not to be due to a direct effect since it 
did not repress the IL-4 promoter transactivation (Szabo et al., 2000). 
  
Another interesting theory is one of competition. As the immune response evolves from a 
Th1 to a Th2 immune response as demonstrated by Salvin in 1958, the level of IL-10 
increases. The Th1 cytokine, IFN-γ and IL-10 produced by Th2 cells compete for the same 
cytokine receptors, cytokine receptor II, on the surface of cells.  
 
1.6.4 Factors that influence the Th1/Th2 phenotype of CD4 T cells  
1.6.4.1 Antigen Dose  
The dose of the antigen was one of the first factors identified that influenced the type of 
immune response generated. In 1958 Salvin inoculated guinea pigs with diphtheria toxin 
or OVA protein in incomplete Freund’s adjuvant (Salvin, 1958). The guinea pigs displayed 
delayed type hypersensitivity (DTH), a Th1 immune response, which transitioned into an 
antibody response over a certain period of time. The dose of the antigen determined the 
rate at which the transition from DTH to antibody response occurred. A low dose of antigen 
promoted a DTH response and resulted in a significant delay in the generation of the 
antibody response. In contrast, a high dose of antigen elicited a rapid antibody response 
with a near imperceptible DTH. Several studies using different antigens such as L. major 
(Menon and Bretscher, 1998), BCG (Power et al., 1998), simian immunodeficiency virus 
(SIV) (Dittmer et al., 1996) and in neonatal mice infected with murine leukemia virus 
(Sarzotti et al., 1996) have reported similar findings to that of Salvin in 1958. In each of 
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the studies above a low dose of antigen was associated with a Th1 immune response while 
a high dose of antigen generated a Th2 immune response.  
 
1.6.4.2 The number of responding CD4 T cells 
A study reported by Ismail and Bretscher demonstrated that the number of responding CD4 
T cells had a significant effect on the Th1/Th2 response generated against an antigen 
(Ismail and Bretscher, 2001). Lethally irradiated mice were reconstituted with different 
numbers of syngeneic spleen cells. Thereafter the mice were immunized with a dose of 
SRBC known to elicit a mixed Th1/Th2 immune response. The mice that received a low 
number of spleen cells and more specifically a low number of CD4 T cells generated a 
predominant Th1 immune response, while higher numbers of CD4 T cells generated a 
predominant Th2 immune response to SRBC. 
 
1.7 The interaction between the CD4 T cell and CD8 T cell  
1.7.1 CD4 T cell help required for activation of naïve CD8 T cells 
As described earlier naïve CD8 T cells are activated through signalling of their TCR with 
the MHC class I-peptide complex and the interaction with costimulatory molecules on the 
surface of T cells and APCs. The CD8 T cells take on a cytotoxic phenotype and are 
referred to as cytotoxic T lymphocytes (CTLs) once activated. Different stimuli such as 
intracellular viruses and bacteria as well as transformed cells and major and minor 
histocompatibility molecules may induce the development of the CTLs. The literature 
provides extensive evidence of the role of CD4 T cells in the activation of the CD8 T cell. 
The type of antigen has been shown to determine whether the CTL response generated 
would be helper dependent or helper independent. This was largely based on the 
inflammatory nature of the antigen. It was demonstrated that for the generation of a CTL 
response to a non-inflammatory antigen such as ovalbumin, CD4 T cell help was a 
requirement (Bennett et al., 1998). The CD4 T cell help was also demonstrated for a CTL 
response against allo-MHC (Schoenberger et al., 1998, Via et al., 1987). In contrast, the 
CTL response to inflammatory antigens such as the ectromelia virus (Buller et al., 1987) 
and the influenza virus (Lui and Mullbacher, 1989) has been shown to be independent of 
CD4 T cell help. However, there are studies demonstrating that the generation of CTL 
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responses against inflammatory antigens still require CD4 T cell help. A study by Kast and 
colleagues in 1986 has demonstrated that the cooperation of both the CD4 and CD8 T cell 
is required for the elimination of a lethal Sendai virus.  
 
It appears that with certain inflammatory antigens CD4 T cell help is not a requirement. 
However, on secondary exposure of the antigen the initial CD4 T cell help was shown to 
be critical for the establishment of memory cells as assessed by a secondary challenge 
(Shedlock and Shen, 2003; Sun and Bevan, 2003). The primary CTL responses that did not 
require CD4 T cell help generated impaired CTL responses to secondary exposure to 
antigen. Thus, it appears that although the primary CTL response may not always require 
CD4 T cell help, it is critical for a robust effective secondary CTL response.  
 
It has been suggested that the help afforded to the CD8 T cell by the CD4 T cell is in the 
form of the IL-2 cytokine. This idea evolved in the context of an in vitro system in which 
cytolytic T lymphocyte precursors with a Ly-2+ marker required the addition of IL-2 in 
order to proliferate (Erard et al., 1985). However, it was demonstrated in IL-2 knockout 
mice that islet cell allografts were rejected (Steiger et al., 1995). This led to the suggestion 
that a soluble factor may not be the only requirement in the generation of CTLs. Thus, it 
was suggested that cell-to-cell contact could be a requirement. The interaction between the 
CD40L expressed on activated CD4 T cells and the CD40 expressed by mature dendritic 
cells was demonstrated as being a possible mechanism (Bennett et al., 1998). The 
interaction between the CD40L and the CD40 presumably licenses the dendritic cell to 
activate the CD8 T cells. 
 
1.7.2. Linked recognition of CD4 and CD8 T cells: a requirement for CD8 T cell 
activation 
The CD40-CD40L interaction led to the suggestion that linked recognition may be a 
requirement for providing help. A study was undertaken to explore the need for linked 
recognition in the generation of CTLs (Keene and Forman, 1982). The authors 
demonstrated that unprimed CTLs specific for the Qa-1b alloantigen, needed to be primed 
in vivo with two kinds of epitopes in order to generate a secondary CTL response in vitro. 
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They observed that female B6.Tlaa (Qa-1a) stimulated with congenic spleen cells from 
female B6 (Qa-1b) donors could not mount an anti-Qa-1b CTL response. The inability of 
these cells to generate a CTL response was not due to a deficiency in CTL precursor cells. 
Priming the B6.Tlaa mice with allogeneic spleen cells from A.BY mice resulted in anti-Qa-
1 CTL activity in vitro. Thus, the allogeneic cells provided some sort of help. Thus the 
authors decided to use male B6 (Qa-1b) expressing the H-Y antigens to prime the female 
B6.Tlaa (Qa-1a) mice. The result was that the female B6.Tla mice spleen cells generated a 
CTL response specific to the Qa-1 molecule.  
 
1.7.3 The role of CD8 T cells in suppressing the antibody response 
Effector CD8 T cells kill infected and transformed cells via two pathways. Killing of the 
target cells is mediated by the production of cytolytic granules such as perforin and 
granzyme (Badovinac et al., 2000; Lobe et al., 1986, Podack et al., 1991) or by the Fas/FasL 
(ligand) interaction (Kataoka et al., 2001; Russell and Ley, 2002). CD8 T cells also produce 
IFN-γ (Fong and Mosmann, 1990). In order to exert its regulatory effect, CD8 T cells 
require CD4 T cell help to become fully activated effector cells as described in 1.7 (Bennett 
et al., 1998; Shedlock and Shen, 2003; Sun and Bevan, 2003).  
 
As described in 1.5.6 of the introduction several studies demonstrated that T cells were 
able to either suppress or stimulate the antibody response (Gershon and Kondo, 1970; 
Gershon et al., 1972). A study by Basten and colleagues in 1974 provided further evidence 
of T cells suppressing the antibody response. Mice were rendered tolerant to fowl 
immunoglobulin by the inoculation of a high dose of deaggregated immunoglobulin, which 
was known to elicit a tolerant state. Tolerance at that time was considered to be an absence 
of an antibody response to the antigen, although a cell-mediated immune response may 
have occurred. Tolerant spleen cells were transferred into irradiated syngeneic hosts. The 
host mice were unable to mount an antibody response against the fowl immunoglobulin 
when challenged with the antigen, demonstrating the successful transfer of tolerance. The 
role of the T cells in suppressing the antibody response was confirmed when spleen cells 
of the tolerant donor were treated with anti-Thy1 antibody prior to being adoptively 
transferred. The syngeneic recipients of these spleen cells were able to mount an antibody 
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response upon challenge with the fowl immunoglobulin comparable to that of the controls. 
Notably the transfer of a high enough number of, tolerant spleen cells, 25 x 107, was able 
to significantly reduce the PFC in normal mice when challenged with the antigen. This 
finding suggests that a high number of suppressor T cells were required to inhibit antibody 
production in mice that had not been irradiated. To test whether B cells were tolerant, the 
tolerant spleens were treated with anti-Thy1 serum to remove the T cells and then 
transferred with normal T cells into the syngeneic hosts. A strong antibody response to 
fowl immunoglobulin was generated in these mice. This suggested that tolerance operated 
only at the T cell level. 
 
In addition to the in vivo studies demonstrating the T cell suppression of the antibody 
response, in vitro studies were also undertaken (Rich and Pierce, 1974). The authors 
demonstrated that mouse spleen cells activated with a non-specific plant mitogen, Con A 
produced a highly immunosuppressive factor in the supernatant. The addition of this 
supernatant to a culture containing mouse spleen cells and SRBC inhibited the antibody 
response to SRBC. These findings suggest that a soluble factor obtained from Con A-
activated T cells is able to suppress the antibody response.  
 
After the discovery of two distinct T cell populations, the CD4 and CD8 T cells (Cantor 
and Boyse, 1975) it soon became apparent that the delayed type hypersensitivity reaction 
and antibody responses were reciprocally regulated by the CD4 and CD8 T cell, 
respectively (Bretscher, 1972; Ramshaw et al., 1977). Thus, although suppression of the 
immune response can occur in either direction, our study focuses on the effect of CD8 T 
cells on CD4 T cell differentiation. Therefore, in addition to its ability to lyse infected 
target cells the CD8 T cell gained prominence in the 1970’s as the suppressor cell of the 
antibody response.  
 
Susceptibility to Leishmania (L) major is attributed to an ineffective antibody response. A 
study undertaken by Herath and colleagues in 2003 demonstrated the means by which CD8 
T cells suppressed the antibody response and ensured resistance to the intracellular 
pathogen. Three groups of BALB/c mice were inoculated with 2 x 106, of L major 
 63 
promastigotes, a dose which would render the mice susceptible to the pathogen. At the time 
of infection one group of mice received a single injection of CD4 monoclonal antibody 
(mAb). The transient depletion of the CD4 T cells appeared to provide protection against 
the pathogen. Reducing the number of responding CD4 T cells has been shown to generate 
a cell-mediated immune response (Ismail and Bretscher, 2001). The second group of mice 
received a single dose of CD4 mAb and anti-CD8 mAb twice a week for the duration of 
the infection. The third group was the control group that were only infected with the 
pathogen. The first group of mice in which the CD4 T cells were transiently depleted, were 
able to clear the infection. In contrast the control group and the group in which the CD8 T 
cells were depleted were unable to clear the infection. One month after the initiation of the 
infection the cells of the lymphoid organs were restimulated with the pathogen for 6 days. 
In the first group the number of CD8 T cells increased considerably compared to the control 
group. The authors also found that in the absence of the CD8 T cells a reduction in both 
the IFN-γ production as well as the frequency of IFN-γ -producing CD4 T cells was 
observed. The authors suggested that the CD8 T cells allows for an increase in IFN-γ and 
more importantly regulates the increase of IFN-γ by the CD4 T cells that confers protection. 
 
Moskophidis and colleagues demonstrated in 1992, the role of CD8 T cells in suppressing 
the development of an antibody response against the lymphocytic choriomeningitis virus 
(LCMV) virus. In this study the authors used transgenic mice displaying a TCR specific 
for the 32-42 LCMV gp1 epitopes in association with H-2Db. The mice were infected with 
a high dose of the LCMV strain. A strong CD8 CTL immune response ensued with no 
detectable antibody forming cells (AFC). It could be suggested that the high dose allowed 
for a strong CTL response, which was sufficient to clear the virus and inhibited the 
evolution of the immune response into an antibody mode. A low dose of the virus resulted 
in an antiviral antibody response. Furthermore, to confirm their findings that the CD8 T 
cells suppressed the antibody response, the authors depleted the mice of CD8 T cells using 
rat anti-CD8 monoclonal antibody. After the depletion of the CD8 T cells the spleen cells 
of the transgenic mice exhibited AFC upon infection with LCMV. The authors concluded 
that the CD8 CTLs were responsible for the suppression of the antibody response against 
LCMV. 
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Effector CD8 T cells are able to mount a cell mediated immune response to intracellular 
pathogens and are able to suppress the antibody response to intracellular pathogens. 
However, do the CD8 T cells suppress an antibody response to exogenous antigens? In 
1992, Tuttosi and Bretscher demonstrated the ability of CD8 T cells to suppress the 
antibody response to SRBC an exogenous antigen. In order to generate a strong antibody 
response, mice were immunized initially with a 0.1% suspension of SRBC. A day later 
they were inoculated with a 100-fold higher dose. The spleen cells from these mice were 
restimulated in culture with SRBC. To determine the DTH of the spleen cells, the cells 
were injected into the footpads of the mice and the swelling characteristic of DTH was 
assessed. The IgG response was also assessed. The spleen cells that were originally 
generating an antibody response had switched to a cell-mediated immune mode. Thus, it 
appeared that the antibody response was being suppressed. The authors set out to determine 
which cells were suppressing the antibody response to the SRBC. They depleted the spleen 
cells of CD4 T cells using the anti-CD4 GK1.5 antibody. The remaining cells, which 
contained the CD8 T cells consistently, inhibited the antibody production to SRBC. Thus, 
CD8 T cells have been shown to suppress the antibody response to an exogenous antigen. 
 
Several studies have demonstrated the role of CD8 T cells in suppressing the antibody 
response to alloantigens in the GHVD mouse model (Rolink and Gleichmann, 1983; Rus 
et al., 1995; Tschetter et al., 2000; Via et al., 1987). Two different GVH phenotypes 
developed in F1 mice inoculated with parental lymphocytes. Lymphocytes from the 
C57BL/6 mouse generated an acute GVHR in the F1 mice, while lymphocytes from a 
DBA/2 mouse generated a chronic GHVD characterised by an antibody-mediated 
autoimmune disease that resembles systemic lupus erythematosus (SLE) in humans in the 
F1 mouse. The different GVH phenotypes observed in the F1 mice was attributed to 
differences in the frequency of the CD8 T cells in the parental inoculum (Tschetter et al., 
2000; Via et al., 1987). Further investigation into differences in the frequency determined 
that the frequency of CTL precursors in the spleens of the DBA/2 strain were relatively 
low i.e. 1/20000 in comparison to the frequency in the spleen of the C57BL/6 strain, 
1/1000. (Tschetter et al., 2000) The authors thus concluded that the presence or near 
absence of CD8 T cells in the donor inoculum determined whether an acute GVH reaction 
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or whether a chronic GVHD occurred. Furthermore, to confirm the role of the CD8 T cells 
in generating an acute GVH reaction in the F1 strain, the CD8 T cells were depleted from 
the C57BL/6 inoculum using anti-Ly-2+ serum prior to injection into the F1 mice (Via et 
al., 1987). Subsequently, the F1 mice developed a chronic GVHD similar to the GVHD 
observed when lymphocytes from DBA/2 strain were inoculated into the F1 strain. 
Furthermore, Rolink and Gleichmann demonstrated in 1983 that only CD4 T cells are 
required to generate the chronic GVHD, while both the CD4 and CD8 T cell are necessary 
for an acute GVHR. Thus, we can conclude that the CD8 T cells present in the inoculum 
are able to suppress the antibody response promoted by the CD4 T cells in chronic GHVD. 
 
1.8. The mechanism of antibody suppression by the CD8 T cell  
As interest in suppressor T cells gained momentum, extensive research was undertaken to 
determine the mechanism by which antibody suppression was accomplished. Research into 
the mechanism suggested that there were two ways in which the antibody response could 
be suppressed. One way in which the antibody response can be suppressed is by lysing the 
cells which are critical for antibody production. A second way in which the antibody 
response can be suppressed is via the production of soluble factors that exert a suppressive 
effect on the development of a Th2 immune response.  
 
The lack of an antibody response observed in various studies (Basten et al., 1974; Rich and 
Pierce, 1974), suggested that B cells were suppressed resulting in no antibody production. 
A later study by Via and colleagues in 1987, using the GVHD mouse model reported a 
significant decrease in B cells in F1 mice that developed an acute GVHR. This was in 
contrast to, the F1 mice that developed chronic GVHD in which an increase in B cells and 
autoantibodies were observed. The authors suggested that the antibody response was absent 
in the acute GVHR due to the cytotoxic activity of the donor CD8 T cells, which lysed the 
B cells. It is well documented that an alloresponse occurs due to MHC disparity between 
donor and host cells. The CD8 T cells of the donor recognise differences in the MHC class 
I molecules on the surface of the host B cells resulting in the killing of the B cells. One of 
the ways in which effector CD8 T cells lyse target cells is through the Fas/FasL pathway 
(Shustov et al., 1988). The latter authors demonstrated using the GVHD mouse model that 
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there was a correlation between the lysis of host spleen cells and the Fas/FasL expression 
on effector CD4 and CD8 T cells. Effector CD8 and CD4 T cells expressed increased levels 
of FasL in mice displaying aGVHR, compared to the CD4 and CD8 T cells of mice 
displaying cGHVD that expressed similar levels of FasL to mice in which a GVHR was 
not induced. The upregulation of FasL expression was dependent on the presence of       
IFN-γ produced by both the CD4 and CD8 T cells. The authors suggested that the 
dependence on IFN-γ in the expression of FasL may be due to the Fas-encoding gene 
having an IFN-γ responsive element in its promoter (Shustov et al., 1988). A study 
undertaken by Rozendaal and colleagues in 1989 was consistent with the findings of 
Shustov and colleagues in that direct contact between donor and host cells is required to 
suppress the antibody response. Rozendaal and colleagues reported that the use of a double 
chamber system that separated the donor cells from the hosts did not elicit suppression of 
the antibody response.  
 
However, a study undertaken by Herath and colleagues in 2003 demonstrated the 
significance of a soluble factor produced by CD4 and CD8 T cells in conferring protection 
against L major parasites. Resistance to the parasites requires a cell mediated immune 
response. The authors suggested that the CD8 T cells produced a soluble factor IFN-γ, that 
increased the number of IFN-γ producing CD4 T cells which helped to protect mice 
infected with the parasite in a cell mediated immune response (Herath et al., 2003). 
 
The study by Basten in 1974 demonstrated that suppression of the antibody response was 
specific. The authors transferred tolerant spleen cells to irradiated syngeneic mice together 
with normal T cells, the tolerizing antigen and donkey red blood cells (DRBC). The mice 
were unable to produce an antibody response to the tolerizing antigen. However, a 
concurrent development of a normal antibody response to DRBC occurred (Basten, 1974). 
In contrast to the in vitro system of Rich and Pierce in 1974, the soluble factor produced 
by Con-A- activated T cells was able to suppress the antibody response of T cells activated 
with SRBC. These findings suggest that the suppression of the antibody response is “non-
specific”. This led to extensive research into the specificity of suppression (Rich and 
Pierce, 1974).  
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Studies have demonstrated that the I-region of the H-2 gene complex of the mouse 
regulates the type of immune response generated against different antigens. Thus in 1976 
evidence emerged that a distinction could be made between the T helper and the T 
suppressor cells based on their specific I-region expression (Murphy et al., 1976; Okumura 
et al., 1976). It was believed that the T cells associated with B cell antibody production 
expressed surface markers that were coded by the I-A and I-E sub-regions. In contrast, T 
suppressor cells expressed surface markers that were coded by a newly identified locus the 
I-J region. The authors suggested that this region occurred between the I-A and I-E regions 
(Murphy et al., 1976). Further research into the mechanism of antibody suppression led to 
the identification of an antigen specific suppressive T cell factor that expressed the same 
surface markers as the suppressor T cells. The I-J region was also responsible for the 
expression of these molecules (Tada et al., 1976). However, this turned out not to be the 
case. After the characterization of the mouse histocompatibility complex (Steinmetz, 
1982), the I-J region was not found to be between the I-A and I-E regions as initially 
reported. The area between the I-A and I-E regions was only two kilobases which was part 
of the I-Eβ (Kronenberg et al., 1983). These findings had a devastating effect on research 
into CD8 I-J suppressor T cells and ultimately led to the decline in research into the CD8 
T cell as the suppressors of the antibody response.  
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CHAPTER 2 
2.1 RATIONALE  
The studies of this thesis arose from the interest of our laboratory in the aetiology of 
generalised, antibody mediated autoimmunity initiated by the immune response to 
transplantation antigens. They are based on findings made several decades ago in a model 
system of tolerance and autoimmunity in chickens made chimaeric during embryonic 
development (Havele, 1982). Chimeras were generated by injecting donor stem cells 
obtained from the embryonic spleens of inbred chickens differing at the MHC locus, into 
the embryo of the recipient. The chimaeric birds that developed by embryonic manipulation 
belonged to two major categories: 
 
(i) Chimaeras developed at an early stage of development (up to 15 days, the full period of 
gestation being 21 days) displayed permanent chimaerism and complete unresponsiveness 
at both the cell mediated and humoral level against the donor antigens over the life period 
of approximately four years. These birds appeared to be tolerant in a way that is analogous 
to the unresponsiveness displayed by the immune system to self-antigens. 
(ii) Chimaeras generated at about day 17 of gestation were unresponsive at the cell-
mediated level but they produced specific anti-donor strain allo-antibodies detected as early 
as 10 days post hatching. With time, they developed a severe autoimmune syndrome 
characterized by the production of multiple autoantibodies directed against self tissue 
antigens. 
 
Subsequent to these observations van Rappard-van Der Veen and colleagues reported in 
1982, a remarkably similar observation in the parent-to-F1 mouse model mice inoculated 
with histoincompatible lymphocytes differing only in the I-A and I-E locus (identical in 
the K and D loci) developed a severe syndrome of antibody mediated autoimmune 
syndrome resembling the human condition of systemic lupus erythematosus (SLE). In 
subsequent years, Via and colleagues studied systematically the aetiology of Graft versus 
Host Reaction, GVHR. The advancement of technology allowed them to explore the 
requirements for, CD4 or CD8 T cells in the donor inoculum in causing Graft versus Host 
Rejection, GVHR or an autoimmune syndrome resembling the human condition of SLE, 
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which they named Graft versus Host Disease (GVHD). Graft versus host autoimmune 
disease could be initiated upon injection of DBA/2 parental lymphocytes into C57BL/6 x 
DBA/2, F1, hosts, while a lethal GVH disease occurs upon administration of C57BL/6 
lymphocytes into the same F1 mice. Furthermore, depletion of CD8 T cells from the 
C57BL/6 inoculum before administration into F1 mice converts the lethal GVH phenotype 
to chronic autoimmune disease. Via and Shearer have argued that the development of the 
autoimmune phenotype involving extensive lymphoproliferation is the outcome of a 
deficient CD8 T cell activation unable to control the antibody autoimmune state.  
 
From these collective observations it became important to us to delineate the role of  
CD8 T cells in regulating the cell mediated or antibody response exploring an in vitro 
experimental system of one-way mixed lymphocyte response.  
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2.2 HYPOTHESIS 
We hypothesised that the generation of CD4, Th1(IFN-γ) or Th2(IL-4) immunity depends 
on both:   
i) the ratio of CD4 T cells:CD8 T cells specific for antigen at the initiation of the 
immune response and  
ii) on the ability of antigens to co-ordinately induce both CD4 T cells and CD8 T 
cells. 
 
The MHC class I and class II alloantigens expressed on the APCs of the F1 mouse strain 
have the potential for being dually recognized by both CD8 T cells and CD4 T cells, 
respectively. Therefore, according to the above model, CD4 Th1/Th2 immunity is 
subjected to the cognate regulation by CD8 T cells. Our model suggests that efficient 
induction of CD8 T cells at the initiation of the immune response results in increased and 
stable CD4/Th1-type immunity with concomitant inhibition of Th2-type specific immune 
responses. We believed that the mechanism by which the CD8 T cells exert their regulatory 
function on CD4 T cell differentiation is through the production of the soluble factor,     
IFN-γ that provides a particular cytokine environment that is conducive for enhancing a 
Th1 immune response (Figure 2.1A). In contrast, in the absence of efficient CD8 T cell 
activation, and therefore, an absence of the critical cytokine environment, IFN-γ, 
alloantigen stimulates a Th2 response (Figure 2.1B). 
 
 
 
 71 
  
 
 
 
Figure 2.1: A Three-Cell Model of Antigen Specific Regulation of Immune Responses 
to Alloantigens by CD8 T cells  
(A) The CD8 T cells provide the cytokine environment, IFN-γ, that drive CD4 T cell 
differentiation towards the Th1 mode. 
(B) In the absence of the cytokine environment provided by the CD8 T cells, the CD4 T 
cells would predominantly differentiate to Th2 phenotype characterized by IL-4 
production. 
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2.3 AIMS 
There are three fundamental aims to this study.  
 
The first aim was to analyze the role of the naturally occurring CD4:CD8 T cell ratio in 
adult mice in determining the class of immunity, Th1 (IFN-γ) or Th2 (IL-4), generated 
upon allo-MHC stimulation. 
 
The second aim of the study was to determine the regulatory role of the CD8 T cells in the 
differentiation of naïve CD4 T cells towards a Th1 (IFN-γ) phenotype and away from a 
Th2 (IL-4) phenotype. 
 
The third aim of the study was to determine the mechanism by which the CD8 T cells exert 
their regulatory role on the differentiation of naïve CD4 T cells. 
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CHAPTER 3  
MATERIALS AND METHODS 
3.1 Mice  
BALB/c, H-2d, C57BL/6, H-2b, CBA/J, H-2k, C3H, H-2k, DBA/2J, H-2d, and DBA/1J,  
H-2q, all 8-12-week-old female mice were used as the Responders in our study. The 
Stimulators were irradiated spleen cells of heterozygous (BALB/c x C57BL/6), F1,           
(H-2d/b) female mice. To illustrate antigen specificity, we used 8-12-week-old C3H mice 
with an H-2k haplotype. The BALB/c, C57BL/6 and C3H mice were obtained from the 
Charles River Laboratories (Montreal, Quebec). The CBA/J, DBA/1 and DBA/2 mice were 
obtained from Jackson Laboratory (Bar Harbour, Maine, USA). All mice were housed at 
the Health Sciences, Laboratory and Animal Services Unit (LASU), University of 
Saskatchewan. All our experiments were conducted under a protocol approved by the 
University of Saskatchewan’s Animal Research Ethics Board that adhered to the Canadian 
Council on Animal Care guidelines for humane animal use. 
 
3.2 Media and Solutions 
3.2.1 Roswell Park Memorial Institute Culture Medium 
The culture medium was prepared with Roswell Park Memorial institute (RPMI-1640) 
medium (Gibco, Grand Island, N.Y.), 10% heat inactivated characterized Fetal Bovine 
Serum (FBS) (Thermo Scientific), 100U/ml of penicillin-streptomycin (Gibco, Grand 
Island, N.Y.), 0.8 mM sodium pyruvate and 0.5M 2-mercaptoethanol (Sigma). This medium 
was also used in the blocking step of the ELISPOT assay. 
 
3.2.2 Phosphate Buffered Saline  
A 10x stock of phosphate buffered saline (PBS) was prepared by combining 80.0 g/L NaCl, 
2.0 g/L KCl, 11.5 g/L Na2HPO4 • 12 H2O and 2.0 g/L KH2PO4 in distilled deionized water 
(ddH2O). The pH was adjusted to 7.2. A 1x working stock of PBS was obtained by diluting 
the stock in ddH2O. 
 
3.2.3  Phosphate Buffered Saline-Tween 20  
PBS-Tween (PBST) was prepared by adding 0.05% v/v Tween 20 (Fisher Scientific, USA) 
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to a working solution of PBS. PBST was used for the washing steps in the development 
stage of the enzyme-linked immunospot (ELISPOT) assay. 
 
3.2.4 Magnetic Activated Cell Sorting buffer 
Magnetic Activated Cell Sorting (MACS) Buffer consisted of PBS supplemented with 
2mM NaEDTA. 
 
3.2.5 Fluorescence Activated Cell Sorting buffer 
Fluorescence Activated Cell Sorting (FACS) Buffer consisted of PBS supplemented with 
2mM NaEDTA 
 
3.2.6  Carbonate/Bicarbonate Buffer for Coating ELISPOT Plates 
• Preparation of Solution A: 8.4g NaHCO3 + 100mL H2O 
• Preparation of Solution B: 10.6g Na2CO3 + 100mL H2O 
A mixture of 45.3mL of A + 18.2mL of B + 936.5mL H2O was prepared. The pH of the 
solution was adjusted to 9.6 using A or B.  
 
3.2.7 NBT/BCIP Developing Solution for ELISPOT assay 
ELISPOT plates (Millipore) were developed by applying a solution of nitro-blue 
tetrazolium chloride/5-bromo-4-chloro-3-indolylphosphate toluidine (NBT/BCIP), 
(Roche), substrate diluted 1:100 in an alkaline (pH 9.5) substrate buffer consisting of 0.1M 
Tris-HCl, 0.1M NaCl and 0.05M MgCl2. 
 
3.2.8 Recombinant Interferon Gamma and Anti-Interferon Gamma antibody 
The dose of recombinant interferon gamma (rIFN-γ) (BioLegend) needed in our 
experiment was determined by a bioassay. Previously in our laboratory the bioactivity of 
IFN-γ was determined by employing a bioassay which measured the protection provided 
by the IFN-γ to L929 cells, a rat fibroblast cell line, when infected with endomyocarditis, 
EMC, virus. Briefly, 3 x 104 L929 cells/well were incubated in 96 well flat-bottomed plates 
for 24 hours, in the presence of different dilutions of a given supernatant. Thereafter, media 
was suctioned, and the cultures were infected with 100-fold higher titre of EMC virus in 
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media. The titre of the virus was predetermined using the Karber assay to define the dose 
which caused the death of 50% of the cells. The reciprocal dilution which protects 50% of 
the L929 cells from destruction by the virus was designated as 1 unit of IFN-γ bioactivity. 
Recombinant, purified IFN-γ was used as a standard in all assays. Based on the findings of 
these experiments we determined that 2000 units were required. A unit of IFNg activity 
equalled that of the international unit as calculated by the commercial supplier. Thus, we 
used 10ul/well of 0.1ng/ml rIFN-γ in our experiments. The standard amount of neutralizing 
anti-IFN-γ monoclonal antibody (XMG1.2, BioLegend) was chosen based on its ability to 
neutralise 2000 units of rIFN-γ activity.  
 
3.3 Preparation of Spleen Single Cell Suspensions 
Mice were euthanized via cervical dislocation and the spleens were aseptically removed 
and placed in complete RPMI medium on ice. Spleens were gently ground through a sterile 
wire mesh using the rubber end of a sterile syringe. The cells were separated into a single 
suspension by continuous pipetting. Thereafter, they were placed in a 15ml centrifuge tube 
(Costar) for two minutes in order to allow large particles to settle. The cells present in the 
supernatant were transferred to a fresh 15 mL centrifuged tube and centrifuged at 500xg 
for 7 minutes. The cell pellet was resuspended in 5ml of complete RPMI medium per 
spleen. The number of leukocytes present in the suspension was determined using a 
haemocytometer and by counting the viable white cells at a 1:5 dilution in Trypan blue. 
Viable white cells were finally adjusted to a concentration of 107 cells/ml.  
 
3.4 Mixed Lymphocyte Reaction  
The Mixed Lymphocyte Reaction (MLR) occurs when lymphocytes obtained from 
individuals that differ at their MHC are mixed together. The small lymphocytes in the in 
vitro system are activated when they recognise the foreign MHC. Subsequently these small 
lymphocytes differentiate into large cells that exhibit an effector function against target 
cells that express the specific foreign MHC. The MLR is fully discussed in the Introduction 
section 1.3. We used three different culture preparations in our study that represented the 
MLR. These include our Control Cultures, CD8 T cell Depleted Cultures and CD4 T cell 
Depleted Cultures. 
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3.4.1 Control Cultures  
The basic experimental system we employed is One-Way Mixed Lymphocyte Reaction. 
The stimulators in our MLR were always irradiated in order to prevent their proliferation 
and their participation in the reaction. In particular, Responder spleen cells from different 
inbred strains of mice, homozygous at the MHC locus, were cultured with irradiated spleen 
cells from different strains of mice under defined conditions of Responder and Stimulator 
cell density. The strain combination of Responder and Stimulator spleen cells is indicated 
in particular Figure Legends in the Results section. We refer to these cultures as our Control 
Cultures.  
 
For optimal cell interaction between Responder and Stimulator spleen cells and dependent 
on the aim of the experiment as described in the legends of the figures we used 107cells per 
well in 6-well plates (9.5cm2 growth area), 4 X 106 cells per well in 12-well plates (3.8 cm2 
growth area) and 2 x 106 cells per well in 24-well plates (1.88cm2 growth area) for the 
responders. Stimulator spleen cells were used at a 1:1 ratio with the responder spleen cells. 
 
3.4.2 CD8 T cell Depleted Cultures 
Depletion of CD8+ T cells from the spleens of mice was achieved by employing the rat 
monoclonal antibody TIB-211 (American Type Culture Collection) specific for a non-
polymorphic part of the Ly2 antigen. The number of spleen cells used is dependent on the 
culture plate used: see 3.4.1 of Materials and Methods and detailed in particular Figure 
legends. The spleen cells were incubated for one hour on ice with a ten-fold higher titre of 
TIB 211 antibody in ascites fluid than that required to obtain maximal complement 
dependent lysis of the splenic T cells. The spleen cells were then incubated with 1/20 
dilution of Low-Tox-M rabbit complement (Cedarlane) at 37°C. The depletion of the CD8 
T cell was verified by flow cytometry: see 3.8 of Materials and Methods. Equivalent 
numbers of Control cultures depleted of CD8+ T cells were cultured with identical numbers 
of Stimulator cells as in the Control cultures. The number of Responder and Stimulators 
spleen cells per CD8 T cell depleted culture varied as per the plate type used (a 6-well 
plate, a 12-well plate or a 24-well plate) and is expanded on in the result section. 
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3.4.3 CD4 T cell Depleted Cultures 
A similar procedure as that which was followed to deplete CD8+ T cells from the spleens 
of mice was used to deplete the CD4+ T cells from the spleens of mice. Monoclonal 
antibody GK1.5 and Low Tox-M rabbit complement were used to deplete the CD4+T cells 
from the spleens. Depletion of the CD4+T cells from the spleens was verified by flow 
cytometry. Thus, equivalent numbers of Control cultures, which were depleted of CD4+ T 
cells, were cultured with identical numbers of Stimulator cells as in the Control cultures. 
 
3.4.4 Transwell Membrane Cultures  
The transwell-membrane plates (Costar, USA) consisted of 12-well plates in the lower 
chamber while the upper chamber consisted of 24-well plate inserts. The membrane 
separating the two chambers had a pore size of 0.4 µm that only allowed molecules to pass 
through and not cells. The cultures prepared in the upper and lower chambers of the 
transwell-membrane plates varied and are detailed in the Figure legends in the results 
sections. 
 
3.5 Irradiation of Stimulator Spleen Cells 
The spleen cells of the F1, (BALB/c x C57BL/6) and C3H mice, which, were used as the 
stimulators in our experiments were irradiated with 1000-1500 Rads from a Cobalt 60 
(University of Saskatchewan). This abrogated the stimulator cells’ ability to replicate and 
ensured that a one-way mixed lymphocyte reaction was obtained. 
 
3.6 Sorting out of unprimed CD8 T cells from the spleens of mice for use in 
Reconstruction assays 
Naïve CD8 T cells were isolated from spleen cells of mice for use in Reconstructed 
Cultures as detailed in particular Figure legends. The isolation of these cells occurred in 
two steps: 
 
3.6.1 T cell enrichment of the spleen cells using Nylon wool  
Nylon wool columns (Polysciences, Inc.) were used for T cell enrichment of the mouse 
spleen cells. The columns were prepared the day prior to the cell isolation. The columns 
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were rinsed with warm RPMI culture medium and then filled with 7ml RPMI culture 
medium. Columns were incubated overnight at 37°C and 5% CO2. The following day the 
spleen cells of the mice were centrifuged at 500 x g for 7 minutes and resuspended in 2ml 
of warm RPMI culture medium. The columns were washed once with 5ml warm medium. 
Thereafter, cells were transferred to columns and incubated for one hour at 37°C and 5% 
CO2. After incubation, the columns were washed twice with 5 mL of warm RPMI culture 
medium. Cells were centrifuged at 500 x g for 7 minutes. The pellet was resuspended in 
5ml per spleen in RPMI culture medium.  
 
3.6.2 Magnetic Activated Cell Sorting  
After T cell enrichment, CD8 T cells were sorted by negative selection using Magnetic 
Activated Cell Sorting (MACS) monoclonal antibodies to CD4 T cells (CL012) Miltenyi 
Biotec. The cell number of the T cell enriched spleen cells was determined using Trypan 
blue (Biomedical Ltd) and a haemocytometer. The spleen cells were centrifuged at 500 x 
g for 7 minutes. The pellet was then, resuspended in MACS buffer (90µl per 107 cells). 
Monoclonal antibodies to CD4 T cells were added at 10µl per 107 cells. Thereafter cells 
were incubated for 30 minutes at 4°C. The cells were separated in MACS columns placed 
in a MACS separator. The flow through which consisted of the unlabelled CD8 T cell 
population was collected. Cells were centrifuged at 500xg for 7 minutes. The pellet was 
resuspended in 2ml of complete RPMI medium. Cells were counted using Trypan blue and 
sorting of the CD8 T cells was verified using flow cytometry: see 3.8 of Materials and 
Methods.  
 
3.7 Assessment of the Immune Responses by ELISPOT assay 
An ELISPOT assay was used to enumerate the number of antigen specific effector T cells 
producing the signature cytokines, IFN-γ and IL-4 of a Th1 or Th2 response, respectively.  
• ELISPOT plate preparation 
On the first day of the ELISPOT assay, 96-well cellulose ester filtration plates (Millipore) 
were coated with either purified rat anti-mouse anti-IFN-γ (1µL/mL of 1 mg/mL) or purified 
rat anti-mouse anti-IL-4 (2µL/mL of 0.5 mg/mL) antibody (BD Pharmingen) in 
carbonate/bicarbonate buffer and incubated overnight at 4°C. 
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• Plating of effector T cells 
On the following day, the coated plates were blocked with 100µl/well of complete RPMI 
medium for 1 hour at 37°C in a 5% CO2 incubator. The cultures that had been prepared on 
day 0 were harvested on day 5 to assess the IFN-γ and IL-4 production by the effector cells. 
Cells were subsequently plated on the ELISPOT plate in duplicate on three different two-
fold cell dilutions with plus or minus fresh nominal F1 antigen or an unrelated alloantigen 
to assess specificity of the response. The number of cells per well ranged between 3-4 x 
103 cells at the highest concentration. Plates were incubated at 37°C in a 5% CO2 incubator 
for 16 to18 hours. 
 
• Plate development and counting 
The plates were subsequently washed 4 times with PBST solution, 3 times with water and 
once with PBS. Thereafter 100µl per well of biotinylated rat anti-mouse anti-IFN-γ 
monoclonal antibody (2µl/ml in 1ml PBS, BD Pharmingen) or 100µl per well of 
biotinylated rat anti-mouse anti-IL-4 monoclonal antibody (2µl/ml in 1ml PBS, BD 
Pharmingen) were added to the appropriate wells and incubated at room temperature for 2 
hours. The plates were washed with PBST seven times and once with PBS to remove 
unbound secondary antibody. Thereafter 100µl per well (0,2µg/ml) streptavidin-alkaline 
phosphatase conjugate in PBS (Cedarlane, Ontario) was added and subsequently incubated 
at room temperature for 1hour. Plates were washed 8 times, with water. A color reaction 
developed with the addition of 100µl per well NBT/BCIP (Roche; 200µl per 10ml PBS). 
Plates were incubated for approximately 15 minutes in a dark area at room temperature. 
With the appearance of spots, plates were washed with cold water to stop the enzymatic 
reaction. Plates were left to dry overnight. Spots were counted by direct visualization and 
were expressed as number of spots per 107 input cells per culture. Antigen-dependent 
cytokine producing cells were enumerated by counting cytokine spots in antigen positive 
wells. The number of spots in antigen negative wells were counted and then subtracted 
from the number of spots obtained in the antigen positive wells. 
 
Generally, 0.1% (3 -5 x 103 cells) of the culture was plated per ELISPOT well. Thus, the 
total number of spots per 107 cells input per culture at day 0 was 100% of the culture. 
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3.8 Flow Cytometric Analysis 
We determined the CD4 T cell and CD8 T cell percentages employing PE-anti-mouse CD4 
(L3/T4) (CL012) and FITC anti-mouse CD8a (Ly2) (CL169) antibodies (Cedarlane 
Ontario) and flow cytometry at a cell concentration of approximately one million cells per 
sample. The cells were incubated at 4°C for 30 minutes. Cells were washed twice, 
centrifuging at 850 x g for two minutes. Cells were resuspended in 500µl FACS buffer for 
analysis. Flow cytometry was undertaken using an BD Accuri C6 cytometer or BD EPIC 
XL Cytometer (Becton Dickinson) and analyzed using BD Accuri C6 software or Flow Jo 
software (Tree Star). To verify that the percentages obtained for CD4 T cells and CD8 T 
cells, APC anti-mouse CD3 monoclonal antibody (BioLegend) (CL17) was used. 
Employing the forward and side scatter ells were gated on the lymphocyte population. 
Thereafter, APC anti-mouse CD3 antibodies was gated in the lymphocyte population. The 
CD4 T cell and the CD8 T cell percentages were obtained by gating on the anti-CD3 
population. 
 
3.9 Statistical Analysis 
Significance was set at p < 0.05 and assessed by t tests or by analysis of variance (ANOVA) 
with post hoc analyses relying on Tukey’s multiple comparison test (GraphPad Prism 7). 
Data are represented as mean ± standard deviation (SD) of the mean from duplicate 
cultures. The minimal variability and very strong consistent results between cultures 
allowed us to use duplicate cultures.
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RESULTS 
The results section is divided into three chapters, which report on the findings of the three 
main aims of our study.  
 
CHAPTER 4 
Analysis of the role of the naturally occurring CD4:CD8 T cell ratios of the spleens of 
adult BALB/c, C57BL/6, C3H, CBA/J, DBA/1 and DBA/2, mice in determining the 
Th1 (IFN-γ) /Th2 (IL-4) phenotype of the immune response when stimulated with 
allo-MHC as assessed at day 5 of culture 
 
Preamble 
The first chapter assesses variations in the ratio of the number of CD4 T cells to that of 
CD8 T cells (subsequently referred to as the CD4:CD8 T cell ratio) that occur in the spleens 
of different strains of mice. Subsequently we assessed whether different CD4:CD8 T cell 
ratios were associated with the generation of immune responses of different Th1(IFN-γ)/ 
Th2 (IL-4) phenotypes. We used an in vitro system of direct alloreactivity to assess the 
cytokine production of the effector T cells. We initially set out to determine the CD4:CD8 
T cell ratio of the BALB/c and C57BL/6 mouse strains as they are considered to be the 
antibody (Th2) and the cell-mediated (Th1) strains, respectively. We hypothesised that a 
relatively low CD4:CD8 T cell ratio would characterize the C57BL/6 strain comparatively 
to a relatively high ratio that would characterize the BALB/c mouse, putatively explaining 
their propensity to generate a cell mediated immune response (Th1) or antibody response 
(Th2), respectively. We determined, that the relatively high CD4:CD8 T cell ratio of the 
spleens of BALB/c mice correlated with a mixed Th1(IFN-γ)/Th2(IL-4) immune response 
upon allo-MHC stimulation and that a relatively low ratio in C57BL/6 mice correlated with 
a predominant Th1 (IFN-γ) response. Subsequently we tested if the above findings were 
consistent amongst other mouse strains such as the CBA/J, C3H, DBA/1 and DBA/2 mice. 
We consistently found that a relatively high CD4:CD8 T cell ratio of the spleens of mice 
tends towards a mixed Th1 (IFN-γ)/Th2(IL-4) immune response while a relatively low 
ratio tends towards a predominant Th1(IFN-γ) immune response upon allo-MHC 
stimulation. 
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4.1 Correlation between the CD4:CD8 T cell ratio and the phenotype of the immune 
response, Th1 or Th2, generated by the spleen cells of different strains of adult 
mice upon allo-MHC stimulation 
 
4.1.1 The naturally occurring CD4:CD8 T cell ratio of the spleens of adult BALB/c 
and C57BL/6 mice are different 
The findings of Via in 1987 have demonstrated that the frequency of the CD8 T cells in 
the spleens of C57BL/6 and DBA/2 mice were different, whereas the frequency of the CD4 
T cells in the spleens of the two mouse strains were comparable. This indicated to us that 
the CD4:CD8 T cell ratio is different in the C57BL/6 and DBA/2 mice. Furthermore, this 
difference in the frequency of the CD8 T cells of the two strains of mice correlated with a 
distinctly different immune response when their lymphocytes were injected into F1, 
(C57BL/6 x DBA/2) mice. The administration of DBA/2 lymphocytes consisting of a low 
frequency of CD8 T cells resulted in an antibody mediated autoimmune disease in the F1 
mice. In contrast, the administration of the lymphocytes of the C57BL/6 mice consisting 
of a higher frequency of CD8 T cells resulted in acute graft rejection and in the inhibition 
of the antibody response. The authors reported that the suppression of the antibody 
response was due to the lysis of recipient B cells expressing allo-MHC by the cytotoxic 
activity of the CD8 T cells.  
 
We wished to determine whether BALB/c and C57BL/6 spleen cells also displayed 
different CD4:CD8 T cell ratios and what effect the difference would have on the type of 
immune response generated against the irradiated spleen cells of F1, (BALB/c x C57BL/6) 
mice. Consequently, our first step was to systematically characterize the naturally 
occurring CD4:CD8 T cell ratio of the spleens in these two strains of mice. Naïve mice 
were euthanized by cervical dislocation and their spleens were aseptically removed. We then 
determined the CD4 T cell and CD8 T cell percentages in the spleens of individual, adult 
BALB/c and C57BL/6 mice employing flow cytometry (Figure 4.1). In naïve BALB/c 
mice there were approximately twice as many CD4 T cells as CD8 T cells as illustrated by 
the flow cytometric results in Figure 4.2A. In contrast, the percentage of the CD4 T cells 
and the CD8 T cells of the C57BL/6 mice were similar as shown in Figure 4.2B. These 
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findings corresponded to a CD4:CD8 T cell ratio of approximately 2:1 and 1:1 in the 
spleens of BALB/c and C57BL/6 mice, respectively. Furthermore, the difference in the 
CD4:CD8 T cell ratio of the spleens of the BALB/c and C57BL/6 mice, is statistically 
significant as indicated in Figure 4.2C. 
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Figure 4.1: Characterization of the CD4 T cell and the CD8 T cell percentages of the 
spleens of unprimed, adult BALB/c and C57BL/6 mice. Spleen cells of naïve, adult (8-
12-week-old) BALB/c (A, B and C) and C57BL/6 (D, E and F) mice were stained with 
PE-anti-mouse CD4 (L3/T4) and FITC anti-mouse CD8a (Ly2) antibodies. We firstly 
gated the lymphocyte population, based on forward and side scatter (A and D). Thereafter 
the percentages of CD4 T cells (B and E) and CD8 T cells (C and F) were determined from 
the gated lymphocyte population, P1. Data show one representative experiment of at least 
ten independent experiments per mouse strain. 
A B C 
D E F 
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Figure 4.2 
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B 
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Figure 4.2: Significant difference between the naturally occurring CD4:CD8 T cell 
ratio among spleen cells of adult BALB/c and C57BL/6 mice. Unprimed spleen cells of 
individual, adult BALB/c and C57BL/6 mice (8-12-week-old) were stained with PE-anti-
mouse CD4 (L3/T4) and FITC anti-mouse CD8a (Ly2) antibodies. The percentage of CD4 
T cells and CD8 T cells of BALB/c (A) and C57BL/6 (B) mice were assessed via flow 
cytometry as described in Figure 4.1. The CD4:CD8 T cell ratio of the 10 BALB/c and 10 
C57BL/6 mice was compared (C). Data are represented as mean ± standard deviation (SD) 
of the mean from duplicate cultures. Data are representative of three independent 
experiments with the spleens from ten mice per strain. Statistical significance was assessed 
using unpaired students’ t test.  **** p < 0.0001 
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4.1.2 The CD4:CD8 T cell ratio are similar among the spleen cells and the cells of the 
inguinal lymph nodes  
We chose spleens as the secondary lymphoid tissue in our study. This was based on their 
size and the ease with which we could harvest them from the mice. Once we had established 
that a significant difference existed between the naturally occurring CD4:CD8 T cell ratios 
in the spleens of the BALB/c and C57BL/6 mice we needed to determine whether a similar 
CD4:CD8 T cell ratio was also evident in other secondary lymphoid tissue. Thus, we set 
out to determine the CD4:CD8 T cell ratio of the inguinal lymph nodes of the two strains 
of mice. These lymph nodes were chosen because they were easily harvested. Using flow 
cytometry, we found that there was no difference between the naturally occurring 
CD4:CD8 T cell ratio of the spleens and the inguinal lymph nodes of the BALB/c and 
C57BL/6 mice see Figure 4.3. Although the absolute percentages of CD4 T cells and CD8 
T cells in the inguinal lymph nodes were higher than that of the spleens, the CD4:CD8 T 
cell ratio remained the same in these two strains of mice. We infer that the spleens are 
representative of other secondary lymphoid tissue such as the inguinal lymph node. 
Furthermore, the naturally occurring CD4:CD8 T cell ratio in the peripheral blood was 
comparable to that in the spleens of the BALB/c and C57BL/6 mice (Pinchuk and Filipov, 
2008). We therefore, felt it valid to use the spleen cells of the BALB/c and C57BL/6 mice 
in all our experiments. 
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Figure 4.3: The CD4:CD8 T cell ratio are similar among the spleen cells and the cells 
of the inguinal lymph nodes. Unprimed cells of spleens and inguinal lymph nodes of adult 
BALB/c and C57BL/6 mice (8-12-week-old) were stained with PE-anti-mouse CD4 
(L3/T4) and FITC anti-mouse CD8a (Ly2) antibodies. Employing flow cytometry, we 
assessed the percentages of CD4 T cells and CD8 T cells of BALB/c (A) and C57BL/6 (B) 
mice. Data are representative of two independent experiments with spleen cells and 
inguinal lymph nodes from four mice per strain. Statistical significance was assessed using 
paired students’ t test.  NS: not significant 
A 
B 
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4.1.3 Expansion of CD4 T cells and CD8 T cells of the spleens of adult BALB/c and 
C57BL/6 mice assessed at day 5 of culture 
The work of Wilson, reported in 1967, employing the MLR demonstrated, that the mixing 
of blood lymphocytes from rats that differ at the MHC resulted in an increase in large cells. 
Further studies demonstrated that the incorporation of thymidine into the DNA of the cells 
indicated that the cells were undergoing mitosis, which resulted in an increase in cell 
number (Bain, Vas and Lowenstein, 1964). We observed a similar increase in large cells 
in our MLR. The basic experimental system we employed was a one-way MLR (Bach and 
Voynow, 1966; Wilson et al., 1967). In particular, ten million spleen cells from either, 
BALB/c mice, homozygous at the MHC loci, H-2d, or C57BL/6 mice, homozygous at the 
MHC loci, H-2b were cultured with ten million irradiated spleen cells from heterozygous, 
H-2d/b (BALB/c x C57BL/6), F1 mice for 5 days at 37°C and 5% CO2 in 6-well plates. We 
employed flow cytometry to determine the frequency of the CD4 T cells and CD8 T cells 
in the 5-day cultures. Expansion of the spleen cells of BALB/c mice resulted in similar 
percentages of the CD4 T cells and the CD8 T cells, see Figure 4.4A. In contrast, although 
both the CD4 T cells and the CD8 T cells of the spleens of C57BL/6 mice expanded in the 
day 5 cultures, the percentage of the CD8 effector T cells was higher than the CD4 effector 
T cells as illustrated in Figure 4.4B. There is a significant difference in the CD4:CD8 T 
cell ratio of the expanded cells of the BALB/c and C57BL/6 mouse strains as illustrated in 
Figure 4.5.  
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Figure 4.4 
A 
B 
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Figure 4.4: Expansion of CD4 T cells and CD8 T cells of the spleens of adult BALB/c 
and C57BL/6 mice upon allo-MHC stimulation assessed at day 5 of culture. Ten 
million spleen cells of either individual BALB/c (A) or C57BL/6 (B) mice were cultured 
with an equivalent number of irradiated F1, (BALB/c x C57BL/6) spleen cells and RPMI 
complete medium and incubated for 5 days at 37°C and 5% CO2 in 6-well plates. At day 5, 
cells were harvested and stained with PE-anti-mouse CD4 (L3/T4) and FITC anti-mouse 
CD8a (Ly2) antibodies. Employing flow cytometry, we assessed the percentage of CD4 T 
cells and CD8 T cells at day 0 (unprimed T cells) and day 5 (Effector T cells) of BALB/c 
(A) and C57BL/6 (B) mice. Data are representative of five independent experiments. 
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Figure 4.5: Significant difference in the CD4:CD8 T cell ratio of the spleen cells of the 
adult BALB/c and C57BL/6 mice assessed at day 5 of culture. Ten million spleen cells 
of either individual BALB/c or C57BL/6 mice were cultured with an equivalent number of 
irradiated F1, (BALB/c x C57BL/6) mice spleen cells and RPMI complete medium and 
incubated for 5 days at 37°C and 5% CO2 in 6-well plates. At day 5, cells were harvested 
and stained with PE-anti-mouse CD4 (L3/T4) and FITC anti-mouse CD8a (Ly2) 
antibodies. Flow cytometry was employed to assess the percentage of CD4 T cells and CD8 
T cells of the spleens of BALB/c and C57BL/6 mice at day 5 of culture. Data are 
represented as mean ± SD of the mean from duplicate cultures. Data are representative of 
five independent experiments per mouse strain. Statistical significance was determined by 
unpaired students’ t test.     **** p < 0.0001 
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4.1.4 The naturally occurring CD4:CD8 T cell ratio of the spleens of BALB/c and 
C57BL/6 mice is associated with a particular type of immune response, Th1 /IFN-γ or 
Th2/ IL-4, generated upon stimulation with allo-MHC 
We had previously determined that the CD4:CD8 T cell ratio of the spleens of the BALB/c 
and the C57BL/6 mice is different. We thus wanted to assess whether the different 
CD4:CD8 T cell ratios observed in spleens of BALB/c and C57BL/6 mice were associated 
with the generation of immune responses of different Th1(IFN-γ)/Th2(IL-4) phenotypes 
upon stimulation with allo-MHC. Our in vitro system allowed us to explore the differential 
development of T cells through quantitative interactions initiated by antigen and through 
cytokine molecules produced by lymphocytes in an orderly fashion. Thus, five days after 
culturing the spleen cells with irradiated F1 (BALB/c x C57BL/6) spleen cells, we 
harvested and restimulated the cells with the nominal antigen and assessed their allo-MHC-
dependent IFN-γ and IL-4 production employing the ELISPOT assay. Differences in the 
MHC between the spleen cells of the BALB/c mouse and the irradiated spleen cells of the 
F1 mice generated a mixed Th1 (IFN-γ) /Th2 (IL-4), immune response (Figure 4.6A). In 
contrast, the MHC disparity between the spleen cells of the C57BL/6 mice and the 
irradiated spleen cells of the F1 mice generated a predominantly Th1 (IFN-γ) immune 
response (Figure 4.6B). We found that there was a significant difference in the production 
of IL-4 between the spleen cells of these two mouse strains when activated under identical 
conditions. The spleen cells of the BALB/c mice produced significantly higher levels of 
IL-4 than the spleen cells of the C57BL/6 mice (Figure 4.6C). The level of IFN-γ 
production appeared to be similar between the two mouse strains. Thus, the IFN-γ:IL-4 
ratio of the two mouse strains was significantly different (Figure 4.7). We thus concluded 
that the relatively high CD4:CD8 T cell ratio of the spleens of the BALB/c mice is 
associated with a mixed Th1(IFN-γ)/Th2(IL-4) immune response upon stimulation with 
allo-MHC while the relatively low CD4:CD8 T cell ratio of the spleens of the C57BL/6 
mice is associated with a predominant Th1(IFN-γ) immune response upon allo-MHC 
stimulation. 
 
The MHC disparity between donor and host cells is a known activator of alloreactive T 
cells (Rolink et al., 1983, van Rappard-van der Veen, et al., 1982). Alloreactive T cells can 
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recognise allo-MHC directly without the need for processing the antigen, thus reducing the 
time of activation and proliferation of effector T cells (Letchler and Batchelor, 1982). The 
large number of spots observed on our ELISPOT plate after only 5 days with allo-MHC 
stimulation provides strong evidence for direct allorecognition and further verifies the 
observation of a high frequency of T cell alloreactivity. The frequency of T cells specific 
for allo-MHC is approximately 1 in102, whereas the frequency of T cells specific for a 
typical foreign antigen is of the order of 1 in 105 (Wilson et al., 1968). 
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Figure 4.6 
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B 
C 
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Figure 4.6: IFN-γ and IL-4 production of the Effector T cells of spleens of adult 
BALB/c and C57BL/6 mice assessed at day 5 of culture. Ten million unprimed spleen 
cells of either individual, adult BALB/c (A) or individual adult C57BL/6 (B) mice were 
cultured with an equivalent number of fresh, irradiated F1, (BALB/c x C57BL/6) spleen 
cells and incubated for 5 days at 37°C and 5% CO2 in 6-well plates. On day 5, culture 
equivalent effector cells, typically 3-5 x 103 cells/well at the highest concentration, were 
assessed for IFN-γ and IL-4 production in our ELISPOT assay. The comparison between 
the IFN-γ and IL-4 producing cells in individual BALB/c and C57BL/6 mice is depicted 
in C. Data are represented as mean ± SD of the mean from duplicate cultures. Data are 
representative of three independent experiments with the spleen cells from two to three 
mice per experiment. Data are plotted as the number of spots per 107 spleen cells input at 
day 0 per culture. The p values were obtained with two-way analysis of variance (ANOVA) 
and Tukey’s post-test for multiple comparisons. 
 **** p < 0.0001 
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Figure 4.7: Significant difference between the ratio of IFN-γ:IL-4 producing cells of 
spleens of adult BALB/c and C57BL/6 mice. The figure represents the re-plotting of the 
data of Figure 4.6. Data are represented as mean ± SD of the mean from duplicate cultures. 
Data are representative of three independent experiments with the spleen cells from two to 
three mice per experiment. Statistical significance was determined by unpaired students’ t 
test.  **** p < 0.0001 
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4.1.5 The CD4:CD8 T cell ratio of the spleens of CBA/J, C3H, DBA/2 and DBA/1 
strains of mice affects is associated with a particular type of immune response, 
Th1/IFN-γ or Th2/IL-4, generated upon stimulation with allo-MHC  
Once we had determined that the CD4:CD8 T cell ratio of the spleens of the BALB/c and 
C57BL/6 mice is associated with a particular type of immune response generated against 
allo-MHC we wanted to determine if this finding was consistent in other strains of mice. 
We used the CBA/J and C3H strains of mice that display a H-2k MHC haplotype as well 
as the DBA/2 and the DBA/1 strains of mice, which display a H-2d and a H-2q MHC 
haplotype, respectively. Our first step was to characterize the CD4:CD8 T cell ratio of the 
spleens of the different strains of mice. Employing flow cytometry, we found that the 
spleen cells of the CBA/J and the C3H mice exhibited a CD4:CD8 T cell ratio below 2 
while the spleens of the DBA/2 had a ratio above 2 (Figure 4.8 and Figure 4.9). The spleen 
cells of the DBA/1 mouse strain had a CD4:CD8 T cell of 2. We thus wanted to determine 
the type of immune response the spleen cells of the above-mentioned strains of mice would 
display upon stimulation with allo-MHC. Five days after culturing the spleen cells with 
irradiated F1, (BALB/c x C57BL/6) we harvested the cells and determined the expansion 
of cells in the different strains of mice using flow cytometry (Figure 4.10A and 4.10B). 
Thereafter spleens cells were restimulated with the nominal antigen and their allo-MHC-
dependent IFN-γ and IL-4 production was assessed by employing the ELISPOT assay 
(Figure 4.10C and Figure 4.11). We found that the spleen cells of the CBA/J and C3H 
strains of mice that displayed a CD4:CD8 T cell ratio below 2 generated a predominant 
Th1 (IFN-γ) immune response, albeit, more so in the CBA/J mice than in the C3H strain. 
In contrast, the spleen cells of the DBA/1 and DBA/2 mouse strains that exhibited a 
CD4:CD8 T cell ratio of 2 and above 2, respectively generated a mixed Th1 (IFN-γ)/ Th2 
(IL-4) immune response upon stimulation with allo-MHC.  
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Figure 4.8: Variations in the CD4:CD8 T cell ratio of the spleens of individual, adult 
CBA/J, C3H, DBA/2 and DBA/1 mice. Unprimed cells of the spleens of the different 
strains of mice were stained with PE-anti-mouse CD4 (L3/T4), FITC anti-mouse CD8a 
(Ly2) and APC anti-mouse CD3 antibodies. Flow cytometry was employed to assess the 
percentage of CD4 T cells and CD8 T cells of the spleens of the different strains of mice 
at day 0. Data are representative of two independent experiments with three mice per strain 
per experiment.  
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Figure 4.9: Comparison of the naturally occurring CD4:CD8 T cell ratios of different 
strains of mice. The figure represents the re-plotting of the data of Figure 4.5 and Figure 
4.8. Data are represented as mean ± SD of the mean from duplicate cultures. Data are 
representative of two independent experiments with the spleen cells from three individual, 
CBA/J, C3H, DBA/1 or DBA/2 mice per experiment and three independent experiments 
with the spleen cells from two to three individual, BALB/c and C57BL/6 mice per 
experiment.  
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Figure 4.10C
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Figure 4.10: The IFN-γ and IL-4 production of the Effector T cells of spleens of 
individual, adult CBA/J, C3H, DBA/2 and DBA/1 mice were assessed at day 5 of 
culture. (A) Four million unprimed spleen cells of either individual adult CBA/J, or C3H, 
or DBA/1 or DBA/2 mice were each cultured with an equivalent number of fresh, irradiated 
F1, (BALB/c x C57BL/6) spleen cells and incubated for 5 days at 37°C and 5% CO2 in 12-
well plates. (A) On day 5, effector cells of the different strains of mice were stained with 
PE-anti-mouse CD4 (L3/T4), FITC anti-mouse CD8a (Ly2) and APC anti-mouse CD3 
antibodies. Flow cytometry was employed to assess the percentage of CD4 T cells and CD8 
T cells of the spleens of the different strains of mice at day 5. (B) Flow cytometry data 
show one representative experiment of two independent experiments of the DBA/2 (I) and 
CBA/J (II) mouse strains. (C) Culture equivalent effector cells, typically 3-5 x 103 
cells/well at the highest concentration, were assessed for IFN-γ and IL-4 production in our 
ELISPOT assay. Data are representative of two independent experiments with two or three 
individual mice per experiment and are plotted as the number of spots per 107 spleen cells 
input at day 0 per culture. 
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Figure 4.11: Comparison of the ratio of IFN-γ:IL-4 producing cells in different strains 
of mice. The figure represents the re-plotting of data from Figures 4.7 and 4.10C. Data are 
represented as mean ± SD of the mean from duplicate cultures. Data are representative of 
two independent experiments with the spleen cells from five or seven mice per strain.  
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4.1.6 Characterization of the Phenotype of Effector T cells of the spleens of BALB/c 
mice producing IFN-γ and IL-4 Cytokines: IL-4 is produced exclusively by CD4 T 
cells 
The findings presented in Figure 4.6 indicate that the BALB/c mouse generates a mixed 
Th1 (IFN-γ)/Th2 (IL-4) upon stimulation with allo-MHC, as opposed to the C57BL/6 
mouse that generates a predominantly Th1 (IFN-γ) immune response. Consequently, we 
characterized the phenotype of the T cell that produces the IL-4 in BALB/c cultures 
activated in vitro with fresh irradiated F1, (BALB/c x C57BL/6) spleen cells. On day 5, 
cultures were sorted by negative selection with MACS monoclonal antibodies to CD8 
positive T cell fractions and CD4 positive T cell fractions prior to their assessment for 
alloantigen-dependent cytokine production by the ELISPOT assay. To confirm the 
successful selection of the CD4 T cell and CD8 T cell populations flow cytometry was 
employed (Figure 4.12A). We found that, while IFN-γ, was produced by both CD4 T cells 
and CD8 T cells, IL-4 was produced exclusively by the CD4 T cells (Figure 4.12B).  
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Figure 4.12: Characterization of the phenotype of Effector T cells producing IFN-γ 
and IL-4 cytokines: IL-4 is produced exclusively by CD4 T cells 
Ten million unprimed spleen cells of BALB/c mice were cultured with an equivalent 
number of fresh, irradiated F1, (BALB/c x C57BL/6) mouse spleen cells and incubated for 
5 days at 37°C and 5% CO2 in 6-well plates. On day 5, cultures were fractionated by 
negative selection using MACS monoclonal antibodies to CD4 positive T cell fractions 
and CD8 positive T cell fractions prior to their assessment for allo-MHC dependent 
cytokine production by the ELISPOT assay. Fractionation was verified using Flow 
Cytometry. (A) Flow cytometry data show one representative experiment of three 
independent experiments. (B) Culture equivalent effector cells, typically 3-5 x 103 
cells/well at the highest concentration, were assessed for IFN-γ and IL-4 production in our 
ELISPOT assay. Data are plotted as the number of spots per 107 spleen cells input at day 
0 per culture. Data are represented as mean ± SD of the mean from duplicate cultures. Data 
are representative of three independent experiments with the spleen cells from six mice per 
strain. The p values were obtained with ANOVA and Tukey’s post-test for multiple 
comparisons.  *** p = 0.0001, ****p < 0.0001 
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4.1.7 The production of IFN-γ and IL-4 cytokines by Effector T cells is antigen-
dependent and antigen specific 
From this point on we continued our experiments using only our initial choice of mouse 
strains, the BALB/c and C57BL/6 mice. The next step was to determine if the immune 
response to allo-MHC that we observed for the BALB/c and C57BL/6 mice was dependent 
on the priming antigen as well as being able to discriminate between various antigens. In 
order to achieve this objective, we primed the spleen cells of either the BALB/c or the 
C57BL/6 mice with the irradiated F1 spleen cells for 5 days. Thereafter, the production of 
IFN-γ and IL-4 was ascertained either, with or without the restimulation with the nominal 
F1 antigen, to determine if the immune response generated was antigen dependent. 
Furthermore, the cells were also restimulated with unrelated allo-MHC cells that were from 
the freshly, irradiated spleen cells of a C3H mouse strain that exhibits the H-2k haplotype. 
In the absence of the antigen or when stimulated with an unrelated antigen the spleen cells 
of the BALB/c mice (Figure 4.13A) and C57BL/6 mice (Figure 4.13B) produce negligible 
amounts of IFN-γ and IL-4. However, restimulation with the nominal F1 antigen, resulted 
in a mixed Th1 (IFN-γ) / Th2 (IL-4) immune response by the spleen cells of the BALB/c 
mice and a predominant Th1 (IFN-γ) immune response by the spleen cells of the C57BL/6 
mice as initially observed in Figure 4.6C. This suggests that the immune response of the 
spleen cells of the BALB/c and the C57BL/6 mice to allo-MHC is antigen-dependent and 
antigen-specific. 
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Figure 4.13: The production of IFN-γ and IL-4 in response to allo-MHC stimulation 
is antigen-dependent and antigen-specific. Ten million unprimed spleen cells of either 
adult BALB/c (A) or C57BL/6 (B) mice were cultured with an equivalent number of fresh, 
irradiated F1, (BALB/c x C57BL/6) spleen cells for 5 days at 37°C and 5% CO2 in 6-well 
plates. On day 5, culture equivalent effector cells, typically 3-5 x 103 cells/well at the 
highest concentration, were assessed for IFN-γ and IL-4 production in our ELISPOT assay. 
Primed cells received either no antigen, were restimulated with the nominal antigen, F1, or 
were restimulated with an unrelated antigen, the irradiated spleen cells of C3H mice. Data 
are represented as mean ± SD of the mean from duplicate cultures. Data are representative 
of three independent experiments with the spleen cells from six mice per strain. The p 
values were obtained with ANOVA with Tukey’s post-test for multiple comparisons.      
*** p = 0.0001,  **** p < 0.0001,    
NS not significant 
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4.1.8 Individual spleen cells versus pooled spleen cells 
(I) No difference was observed in the percentages of CD4 T cells and CD8 T cells of 
individual spleens and pooled spleen cells of BALB/c and C57BL/6 mice 
Due to the many varied objectives we wished to achieve in a single experiment, spleen 
cells from a single mouse would have been insufficient to successfully accomplish this. 
Thus, we decided to pool spleen cells from two or more mice per experiment. In order to 
justify the use of pooled spleen cells we first compared the unprimed CD4:CD8 T cell ratio 
of spleen cells from individual mice with that of pooled spleen cells using flow cytometry. 
There was no difference in the CD4 T cells and CD8 T cells of individual and pooled 
spleens of both BALB/c (Figure 4.14A) and C57BL/6 (Figure 4.14B) mice. 
 
(II) The production of IFN-γ and IL-4 by the cells of individual spleens of BALB/c 
and C57BL/6 mice is equivalent to the IFN-γ and IL-4 production of pooled spleen 
cells upon restimulation with fresh irradiated F1 (BALB/c x C57BL/6) spleen cells 
The next step was to compare the allo-MHC-dependent production of the IFN-γ and IL-4 
by the individual spleens and the pooled spleens when cultured under identical conditions. 
As described above we cultured ten million unprimed spleen cells of either the individual 
spleens or the pooled spleen of both mouse strains with equivalent numbers of irradiated 
F1 allo-MHC for 5 days. Employing the ELISPOT assay we assessed the production of the 
IFN-γ and IL-4. A comparison of individual spleen cells versus pooled spleen cells 
indicated no difference between the frequencies of the IFN-γ or IL-4 producing cells after 
stimulation with allo-MHC in either, BALB/c (Figure 4.15A) or C57BL/6 (Figure 4.15B) 
mice. This result justified our use of pooled spleen cells in subsequent experiments. 
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Figure 4.14: No difference in the percentages of CD4 T cells and CD8 T cells of 
individual spleens and pooled spleen cells of BALB/c and C57BL/6 mice. Unprimed 
cells of individual and pooled spleens of adult BALB/c (A) and C57BL/6 (B) mice (8-12-
week-old) were stained with PE-anti-mouse CD4 (L3/T4) and FITC anti-mouse CD8a 
(Ly2) antibodies. The percentage of CD4 T cells and CD8 T cells were assessed via flow 
cytometry. Data are representative of two independent experiments with two individual 
mice per experiment.
A 
B 
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Figure 4.15: The production of IFN-γ and IL-4 by the cells of individual spleens of 
BALB/c and C57BL/6 mice is equivalent to the IFN-γ and IL-4 production of pooled 
spleen cells at day 5 of culture upon restimulation with F1 (BALB/c x C57BL/6) spleen 
cells. Ten million unprimed spleen cells of either individual spleens or pooled spleen cells 
of either BALB/c (A) or C57BL/6 (B) mice were cultured with an equivalent number of 
fresh, irradiated F1, (BALB/c x C57BL/6) spleen cells and incubated for 5 days at 37°C 
and 5% CO2 in 6-well plates. On day 5, culture equivalent effector cells, typically 3-5 x 103 
cells/well at the highest concentration, were assessed for IFN-γ and IL-4 in our ELISPOT 
assay. Data are represented as mean ± SD of the mean from duplicate cultures. Data are 
representative of two independent experiments with the spleen cells from two individual 
mice per experiment. The p values were obtained with ANOVA and Tukey’s post-test for 
multiple comparisons. NS: not significant 
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CHAPTER 5 
The role of CD8 T cells in promoting the differentiation of naive CD4 T cells towards 
a Th1 (IFN-γ) mode and the concomitant inhibition of the CD4 Th2 (IL-4) subset 
 
Preamble 
The second section of the results explores the role of the CD8 T cell in the differentiation 
of naïve CD4 T cells to either a Th1 (IFN-γ) or a Th2 (IL-4) subset. The importance of 
CD8 T cells in enhancing a Th1 immune response has been demonstrated in various 
studies. In the GVHD mouse model the development of an acute GVHR in F1 mice was 
dependent on a high frequency of CD8 T cells in the parental inoculum of C57BL/6 mice 
injected into the F1 (C57BL/6 x DBA/2) mice (Tschetter et al., 2000; Via et al., 1987). In 
contrast, the near absence of CD8 T cells in the inoculum of DBA/2 mice resulted in an 
antibody mediated autoimmune disease. Herath has demonstrated in 2003 the significance 
of the CD8 T cells in providing protection against an intracellular pathogen, L major 
(Herath et al., 2003). The presence of the CD8 T cells enhanced a Th1 immune response, 
characterized by the presence of IFN-γ which was required for protection, while the 
absence of CD8 T cells resulted in a Th2 immune response, which rendered the individual 
mice susceptible to the pathogen. These findings argue in favour of a regulatory role for 
CD8 T cells in determining the type of immune response, Th1 or Th2, generated.  
 
We thus set out to explore in our in vitro system the effect of the CD8 T cells on the 
differentiation of the naïve CD4 T cell into either a Th1 (IFN-γ) or a Th2 (IL-4) producing 
cell in the spleens of BALB/c and C57BL/6 mice upon allo-MHC stimulation. Undertaking 
in vitro experiments allowed us to manipulate cultures in order to research on the 
mechanism of the regulatory role of the CD8 T cells on CD4 T cell differentiation. 
According to our model in Figure 2.1, differentiation of unprimed CD4 T cells towards a 
stable Th1 phenotype is critically dependent on the concomitant induction of CD8 T cells 
by allo-MHC. In contrast, the absence of the CD8 T cells in the initial priming of 
lymphocytes by allo-MHC greatly facilitates the differentiation of CD4 T cells towards the 
Th2 lineage. To test our hypothesis, we used two approaches. The indirect approach 
examined the immune response of the naïve CD4 T cells upon stimulation with allo-MHC 
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in the absence of CD8 T cells. Spleen cells were depleted of CD8 T cells by using anti-
CD8 TIB 211 antibody and rabbit complement as described in the Material and Methods. 
In the direct approach the original CD4:CD8 T cell ratio of CD8 T cell depleted cultures 
was reconstructed as close as possible to the original ratio by the addition of sorted naïve 
CD8 T cells. The ELISPOT assay was used to assess the production of IFN-γ and IL-4 at 
the single cell level in cultures in which the CD8 T cells were either present or absent or in 
cultures to which different numbers of CD8 T cells were added.  
 
5.1 CD8 T cells regulate the differentiation of the CD4 T cell to either a Th1(IFN-γ) 
or a mixed Th1/Th2 (IFN-γ /IL-4) immune response  
 
5.1.1 The absence of CD8 T cells at the initiation of the immune response to allo-MHC 
results in the CD4 T cells displaying a Th2 (IL-4) phenotype  
(Indirect Approach) 
In the indirect approach the differentiation of the CD4 T cell, in response to stimulation 
with allo-MHC was determined in the absence of CD8 T cells. The CD8 T cells were 
depleted from the spleen cells using anti-CD8 TIB 211 antibody and Low Tox-M rabbit 
complement. Flow cytometry verified the depletion of CD8 T cells from the spleen cells 
of the BALB/c mice (Figure 5.1A) and the C57BL/6 mice (Figure 5.2A) at day 0 and that 
this was maintained after 5 days (Figure 5.1B and Figures 5.2B) in culture. The control 
cultures of the spleens of BALB/c mice contained both CD4 and CD8 T cells and resulted 
in a mixed Th1(IFN-γ) /Th2 (IL-4) immune response. Similarly, the control cultures of the 
spleens of C57BL/6 mice produced a predominant Th1 (IFN-γ) immune response as 
illustrated in Figure 4.6. However, it is evident that in the absence of CD8 T cells, spleen 
cells acquired a Th2 (IL-4) phenotype in response to allo-MHC which is depicted by the 
predominant production of IL-4 in both mouse strains (Figure 5.1C and Figure 5.2C). The 
predominant IL-4 production in the CD8 T cell depleted cultures of both mouse strains 
equate to a significant difference in the IFN-γ:IL-4 ratio of both BALB/c (Figure 5.3A) and 
C57BL/6 (Figure 5.3B). The fact that both types of culture are stimulated under identical 
conditions and the only difference between responder cells is the presence or absence of 
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CD8 T cells argues favourably for a regulatory role for the CD8 T cell in the acquisition of 
the Th1 (IFN-γ) or the Th2 (IL-4) phenotype by naïve CD4 T cells.  
 
In addition, we wanted to ascertain whether these findings were consistent across other 
strains of mice. Thus, the spleen cells of CBA/J, C3H, DBA/2 and DBA/1 mice were 
depleted of CD8 T cells as described above. CD8 T cell depleted spleens were cultured 
with irradiated allo-MHC for 5 days at 37°C and 5% CO2. We found that the depletion of 
the CD8 T cells from the spleens of mice resulted in a predominant Th2 (IL-4) immune 
response in all strains of mice tested, CBA/J, C3H, DBA/2 and DBA/1 (Figure 5.4). Thus, 
we can conclude that in the absence of CD8 T cells, CD4 T cells differentiate into a Th2 
(IL-4) subset upon stimulation with allo-MHC. 
 
We also decided to determine if the immune response of the CD4 T cells in the CD8 T cell 
depleted cultures stimulated with allo-MHC in the BALB/c and C57BL/6 mice was also 
antigen-dependent and antigen-specific. The CD8 T cell depleted cultures were 
restimulated on day 5 with the nominal F1 antigen or an unrelated antigen, the irradiated 
spleen cells of the C3H mouse. CD8 T cell depleted cultures also received no antigen 
stimulation in the ELISPOT plate. We found that the immune response of the CD4 T cells 
to allo-MHC in the CD8 T cell depleted cultures of both BALB/c (Figure 5.5A) and 
C57BL/6 (Figure 5.5B) mice were also antigen-dependent and antigen-specific. 
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Figure 5.1: CD8 T cells regulate the immune response of the spleen cells of BALB/c 
mice away from a Th2 mode towards a mixed Th1/Th2 mode. Ten million spleen cells 
from BALB/c mice or equivalent numbers of CD8 T cell depleted spleen cells, were 
cultured with ten million irradiated F1, (BALB/c x C57BL/6), spleen cells for 5 days, at 
37°C and 5% CO2 in 6-well plates. Cultures were depleted of CD8 T cells by using anti-
CD8 TIB 211 antibody and Low Tox-M rabbit complement. Percentages of CD4 T cells 
and CD8 T cells were assessed by flow cytometry on day 0 (A) and day 5 (B). Flow 
cytometry data show one representative experiment of three independent experiments. (C) 
On day 5, culture equivalent effector cells, typically 3-5 x 103 cells/well at the highest 
concentration, were assessed for IFN-γ and IL-4 production in our ELISPOT assay. 
ELISPOT data are plotted as the number of spots per 107 spleen cells input at day 0 per 
culture. Data are represented as mean ± SD of the mean from duplicate cultures. Data are 
representative of three independent experiments with the spleen cells from two individual 
mice per experiment. The p values were obtained with ANOVA and Tukey’s post-test for 
multiple comparisons.                 
****p < 0.0001 
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Figure 5.2: CD8 T cells regulate the immune response of the spleen cells of C57BL/6 
mice towards a Th1 mode. Ten million spleen cells from the C57BL/6 mouse or 
equivalent numbers of CD8 T cell depleted spleen cells, were cultured with irradiated F1, 
(BALB/c x C57BL/6), spleen cells for 5 days, at 37°C and 5% CO2 in 6-well plates. 
Cultures were depleted of CD8 T cells by using anti-CD8 TIB 211 antibody and Low Tox-
M rabbit complement. Percentages of CD4 T cells and CD8 T cells were assessed by flow 
cytometry on day 0 (A) and day 5 (B). Flow cytometry data show one representative 
experiment of three independent experiments. (C) On day 5, culture equivalent effector 
cells, typically 3-5 x 103 cells/well at the highest concentration, were assessed for IFN-γ 
and IL-4 production in our ELISPOT assay. Data are represented as mean ± SD of the 
mean from duplicate cultures. Data are representative of three independent experiments 
with the spleen cells from two individual mice per experiment. The p values were obtained 
with ANOVA and Tukey’s post-test for multiple comparisons.   
 *** p = 0.0001, ****p < 0.0001 
 
 123 
A 
 
 
 
 
 
 
 
 
Figure 5.3: Significant difference in the ratio of IFN-γ:IL-4 producing spleen cells in 
the control cultures and the CD8 T cell depleted cultures of BALB/c and C57BL/6 
mice. The figure represents the re-plotting of the data of BALB/c mice in Figure 5.1C and 
the C57BL/6 mice in Figure 5.2C. Data are represented as mean ± SD of the mean from 
duplicate cultures. Data are representative of three independent experiments with the 
spleen cells from two individual mice per experiment. Statistical analysis was determined 
by unpaired student’s t test.  ** p = 0.0039; **** p < 0.0001 
B 
A 
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Figure 5.4
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Figure 5.4: CD8 T cells regulate the immune response towards a Th1 mode and away 
from a Th2 phenotype in the CBA/J, C3H, DBA/2 and DBA/1 strains of mice. Four 
million spleen cells depleted of CD8 T cells, were cultured with four million irradiated F1, 
(BALB/c x C57BL/6), spleen cells at 37°C and 5% CO2 for 5 days. Cultures were depleted 
of CD8 T cells by using anti-CD8 TIB 211 antibody and Low Tox-M rabbit complement. 
On day 5, culture equivalent effector cells, typically 3-5 x 103 cells/well at the highest 
concentration, were assessed for IFN-γ and IL-4 production in our ELISPOT assay. Data 
are representative of two independent experiments with spleen cells from two or three 
individual mice per experiment and are plotted as the number of spots per 107 spleen cells 
input at day 0 per culture.  
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Figure 5.5: The production of IFN-γ and IL-4 by Effector T cells in CD8 T cell 
depleted cultures is alloantigen-dependent and alloantigen-specific. Ten million spleen 
cells depleted of CD8 T cells of either BALB/c (A) or C57BL/6 (B) mice were cultured 
with an equivalent number of fresh, irradiated F1, (BALB/c x C57BL/6) spleen cells for 5 
days, at 37°C and 5% CO2 in 6-well plates. On day 5, culture equivalent effector cells, 
typically 3-5 x 103 effector cells/well at the highest concentration, were assessed for       
IFN-γ and IL-4 production in our ELISPOT assay. Primed cells received no antigen, or 
were restimulated with the nominal antigen, irradiated F1 spleen cells or restimulated with 
an unrelated alloantigen, irradiated spleen cells of C3H mice. Data are plotted as the 
number of spots per 107 spleen cells input at day 0 per culture. Data are represented as 
mean ± SD of the mean from duplicate cultures. Data are representative of three 
independent experiments with the spleen cells from two individual mice per experiment. 
The p values were obtained with ANOVA and Tukey’s post-test comparing for multiple 
comparisons.  
NS not significant 
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5.1.2 The reconstruction of the CD4:CD8 T cell ratio in CD8 T cell depleted cultures 
with sorted unprimed CD8 T cells switches the immune response from a Th2 to a Th1 
mode in C57BL/6 mice or to a mixed Th1/Th2 phenotype in BALB/c mice 
(Direct Approach) 
We further tested the regulatory role of CD8 T cells in the decision-making process of 
switching the Th2 (IL-4) immune response to a Th1 (IFN-γ) mode by reconstructing the 
CD4:CD8 T cell ratio of CD8 T cell depleted cultures to that of normal controls (as closely 
as possible) and comparing the IFN-γ and IL-4 producing cells in the reconstructed 
cultures. We obtained a sorted CD8 T cell population from the spleens of the BALB/c 
(Figure 5.7A) and C57BL/6 (Figure 5.8A) mice as described in Materials and Methods. 
The production of IFN-γ and IL-4 by the control cultures, CD8 T cell depleted cultures and 
reconstructed CD8 T cell depleted cultures were assessed by ELISPOT assay on day 5 of 
culture. We found that the CD8 T cells were able to quantitatively switch the immune 
response from a Th2 (IL-4) immune response to a mixed Th1(IFN-γ)/Th2(IL-4) mode, 
through the restoration of the IFN-γ in the CD8 T cell depleted cultures of the BALB/c 
mice (Figures 5.7B and C). Similarly, the addition of CD8 T cells to the CD8 T cell 
depleted cultures of C57BL/6 mice at day 0 was able to switch the immune response from 
a predominant Th2 (IL-4) immune response to a predominant Th1 (IFN-γ) mode (Figures 
5.8B and C). Thus, we found that the immune response observed in the control cultures 
was restored in the reconstructed CD8 T cell depleted cultures. The findings in Figure 5.7 
and Figure 5.8 confirms the regulatory role of CD8 T cells in the differentiation of naïve 
CD4 T cells towards a mixed Th1/Th2 immune response in BALB/c mice and towards a 
predominant Th1 immune response in C57BL/6 mice. 
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Figure 5.6: The presence of CD8 T cells results in a switch from a Th2 to a mixed 
Th1/Th2 immune response in reconstructed CD8 T cell depleted cultures of the 
BALB/c mice. Ten million spleen cells from BALB/c mice and equivalent numbers of 
CD8 T cell depleted spleen cells were cultured with ten million irradiated F1, (BALB/c x 
C57BL/6), spleen cells at 37°C and 5% CO2 for 5 days in 6-well plates. A specific number 
of sorted CD8 T cells, representing their natural percentage in normal spleens, were added 
to the cultures at day 0 in order to reconstruct the naturally occurring CD4:CD8 T cell ratio. 
Sorted CD8+CD4- T cells were obtained using the non-adherent fraction of the Nylon wool 
column for T cell enrichment. Subsequently CD8 T cells were obtained by negative 
selection using MACS monoclonal antibodies to CD4 T cells. (A) Verification of sorted 
CD8 T cells was assessed by flow cytometry. Flow cytometry data show one representative 
experiment of three independent experiments. (B) On day 5, culture equivalent effector 
cells, typically 3-5 x 103 cells/well at the highest concentration, were assessed for IFN-γ 
and IL-4 production in our ELISPOT assay. (C) Comparison of the IFN-γ:IL-4 ratio of the 
control, CD8 T cell depleted and reconstructed CD8 T cell depleted cultures. Data are 
plotted as the number of spots per 107 spleen cells input at day 0 per culture. Data are 
represented as mean ± SD of the mean from duplicate cultures. Data are representative of 
three independent experiments with the pooled spleen cells from three mice per 
experiment. Statistical analysis was determined by unpaired student’s t test.        
NS: not significant  
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Figure 5.7: The presence of CD8 T cells results in a switch from a Th2 to a Th1 
immune response in reconstructed CD8 T cell depleted cultures of the C57BL/6 mice. 
Ten million spleen cells from C57BL/6 mice and equivalent numbers of CD8 T cell 
depleted spleen cells were cultured with irradiated F1, (BALB/c x C57BL/6), spleen cells 
for 5 days, at 37°C and 5% CO2 in 6-well plates. A specific number of sorted CD8 T cells, 
representing their natural percentage in normal spleens, were added to the cultures at day 
0 in order to reconstruct the naturally occurring CD4:CD8 T cell ratio. Sorted CD8+CD4- 
T cells were obtained using Nylon wool for T cell enrichment and thereafter, negative 
selection using MACS monoclonal antibodies to CD4 T cells. Verification of sorted CD8 
T cells was assessed by flow cytometry. (A) Flow cytometry data show one representative 
experiment of three independent experiments. (B) On day 5, culture equivalent Effector 
cells were assessed for IFN-γ and IL-4 production in our ELISPOT assay. (C) Comparison 
of the IFN-γ:IL-4 ratio of the Control, CD8 T cell depleted and Reconstructed CD8 T cell 
depleted cultures are depicted. ELISPOT data are plotted as the number of spots per 
107cells input per culture. Data are represented as mean ± SD of the mean from duplicate 
cultures. Data are representative of three independent experiments with the pooled spleen 
cells from three mice per experiment. Statistical analysis was determined by unpaired 
student’s t test. NS: not significant 
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5.1.3 The reconstruction of the CD4:CD8 T cell ratio in CD8 T cell depleted cultures 
with sorted unprimed CD8 T cells switches the CD4 Th2 (IL-4) immune response to 
a mixed Th1(IFN-γ)/Th2 (IL-4) phenotype 
Immune regulation as described in the introduction states that the CD8 T cell inhibits the 
antibody response (Bretscher, 1974; Ramshaw et al., 1977). Our work assessed the 
differentiation of naïve CD4 T cells by cognate regulation of CD8 T cells at the level of 
cytokines produced. Our findings in Figures 5.6 and 5.7 show that the addition of sorted 
unprimed CD8 T cells to CD8 T cell depleted cultures resulted in an increase in the 
production of IFN-γ and a decrease in IL-4 in both the BALB/c and the C57BL/6 cultures. 
We, however, wished to determine the effect the addition of sorted CD8 T cells would have 
on the production of cytokines by the CD4 T cells. We wanted to determine whether the 
increase in IFN-γ observed in the reconstructed CD8 T cell depeted cultures occured at the 
CD4 T cell level and was not only due to the addition of CD8 T cells which is known to 
produce IFN-γ. Thus at day 5 of culture we obtained CD4+CD8- T cell populations from 
the control cultures, the CD8 T cell depleted cultures and the reconstructed CD8 T cell 
depleted cultures by negative selection using MACS monoclonal antibodies to CD8 T cells. 
The CD4 T cells in the reconstructed CD8 T cell depleted cultures of the BALB/c spleen 
cells (Figure 5.8) showed a decrease in IL-4 and an increase in IFN-γ. Similarly, the CD4 
T cells in the reconstructed CD8 T cell depleted cultures showed a decrease in IL-4 and an 
increase in IFN-γ (Figure 5.9). Our findings demonstrate that the addition of sorted 
unprimed CD8 T cells to the reconstructed cultures causes a switch from a predominant 
Th2 (IL-4) response to a mixed IFN-γ /IL-4 response by the CD4 T cell.
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Figure 5.8: The presence of CD8 T cells switches the CD4 Th2 (IL-4) response to a 
mixed Th1 (IFN-γ)/Th2 (IL-4) immune response in reconstructed CD8 T cell depleted 
cultures in BALB/c mice. Ten million spleen cells from BALB/c mice and equivalent 
numbers of CD8 T cell depleted spleen cells were cultured with ten million irradiated F1, 
(BALB/c x C57BL/6), spleen cells at 37°C and 5% CO2 for 5 days in 6-well plates. A 
specific number of sorted, unprimed CD8 T cells were added to the CD8 T cell depleted 
cultures at day 0 in order to reconstruct the naturally occurring CD4:CD8 T cell ratio. On 
day 5, control and reconstructed cultures were fractionated into CD4+CD8- T cell 
populations by negative selection using MACS monoclonal antibodies to CD8 T cells prior 
to their assessment for allo-MHC dependent cytokine production by the ELISPOT assay. 
Culture equivalent Effector cells of the CD4+CD8- T cell populations were assessed for 
IFN-γ and IL-4 production in our ELISPOT assay. Data are plotted as the number of spots 
per 107 spleen cells input at day 0 per culture. Data are represented as mean ± SD of the 
mean from duplicate cultures. Data are representative of three independent experiments 
with the pooled spleen cells from three mice per experiment.
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Figure 5.9: The presence of CD8 T cells switches the CD4 Th2 (IL-4) response to a 
mixed Th1 (IFN-γ)/Th2 (IL-4) in reconstructed CD8 T cell depleted cultures in 
C57BL/6 mice. Ten million spleen cells from C57BL/6 mice and equivalent numbers of 
CD8 T cell depleted spleen cells were cultured with ten million irradiated F1, (BALB/c x 
C57BL/6), spleen cells for 5 days, at 37°C and 5% CO2 in 6-well plates. A specific number 
of sorted, unprimed CD8 T cells were added to the CD8 T cell depleted cultures at day 0 
in order to reconstruct the naturally occurring CD4:CD8 T cell ratio. On day 5, control and 
reconstructed cultures were fractionated into CD4+ CD8-T cell populations by negative 
selection using MACS monoclonal antibodies to CD8 T cells prior to their assessment for 
allo-MHC dependent cytokine production by the ELISPOT assay. Culture equivalent 
Effector cells of the CD4+CD8- T cell populations were assessed for IFN-γ and IL-4 
production in our ELISPOT assay. Data are plotted as the number of spots per 107 spleen 
cells input at day 0 per culture. Data are represented as mean ± SD of the mean from 
duplicate cultures. Data are representative of three independent experiments with the 
pooled spleen cells from three mice per experiment.
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CHAPTER 6 
Revisiting the mechanism by which CD8 T cells exert their regulatory role on the 
differentiation of naïve CD4 T cells by employing the transwell membrane plate 
 
Preamble 
The prominence of CD8 T cells as suppressor cells of the antibody response arose in the 
1970’s. Extensive research into the mechanism by which the CD8 T cells exerted their 
suppressor effect gave rise to two possible pathways. Several studies employing the GVHD 
mouse model demonstrated that direct cell-to cell contact was required in which the donor 
cells lysed the host cells. Host B cells differing at the MHC class I molecule, were lysed 
by donor CD8 T cells (Via et al., 1987) by means of the Fas/FasL pathway (Kataoka et al., 
2001; Shustov et al., 1998) or through the production of cytolytic granules.  B cells are 
critical for antibody production. Thus, a significant reduction in B cells would abrogate an 
antibody response. In contrast, studies using the GVHD mouse model (Shand, 1976) 
demonstrated, using the double chamber, the role of a soluble factor in suppressing the 
antibody response upon stimulation with allo-MHC. However, the soluble factor was not 
identified in the above study. Similarly, the antibody response to the intracellular pathogen, 
L major was shown to be suppressed by means of a soluble factor. In this study IFN-γ was 
identified as the soluble factor, which was produced by both the CD8 and CD4 T cells 
(Herath et al., 2003). Conflicting results in the specificity of suppression were reported. 
Studies demonstrated that CD8 suppressor T cells produced antigen specific molecules 
coded by the I-J region in the MHC (Murphy et al., 1976; Tada et al., 1976). However, 
studies emerged that disproved these findings (Kronenberg et al., 1983; Steinmetz, 1982). 
This ultimately led to the decline in research into the CD8 T cell’s role as the suppressor 
of the antibody response.  
 
Thus, we wanted to revisit, in the third section of the results, the concept of the CD8 T cells 
as suppressors of the Th2 antibody response and provide a mechanism by which the CD8 
T cells exert this role on the differentiation of the naïve CD4 T cell. In previous experiments 
we observed the effect of CD8 T cells on CD4 T cells while they were in direct contact 
with each other. However, studies have demonstrated that high levels of IFN-γ 
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characterized the acute rejection while chronic GVHD was characterized by IL-4 (Rus et 
al., 1995). Therefore, based on our model in Figure 2.1, we hypothesised that CD8 T cells 
exerted their regulatory role on the differentiation of naïve CD4 T cells through the 
production of the soluble factor, IFN-γ. In order to assess this, we employed transwell-
membrane plates with a pore size of 0.4µm that only allowed molecules to pass through 
and not cells. In addition, we employed a neutralizing antibody to assess whether the 
soluble factor was indeed IFN-γ. 
 
6.1 The effect of the addition of IFN-γ on the production of cytokines by CD8 T cell 
depleted cultures 
IFN-γ, the signature cytokine of the Th1 immune response has been shown to suppress the 
Th2 (IL-4) immune response (Gajewski and Fitch, 1988). Based on our model we 
hypothesized that IFN-γ is the soluble factor that is produced by CD8 T cells upon 
stimulation with allo-MHC at the initiation of the immune response that drives the 
differentiation of a naïve CD4 T cells towards a Th1 mode. We decided thus, to first test 
the effects of the addition of IFN-γ to a CD8 T cell depleted culture in the lower chamber 
of a transwell-membrane plate. In the lower chamber of the transwell membrane plate four 
million spleen cells depleted of CD8 T cells using anti-CD8 TIB211 antibody and 
complement, were cultured with an equivalent number of irradiated F1 spleen cells for 5 
days. In the upper chamber, which was equivalent to the growth area of a 24-well plate, we 
added either RPMI complete medium or 10µl/well recombinant (r) IFN-γ, or 10µg/well 
anti-IFN-γ antibody, or 10µl/well of rIFN-γ and 10µg/well anti-IFN-γ antibody as depicted 
in Figure 6.1. On day 5, culture equivalent Effector cells were assessed for IFN-γ and IL-
4 production in our ELISPOT assay. Recombinant (r) IFN-γ added to the upper chamber 
of the transwell membrane plate resulted in switch from a predominant Th2 (IL-4) to a 
predominant Th1 (IFN-γ) immune response by the CD8 T cell depleted cultures in the 
lower chamber of the BALB/c (Figure 6.1A) and the C57BL/6 (Figure 6.1B) mice. These 
findings suggest that IFN-γ was able to migrate through the membrane and bring about this 
effect. The addition of the neutralising anti-IFN-γ antibody together with rIFN-γ to the 
upper chamber abrogated the effects of the rIFN-γ. The anti-IFN-γ antibody neutralised the 
rIFN-γ and thus it did not have any effect on the immune response of the CD8 T cell 
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depleted cultures in the lower chamber. Thus, the CD8 T cell depleted cultures in this 
instance exhibited an immune response similar to that observed when only RPMI medium 
was added. These findings augmented the IFN-γ’s role in causing a switch from a 
predominant Th2 (IL-4) to a predominant Th1 (IFN-γ) immune response in the CD8 T cell 
depleted cultures. 
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Figure 6.1: IFN-γ switches the CD4 Th2 (IL-4) immune response to a Th1 (IFN-γ) 
immune response in CD8 T cell depleted cultures.  
Four million spleen cells depleted of CD8 T cells of either BALB/c (A) or C57BL/6 (B) 
mice were cultured with an equivalent number of irradiated F1, (BALB/c x C57BL/6) 
spleen cells in the lower chamber of 12-well transwell membrane plates for 5 days, at 37°C 
and 5% CO2. In the upper chamber, we added either RPMI complete medium or 10µl/well 
rIFN-γ, or 10µg/well anti-IFN-γ antibody, or 10µl/well of rIFN-γ plus 10ug/well anti-IFN-
γ antibody. On day 5, culture equivalent Effector cells of the CD8 T cell depleted cultures 
in the lower chambers were assessed for IFN-γ and IL-4 production in our ELISPOT assay. 
Data are plotted as the number of spots per 107 spleen cells input at day 0 per culture. Data 
are represented as mean ± SD of the mean from duplicate cultures. Data are representative 
of three independent experiments with the pooled spleen cells from three mice per 
experiment.
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6.2. The effect of the CD4 and CD8 T cells in control cultures in switching the CD4 
Th2 (IL-4) immune response to a mixed Th1 (IFN-γ)/Th2 (IL-4) immune response in 
CD8 T cell depleted cultures 
Subsequently we tested the effect the cytokines, produced by the control cultures of 
BALB/c and C57BL/6 mice that contained both CD4 T cells and CD8 T cells, would have 
on the cytokine production in a CD8 T cell depleted cultures of the same mouse strain. 
Four million spleen cells depleted of CD8 T cells of either the BALB/c mice (Figure 6.2A) 
or the C57BL/6 mice (Figure 6.2B) were cultured with equivalent numbers of irradiated 
F1, (BALB/c x C57BL/6) spleen cells in the lower chamber of the 12-well transwell 
membrane plate. In the upper chamber, which was equivalent to the growth area of a 24-
well plate, two million spleen cells of either BALB/c mice (Figure 6.2A) or C57BL/6 mice 
(Figure 6.2B) were cultured with equivalent numbers of irradiated F1 spleen cells. On day 
5 of culture, the frequency of the IFN-γ and IL-4 producing cells of the CD8 T cell depleted 
cultures in the lower chamber of the two mouse strains were assessed by ELISPOT assay.  
 
The control cultures of the spleens of BALB/c mice have been shown to produce both   
IFN-γ and IL-4 upon stimulation with allo-MHC as seen in Figure 4.6. In Figure 6.2A the 
control culture of the BALB/c mice in the upper chamber, produced both IFN-γ and IL-4 
which resulted in an increase in IFN-γ production by the CD8 T cell depleted culture in the 
lower chamber but appeared to have no effect on the production of IL-4. The control 
cultures of the spleens of C57BL/6 mice produce predominantly IFN-γ as depicted in 
Figure 4.6. This resulted in a significant change in the IFN-γ production by the CD8 T cell 
depleted culture in the lower chamber as observed in Figure 6.2B. Furthermore, the 
predominant production of IFN-γ by the control culture spleen cells of the C57BL/6 mice 
in the upper chamber resulted in a significant decrease in the production of IL-4 by the 
CD4 T cells, which was not evident when the control cultures of the BALB/c mice were 
added to the upper chamber. These findings suggest that IFN-γ has an inhibitory effect on 
the production of IL-4 by the CD8 T cell depleted culture, which is consistent with the 
findings reported by Gajewski and Fitch in 1988. 
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Figure 6.2: The effect of the control culture in switching the CD4 Th2 (IL-4) immune 
response to a mixed Th1 (IFN-γ)/Th2(IL-4) immune response in CD8 T cell depleted 
cultures. Four million spleen cells depleted of CD8 T cells of either BALB/c (A) or 
C57BL/6 (B) mice were cultured with equivalent numbers of irradiated F1, (BALB/c x 
C57BL/6) spleen cells in the lower chambers of 12-well transwell membrane plates at 37°C 
and 5% CO2 for 5 days. In the upper chamber we added either RPMI complete medium or 
two million spleen cells of either BALB/c (A) or C57BL/6 (B) mice cultured with 
equivalent numbers of irradiated (BALB/c x C57BL/6), F1 spleen cells. On day 5, culture 
equivalent Effector cells of the CD8 T cell depleted cultures in the lower chambers were 
assessed for IFN-γ and IL-4 production in our ELISPOT assay. Data are plotted as the 
number of spots per 107 spleen cells input at day 0 per culture. Data are represented as 
mean ± SD of the mean from duplicate cultures. Data are representative of three 
independent experiments with the pooled spleen cells from three mice per experiment. The 
p values were obtained with ANOVA and Tukey’s post-test comparing for multiple 
comparisons.   
*p = 0.0148; **p = 0.0016 
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6.3 CD8 T cells require CD4 T cell help to differentiate into IFN-γ producing Effector 
cells  
We had demonstrated in Figure 6.2 that the control culture with both CD4 and CD8 T cells 
in the upper chamber of a transwell membrane was able to increase the production of     
IFN-γ of the CD8 T cell depleted culture in the lower chamber. The next step was to 
determine if unprimed CD8 T cells in the absence of CD4 T cells added to the upper 
chamber had any affect on cytokine change in the CD8 T cell depleted culture in the lower 
chamber. Numerous studies have provided evidence for CD4 T cell help being a 
requirement for the activation and differentiation of CD8 T cells to effector and memory 
cells (Bennet et al., 1998, Bos and Sherman, 2010; Shedlock and Shen, 2003; Sun and 
Bevan, 2003). We therefore wished to determine if the unprimed CD8 T cells in our system 
required CD4 T cell help. Thus, we prepared cultures containing CD4 T cells and CD8 T 
cells and fractionated cultures with either CD4+CD8- T cells or CD4-CD8+ T cells only in 
6-well plates for BALB/c (Figure 6.3A) and C57BL/6 (Figure 6.3B). The CD4 T cells and 
CD8 T cells were depleted using complement together with either anti-CD4 GK1.5 
antibody or anti-CD8 TIB 211 antibody, respectively. The CD4 T cells and CD8 T cells of 
both strains of mice were cultured with irradiated (BALB/c x C57BL/6), F1 spleen cells. 
As observed in Figure 6.3 the CD8 T cell depleted cultures were able to produce IL-4, 
while the CD4 T cell depleted cultures were unable to produce IFN-γ or IL-4 upon 
stimulation with the F1 alloantigen. We had previously demonstrated in Figure 4.12 that 
CD8 T cells are able to produce IFN-γ upon allo-stimulation. Thus, our findings in Figure 
6.3 suggests that the CD8 T cells require CD4 T cell help in both strains of mice in order 
to produce IFN-γ upon stimulation with alloantigen.  
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Figure 6.3: CD8 T cells require CD4 T cell help in order to produce IFN-γ upon 
stimulation with allo-MHC 
Ten million spleen cells from BALB/c (A) and C57BL/6 (B) mouse strains and equivalent 
numbers of CD8 T cell depleted spleen cells and equivalent numbers of CD4 T cell 
depleted spleen cells were cultured with irradiated F1, (BALB/c x C57BL/6) spleen cells 
for 5 days, at 37°C and 5% CO2 in 6-well plates. Cultures were depleted of CD8 T cells 
using anti-CD8 TIB 211 antibody and Low Tox-M rabbit complement. Cultures were 
depleted of CD4 T cells by using anti-CD4 GK1.5 antibody and Low Tox-M rabbit 
complement. On day 5, culture equivalent Effector cells were assessed for IFN-γ and IL-4 
production in our ELISPOT assay. Data are plotted as the number of spots per 107 spleen 
cells input at day 0 per culture. Data are represented as mean ± SD of the mean from 
duplicate cultures. Data are representative of three independent experiments with the 
pooled spleen cells from three mice per experiment.
 147 
6.4 Effector CD8 T cells switch the CD4 Th2 (IL-4) immune response to a mixed 
Th1(IFN-γ)/Th2 (IL-4) immune response 
Our findings in Figure 6 clearly indicate that unprimed CD8 T cells require cognate CD4 
T cells to activate CD8 T cells. Thus, we set out to determine the role of effector CD8 T 
cells and their secretory products on CD4 T cell differentiation. In order to determine this, 
we first generated Effector CD8 T cells as per our normal protocol for control cultures. At 
day 5 of culture we sorted effector CD8 T cells employing negative selection with MACS 
monoclonal antibodies to CD4 T cells. Flow cytometry was used to verify the successful 
sorting of the CD8 T cells of the spleen cells of the BALB/c (Figure 6.4A) and the C57BL/6 
(Figure 6.4B) mouse strains. Thereafter, spleen cells depleted of CD8 T cells were cultured 
with equivalent numbers of irradiated F1 spleen cells in the lower chamber of 12-well 
transwell membrane plates. We added 2 x 105 effector CD8 T cells with either equivalent 
numbers of the nominal, F1 antigen or with the irradiated spleen cells of C3H mice, an 
unrelated antigen to the upper chamber in both BALB/c (Figure 6.4C) and C57BL/6 
(Figure 6.4D) mouse strains. The presence of the Effector CD8 T cells that were 
restimulated with the nominal antigen in the upper chamber resulted in a switch in the CD8 
T cell depleted culture in the lower chamber from an almost exclusive Th2 (IL-4) to an 
almost exclusive Th1 (IFN-γ) response. In addition, the effector CD8 T cells cultured with 
the unrelated alloantigen, irradiated spleen cells of C3H mice, did not result in a change to 
the production of the cytokines produced by the CD8 depleted culture in the lower 
chamber. These findings suggest that the effector CD8 T cells are able to switch the CD4 
Th2 (IL-4) immune response of CD8 T cell depleted cultures to a Th1 (IFN-γ) immune 
response in an antigen specific manner. Furthermore, since the membrane only allows 
soluble factors to pass through we hypothesised that the means by which the Effector CD8 
T cells exerted their effect on the CD4 T cell was through the production of a soluble factor. 
 148 
                
                 CD4                           
                              CD8 
    
 
 
 
 
 
                   
Figure 6.4
A 
D 
B 
C 
 149 
Figure 6.4: Effector CD8 T cells switch the CD4 Th2 immune response to a Th1 
immune response in an antigen specific manner.  
Effector CD8 T cells were prepared as per our standard protocol for control cultures five 
days before addition to transwell membrane plates. On day 5 purified CD8+CD4- T cells 
were obtained using negative selection with MACS monoclonal antibodies to CD4 T cells. 
Flow cytometry was used to verify the sorted CD8 T cells of BALB/c (A) and C57BL/6 
(B) mouse strains. Four million CD8 T cell depleted spleen cells of either BALB/c (C) or 
C57BL/6 (D) mice were cultured with equivalent numbers of irradiated F1 spleen cells in 
the lower chamber of 12-well transwell membrane plates for 5 days, at 37°C and 5% CO2. 
In the upper chamber we added either RPMI complete medium (I), 2 x 105 Effector CD8 
T cells of either BALB/c (A) or C57BL/6 (B) with an equivalent number of irradiated F1 
spleen cells (II) or 2 x 105 Effector CD8 T cells with an unrelated antigen, the irradiated 
spleen cells of C3H mice (III). On day 5, culture equivalent Effector cells of the CD8 T 
cell depleted cultures in the lower chambers were assessed for IFN-γ and IL-4 production 
in our ELISPOT assay. Data are plotted as the number of spots per 107 spleen cells input 
at day 0 per culture. Data are represented as mean ± SD of the mean from duplicate cultures. 
Data are representative of three independent experiments with the pooled spleen cells from 
three mice per experiment. The p values were obtained with ANOVA and Tukey’s post-
test for multiple comparisons.    ***p= 0.0008, **** p < 0.0001, NS not significant 
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6.5 Identification of IFN-γ as an essential factor produced by CD8 T cells that is 
required to switch a predominant Th2 (IL-4) response to a Th1 (IFN-γ) immune 
response 
We have demonstrated in Figure 4.12 that the CD8 T cells of the spleens of the BALB/c 
mouse strain produce IFN-γ and not IL-4 upon stimulation with alloantigens. Thus, we 
surmised that the CD8 T cells of the BALB/c and C57BL/6 mouse strains would produce 
IFN-γ upon allo-MHC stimulation, which migrate across the membrane of the 12-well 
transwell membrane plate. The IFN-γ would thus exert an inhibitory effect on the 
development of a Th2 immune response by the CD4 T cells in the lower chamber resulting 
in a switch from a Th2 (IL-4) to a predominant Th1 (IFN-γ) response. Four million spleen 
cells depleted of CD8 T cells from BALB/c mice (Figure 6.5A) and from C57BL/6 mice 
(Figure 6.5B) were cultured with equivalent numbers of irradiated F1 spleen cells in the 
lower chamber of the 12-well transwell membrane plate. 2 x 105 Effector CD8 T cells were 
cultured with equivalent numbers of irradiated F1 spleen cells in the upper chamber with 
or without 20µg/well neutralising anti-IFN-γ antibody. The presence of the effector CD8 
T cells in the upper chamber resulted in a switch from a Th2 (IL-4) immune response to a 
Th1 (IFN-γ) immune response in the CD8 T cell depleted cultures in the lower chamber. 
The addition of the neutralizing anti-IFN-γ antibody to the upper chamber prevented 
effector CD8 T cells exerting the switch in the CD8 T cell depleted cultures. We thus can 
conclude that CD8 T cells inhibit the Th2 (IL-4) response of CD4 T cells specific for allo-
MHC through the production of IFN-γ.  
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Figure 6.5: Effector CD8 T cells switch CD4 Th2 (IL-4) immune response to a Th1 
(IFN-γ) phenotype by producing IFN-γ.  
Effector CD8 T cells were prepared as per our standard protocol for control cultures 5 days 
prior to addition to the transwell membrane plates. On day 5, purified Effector CD8+CD4- 
T cells were obtained using negative selection with MACS monoclonal antibodies to CD4 
T cells. Four million CD8 T cell depleted spleen cells of either BALB/c (A) or C57BL/6 
(B) mice were cultured with equivalent numbers of irradiated (BALB/c x C57BL/6), F1 
spleen cells in the lower chamber of 12-well transwell membrane plates at 37°C and 5% 
CO2 for 5 days. In the upper chamber we added either RPMI complete medium (I), 2 x 105 
sorted Effector CD8 T cells of either BALB/c (A) or C57BL/6 (B) with the nominal F1 
spleen cells (II) or 2 x 105 sorted Effector CD8 T cells with 20ug/well of neutralizing anti-
IFN-γ antibody plus the nominal F1 spleen cells (III). Flow cytometry was employed to 
verify the sorted CD8 T cells. On day 5, culture equivalent Effector cells of the CD8 T cell 
depleted culture in the lower chamber were assessed for IFN-γ and IL-4 production in our 
ELISPOT assay. Data are plotted as the number of spots per 107 spleen cells input at day 0 
per culture. Data are represented as mean ± SD of the mean from duplicate cultures. Data 
are representative of three independent experiments with the pooled spleen cells from three 
mice per experiment. The p values of the number of alloantigen specific IFN-γ and IL-4 
producing cells were obtained with ANOVA with Tukey’s post-test for multiple 
comparisons. **** p < 0.0001, NS not significant 
 153 
CHAPTER 7 
DISCUSSION 
 
Preamble 
Resistance to some infections and the successful elimination of some intracellular 
pathogens or the rejection of tumours often requires a Th1, cell-mediated immune 
response. The generation of a Th2 immune response proved ineffective in clearing certain 
pathogens (Dittmer et al., 1996). Several studies provide evidence for the crucial role of 
cytotoxic T lymphocytes (CTLs), which are largely effector CD8+ T cells, in the protection 
against intracellular pathogens (Sun and Bevan, 2003) and viral infections (Hatziioannou 
et al., Jin et al., 1999; Schmitz et al., 1999). Infiltration of cytotoxic T lymphocytes into 
breast and colon cancer tissue correlates with a good prognosis (Ziai et al., 2018). Although 
their mode of killing infected target cells is through the secretion of cytolytic granules 
(Badovinac et al., 2000; Lobe et al., 1986, Podack et al., 1991) and the Fas-FasL interaction 
(Kataoka et al., 2001; Russell and Ley, 2002), CD8 CTLs also produce IFN-γ (Fong and 
Mosmann, 1990), which is the signature cytokine of a Th1 immune response (Mosmann et 
al., 1986), suggesting a role for CD8 T cells in enhancing the Th1 immune response. 
 
In addition to their ability to kill target cells, CD8 T cells are able to suppress the antibody 
response of the CD4 T cell according to the theory of immune regulation proposed by 
Bretscher in 1974 and its subsequent demonstration by Ramshaw and colleagues in 1977. 
Subsequently, the CD8 T cell gained prominence as the suppressor cell of the CD4 
antibody response and was followed by extensive research into the mechanism by which it 
exerted its suppressor effects. Systemic lupus erythematosus (SLE), a human antibody-
mediated autoimmune disease has been attributed to the inability of the CD8 T cells to 
suppress the persistent antibody response (Filaci et al., 2001). The suppressor function of 
CD8 T cells was also observed in the GVHD mouse model (Rus et al., 1995; Via et al., 
1987).  
 
A substantial effort was made to understand the mechanism by which CD8 T cells 
suppressed the antibody response. Several studies demonstrated that suppression was 
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executed by the cytotoxic activity of the CTL’s (Rozendaal et al., 1989; Shustov et al., 
1998, Via et al., 1987). The CTL’s lysed B cells, which resulted in a decrease in antibody 
production (Via et al., 1987). However, other studies suggested that CD8 T cells produced 
a soluble effector molecule that suppressed the antibody response (Herath et al., 2003; Rich 
and Pierce, 1974; Shand, 1976). Furthermore, conflicting reports emerged as to whether 
the soluble factor was antigen-specific (Takemori and Tada; 1975) or whether it acted in a 
non-specific manner (Rich and Pierce, 1974).  
 
The aim of this thesis was thus to re-examine the role of the CD8 T cell in the inhibition of 
the CD4 Th2 (IL-4) antibody response and to revisit the mechanism by which CD8 T cells 
exerts its suppression. The study employed an allo-MHC specific in vitro system where the 
differential development of CD4 and CD8 T cells could be observed through quantitative 
interactions initiated by allo-MHC and through the production of cytokines, IFN-γ and    
IL-4, by the T cells. We found that the naturally occurring and controlled manipulation of 
CD4:CD8 T cell ratios were predictive of whether a Th1 (IFN-γ) or Th2 (IL-4) immune 
response was generated against allo-MHC. Furthermore, the presence of CD8 T cells at the 
initiation of the immune response against allo-MHC inhibits the differentiation of the CD4 
T cell to a Th2 (IL-4) phenotype. Moreover, we determined that the mechanism by which 
the CD8 T cells exerted their suppressor effects on the Th2 subset was through the 
production of a soluble factor, IFN-γ, which has been reported by others to enhance the 
Th1 immune response and concomitantly inhibit the Th2 immune response (Gajewski et 
al., 1999).  
 
7.1 The relationship between the CD4:CD8 T cell ratio of spleens of various mouse 
strains and the tendency of CD4 T cells to differentiate to either a Th1 (IFN-γ) or a 
Th2 (IL-4) subset in response to allo-MHC 
A naïve CD4 T cell has the potential to differentiate into distinct T cell subsets with specific 
functions and cytokine production. Numerous factors have been shown to play a role in 
determining the type of CD4 T cell subset that is generated upon antigen stimulation. There 
is evidence that the nature of the antigen (Scott et al., 1987, Scott et al., 1988) and the dose 
of the antigen (Dittmer et al., 1996; Menon and Bretscher, 1998; Power et al., 1998; Salvin, 
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1958; Sarzotti et al., 1996) independently influence the type of immune response, Th1 or 
Th2 generated. The cytokine milieu has also been implicated as a determinant of the 
immune response that is generated but this will be elaborated upon later in section 7.4 of 
the discussion. A low antigen dose is associated with a Th1 immune response while a high 
dose elicits a Th2 immune response. However, the antigen dose required to elicit an 
immune response varies between different strains of mice (Menon and Bretscher, 1998). 
This observation suggests that there are other factors, in addition to the antigen dose that 
play a key role in generating either a predominant Th1 or a predominant Th2 immune 
response. The work by various researchers highlighted a possible role for the CD4:CD8 T 
cell ratio in determining a Th1/Th2 immune response to allo-MHC (Rus et al., 1995; Via 
et al., 187). They demonstrated that lymphocytes from distinct parental strains containing 
comparable numbers of CD4 T cells but significantly different numbers of CD8 T cells 
generated either a Th1 (cell-mediated) or a Th2 (antibody-mediated) immune response 
when inoculated into F1 mice. Furthermore, data from a later study revealed that a low 
number of responding CD4 T cells present at the initiation of the immune response were 
shown to generate a Th1 immune response against SRBC, while a high number of CD4 T 
cells generated a Th2 immune response to the same antigen (Ismail and Bretscher, 2001). 
Moreover, work done in our laboratory demonstrated that the spleens cells of neonatal 
C57BL/6 and BALB/c mice displayed a CD4:CD8 T cell ratio, 3-5-fold higher than their 
adult counterparts and that this high ratio correlated with a predominant Th2 (IL-4) immune 
response upon stimulation with allo-MHC (Warner, 2015). Although the immune response 
of neonatal mice is biased towards a Th2 immune response (Adkins et al., 2000; Barrios et 
al., 1996), a low antigen dose has been shown to elicit a Th1 immune response (Sarzotti et 
al., 1996). The collective findings above of the different experiments suggested that the 
CD4:CD8 T cell ratio might have some significance in determining the Th1/Th2 immune 
response to antigens.  
 
We initially set out to explore the role of the CD4:CD8 T cell ratio in the spleens of the 
adult C57BL/6 and BALB/c mice. The C57BL/6 mouse mounts a strong Th1 immune 
response against viral antigens and is generally considered by researchers to be a ‘cell-
mediated’ mouse. In contrast, the BALB/c mouse is considered to be the ‘antibody’ mouse 
 156 
often generating a strong Th2 immune response to antigen. Based on our hypothesis, we 
anticipated that a relatively low CD4:CD8 T cell ratio would characterize the C57BL/6 
strain while a relatively high CD4:CD8 T cell ratio would characterize the BALB/c mouse. 
This difference in CD4:CD8 T cell ratio would explain the antibody behaviour (Th2) or 
cell mediated immunity (Th1) in each of the respective mouse strains. We subsequently 
demonstrated that the spleen cells of the C57BL/6 mouse strain had a CD4:CD8 T cell ratio 
of approximately 1, while the spleen cells of the BALB/c mouse strain had a ratio greater 
than 2.5 (Figure 4.2) Our findings are consistent with the findings of Pinchuk and Filipov 
(2008) who demonstrated a higher CD4:CD8 T cell ratio in the BALB/c than C57BL/6 
mouse strains. Furthermore, the latter authors demonstrated that the CD4:CD8 T cell ratio 
was consistent across both the spleens and the peripheral blood mononuclear cells 
(PBMCs) of the BALB/c and C57BL/6 mice. We in turn demonstrated that the CD4:CD8 
T cell ratio was similar in the spleens and the inguinal lymph nodes of two mouse strains 
(Figure 4.3). Thus, we concluded that the CD4:CD8 T cell ratio was consistent between 
secondary lymphoid organs and in the peripheral blood of the BALB/c and C57BL/6 mice. 
 
We suspect that the difference in the CD4:CD8 T cell ratio between the BALB/c and 
C57BL/6 mouse strains originates from a defective I-Eα gene of the C57BL/6 mouse strain 
(Flavell et al., 1985). The I-Eα gene is critical for the expression of MHC class II, I-E 
molecules on the surface of cells. Consequently, the defective I-Eα gene of the C57BL/6 
mouse results in a lower expression of MHC class II, I-E molecules in the thymus, during 
the development of T cells. Single positive CD4 T cells are positively selected based on 
their recognition of the MHC class II molecules of the thymic epithelium. Fewer MHC 
class II molecules ultimately lead to fewer CD4 T cells being positively selected in the 
thymus. This leads to fewer CD4 T cells in the periphery of the C57BL/6 mice, which 
likely explains in part why a lower CD4:CD8 T cell ratio exists in the C57BL/6 than the 
BALB/c mouse strain. This also suggests that differences in the expression of MHC class 
I and II molecules in the thymus, affects the CD4:CD8 T cell ratio at the periphery which 
may ultimately lead to different immune responses to the same antigen. 
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Once we had determined that there was a significant difference in the naturally occurring 
CD4:CD8 T cell ratio of the spleens between BALB/c and C57BL/6 mouse strains, we set 
out to determine if these differences correlated with either a Th1 or Th2 immune response. 
The Th1 and Th2 immune responses are characterized by the presence of the signature 
cytokines IFN-γ and IL-4, respectively (Mosmann et al., 1986). We found that the high 
CD4:CD8 T cell ratio in the BALB/c mouse strain correlated with a mixed Th1(IFN-γ /Th2 
(IL-4) immune response, while the relatively low ratio CD4:CD8 T cell ratio of the spleens 
of C57BL/6 mouse strain produced a predominant Th1 (IFN-γ) immune response (Figure 
4.6 and 4.7). These findings were consistent across other mouse strains where subtle 
variations in the CD4:CD8 T cell ratios (Figures 4.8 and 4.9), was associated with 
variations in the type of immune response generated (Figure 4.10C). The spleen cells of 
the CBA/J and C3H expressed a CD4:CD8 T cell ratio below 2 and subsequently generated 
a predominant Th1 (IFN-γ) immune response against allo-MHC. Notably the CBA/J and 
C3H mice, both displaying a H-2k haplotype are closely related with a common ancestry 
(Snell et al., 1953). In contrast, the spleen cells of the DBA/1 and DBA/2 mice expressed 
a CD4:CD8 T cell ratio of 2 and more, respectively, and generated a mixed Th1 (IFN-γ) / 
Th2 (IL-4) immune response against allo-MHC. The DBA/1 and DBA/2 mice also have a 
close relationship, which may explain the similarity in immune response (Snell et al., 
1953).  
 
We found that the CD4:CD8 T cell ratio is the same in spleens and lymph nodes as well as 
in the blood (Pinchuk and Filipov, 2008). Our accumulative findings in both adult and 
neonatal studies (Warner, 2015), suggest that the CD4:CD8 T cell ratio is a determining 
factor in the differentiation of CD4 T cells. The differentiation of naïve CD4 T cells 
towards a Th1 phenotype is dependent on the concomitant induction of CD8 T cells by the 
same antigen, driven by a low CD4:CD8 T cell ratio. In contrast, inefficient induction of 
CD8 T cells due to a high CD4:CD8 T cell ratio results in the naïve CD4 T cell 
differentiating into a Th2 subset. Moreover, the type of immune response generated has 
been shown to be antigen-dependent and antigen specific (Figure 4.13).  
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Our data suggest that the CD4:CD8 T cell ratio may predict whether a Th1(IFN-γ) or Th2 
(IL-4) immune response is generated against allo-MHC. This prediction may have 
relevance to the field of transplantation immunity. An important complication associated 
with bone marrow transplantations (BMT) in humans is graft versus host disease (GVHD). 
A graft versus host reaction (GVHR) occurs when donor T cells recognise and mount an 
immune response against allo-MHC on the surfaces of the host’s antigen presenting cells. 
A prerequisite for the development of a GVHR is the presence of immunologically 
competent cells within the donor inoculum and the inability of the host to respond to the 
donor cells (Billingham, 1959). Recipients of bone marrow transplants undergo a 
conditioning regimen which includes chemotherapy and/or radiation prior to the transplant 
(Xun et al., 1994). This regimen destroys the recipient’s immune cells and renders the 
individual incapable of responding to the donor cells (Ferrara et al., 2003). The GVHR can 
result in either an acute or a chronic form of disease. The acute GVHR is characterized by 
a Th1(IFN-γ) immune response, while the chronic form is characterized by a Th2 (IL-4) 
immune response (Rus et al., 1995). Currently HLA-typing is mandatory prior to BMT to 
reduce the risk of GVHD. Despite the rigorous HLA-typing GHVD does occur.  
 
Several studies were undertaken that set out to determine a possible predictor of GVHD in 
BMT. The frequency of the CTL precursors (CTLp) has been suggested as a possible 
predictor of the severity of the GVHD in humans (Affaticati et al., 2000; Batchelor et al., 
1990) and in the mouse model (Via et al., 1987). In the above studies limiting dilution 
analysis was undertaken to determine the frequency of the CTLp. The authors observed 
that a higher frequency of CTLp results in an acute GVHR while a low frequency results 
in the chronic form of the disease. However, there were studies that contradicted this 
finding. Wang and colleagues reported in 2000 that the frequency of CTLp was not a good 
predictor of the severity of GVHD. We, however, suggest that whether an acute GVHR or 
a chronic GVHD manifests after a BMT, can be determined by the CD4:CD8 T cell ratio 
in the donor tissue. A low ratio correlates with a predominant Th1 (IFN-γ) immune 
response which is characteristic of the acute GVHR (Rus et al., 1995). In contrast, a 
relatively high ratio correlates with a mixed Th1 (IFN-γ)/Th2(IL-4) immune response 
suggestive of a chronic GVHD.   
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7.2 The role of CD8 T cells in promoting the differentiation of naive CD4 T cells to a 
Th1 (IFN-γ) subset and the concomitant inhibition of a CD4 Th2 (IL-4) response 
As background to our finding that CD8 T cells have a role in promoting the differentiation 
of a naïve CD4 T cells to a Th1 subset and bring about concomitant inhibition of the CD4 
Th2 subset, we will briefly review pertinent work from the 1970’s. In the early 1970’s it 
became evident that T cells played a primary role in cell-mediated and antibody responses 
and that these responses were mutually exclusive (Parish and Liew, 1972). According to a 
theory of immune regulation (Bretscher, 1974; Ramshaw et al., 1977), the suppressor T 
cell of the antibody response is the CD8 T cell, while the CD4 T cell is able to inhibit the 
cell-mediated response. Several in vivo and in vitro studies confirmed these findings 
(Herath et al., 2003; Kataoka et al., 2001; Pickel and Hoffmann, 1977; Rolink and 
Gleichman, 1983; Tschetter et al., 2000; Via et al., 1987).  
 
Evidence of the CD8 T cells role in suppressing the antibody response was demonstrated 
in the GVHD mouse model and was referred to as allosuppression. In 1977, Pickel and 
Hoffman demonstrated that spleen cells of mice undergoing a GVHR were unable to 
generate PFC upon stimulation with SRBC in vitro. Prior to testing spleen cells for 
antibody production, the mice were injected with allogeneic spleen cells to establish a 
GVHR. The authors tentatively identified the CD8 T cell as the suppressor of the antibody 
response. Independent in vivo studies demonstrated that an antibody response could occur 
in mice in which a GVHR was induced (Rus et al., 1995; Via et al., 1987). The generation 
of the antibody response was however, dependent on the frequency of CD8 T cells present 
in the inoculum of the allogeneic cells. If the inoculum of the donor contained a high 
frequency of CD8 T cells an acute GVHR occurred in the recipient mice with no antibody 
production observed. In contrast, if the inoculum of allogeneic cells had a significant 
reduction in CD8 T cells the recipient mice developed an antibody mediated autoimmune 
disease resembling lupus in humans. These findings suggest that without the regulatory 
role of CD8 T cells, CD4 T cells differentiate into the phenotype that is favourable for the 
development of a Th2 antibody-mediated disease. The importance of the CD8 T cells in 
suppressing the antibody response has also been reported in humans. Individuals with 
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active SLE, the antibody mediated autoimmune disease, appear to have an impaired CD8 
T cell suppressor function (Filaci et al., 2001) 
 
According to our model illustrated in Figure 2.1, the presence of CD8 T cells at the 
initiation of the immune response is critical in the differentiation of the naive CD4 T cell 
to a Th1 (IFN-γ) subset. In contrast, the absence of CD8 T cells results in the differentiation 
of the naive CD4 T cells to a Th2 (IL-4) subset upon stimulation with allo-MHC. In our 
study the spleen cells of different strains of mice generated varying Th1/Th2 phenotypes 
upon stimulation with allo-MHC (Figures 4.6 and 10C). We attributed this variation in 
Th1/Th2 phenotypes to the differences in the CD4:CD8 T cell ratio of the spleens of the 
different strains of mice. The deliberate depletion of CD8 T cells from the spleens of all 
the strains of mice used in the study, (BALB/c, C57BL/6, C3H, DBA/2 and DBA/1) 
elicited a near exclusive Th2 (IL-4) immune response upon stimulation with allo-MHC 
(Figures 5.1 and 5.2 and 5.4). Our results are consistent with those of Via, that were 
reported in 1987. The latter authors demonstrated that an inoculum of spleen cells that had 
originally generated a Th1 immune response in recipient mice generated a Th2 antibody 
mediated autoimmune disease in the recipient mice when the inoculum was depleted of 
CD8 T cells. We are confident to conclude that the CD8 T cell is pivotal in determining 
the type of immune response that is generated when a naïve CD4 T cell is exposed to an 
allo-antigen. 
 
We have evaluated further the defining role of the CD8 T cell in the differentiation of the 
CD4 T cell, by reconstructing the original CD4:CD8 T cell ratio in the CD8 T cell depleted 
cultures of BALB/c and C57BL/6 mice. The addition of sorted unprimed CD8 T cells to 
the CD8 T cell depleted cultures reversed the immune response to the original Th1/Th2 
phenotype (Figures 5.6 and 5.7). In addition, we demonstrated that the presence of CD8 T 
cells in the reconstructed CD8 T cell depleted cultures had a direct effect on the cytokine 
production of the CD4 T cells. In the CD8 T cell depleted cultures; the CD4 T cells 
produced IL-4. However, with the addition of CD8 T cells, the CD4 T cell showed a 
reduction in the production of IL-4 and an increase in the production of IFN-γ in both the 
BALB/c and C57BL/6 mice (Figures 5.8 and 5.9). These findings are consistent with the 
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findings of Herath who reported in 2003 that the presence of CD8 T cells increased the 
number of IFN-γ producing CD4 T cells in response to L major parasites.  
 
Our findings argue in favour of a role for the CD8 T cells to drive the differentiation of the 
CD4 T cell towards a Th1 (IFN-γ) subset and inhibit the differentiation of the naive CD4 
T cell into a Th2 (IL-4) subset in response to allo-MHC. Thus, the inhibition of the Th2 
(IL-4) immune response by the CD8 T cell results in the inhibition of the antibody response. 
The Th2 signature cytokine, IL-4 (Mosmann et al., 1986; Swain et al., 1990) is essential 
for the activation and proliferation of B cells and was initially referred to as the B cell 
growth factor, (BCGF) (Howard, et al., 1982; Swain et al., 1988). The IL-4 stimulates the 
B cells to produce IgM and IgG1 antibodies (Boom et al., 1988) and IgE (Coffman et al., 
1987). We have demonstrated that the addition of unprimed CD8 T cells to the CD8 T cell 
depleted cultures caused a switch from a predominant Th2 (IL-4) immune response to a 
mix Th1(IFN-γ)/Th2 (IL-4) response at the CD4 T cell level (Figures 5.9 and 5.10). The 
CD4 T cells increased their production of IFN-γ and decreased their production of IL-4. 
The reduction in IL-4 reduces B cell activation. We can thus conclude, that the CD8 T cell 
suppresses the Th2 antibody response indirectly, by inhibiting the production of IL-4, 
which in turn is critical for B cell activation and the production of IgM, IgG1 and IgE 
antibodies. Notably, IFN-γ, the signature cytokine of a Th1 immune response promotes the 
production of IgG2a.  
 
7.3 The mechanism by which the CD8 T cells promotes the differentiation of the CD4 
T cell into a Th1 (IFN-γ) phenotype and suppresses a Th2 (IL-4) immune response 
against allo-MHC 
The model that we have proposed in Figure 2.1, describes that the presence of CD8 T cells 
drive the differentiation of naïve CD4 T cells towards a Th1 (IFN-γ) phenotype and away 
from a Th2 (IL-4) phenotype upon allo-MHC stimulation, while the absence of the CD8 T 
cells results in a CD4 Th2 (IL-4) phenotype. To complete the model, we embarked on a 
series of experiments in which we proposed that the regulatory role of the CD8 T cell on 
the differentiation of the CD4 T cell is mediated by a soluble factor, the cytokine, IFN-γ. 
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Researchers proposed two possible mechanisms by which antibody suppression occurred; 
either through the cytotoxic activity of CTLs or by means of a soluble factor produced by 
effector cells. Several studies have demonstrated that the presence of CD8 T cells is a 
determining factor in the suppression of the antibody response to intracellular pathogens 
(Herath et al., 2003) and to alloantigens (Kataoka et al., 2001; Rolink and Gleichmann, 
1983; Tschetter et al., 2000; Via et al., 1987). The presence of CD8 T cells during an L 
major infection greatly enhanced resistance to and the clearance of the pathogen. In 
contrast, the absence of the CD8 T cells resulted in an antibody response, which rendered 
the individual mice susceptible to the pathogen (Herath et al., 2003). In the allo-response, 
studies have demonstrated the role of CTLs in the manifestation of the acute GVHR 
(Kataoka et al., 2001; Rozendaal et al., 1989; Via et al., 1987), which is characterized by a 
significant reduction in host B cells numbers (Via et al., 1987). Differences between MHC 
class I molecules on the surface of host and donor B cells, stimulates the donor CD8 CTLs 
to lyse the host B cells. As B cells are critical for the production of antibody, a reduction 
in host B cells reduces the potential for a Th2 antibody response against allo-MHC. Notably 
CD4 T cell activation is also a requirement for the development of an acute GVHR (Rolink 
and Gleichmann, 1983).  
 
Effector CTLs are known to lyse target cells via two pathways; either by the secretion of 
cytolytic granules or by the Fas-FasL pathway. In a study undertaken by Kataoka and 
colleagues in 2001 they reported an increase in FasL mRNA expression in the spleen, small 
intestines and liver in mice in which an acute graft versus host reaction occurred which was 
not evident in in the chronic GVHD. This finding suggested that there was a correlation 
between the expression of FasL and the type of GVHR observed. The authors thus 
suggested that the CTLs lysed the B cells via the Fas-FasL pathway, which abrogated the 
antibody response. The findings of Kataoka in 2001 expanded upon the earlier findings of 
Rozendaal and colleagues in 1989, which reported that the suppression of the antibody 
response was by the cytotoxic activity of CTL and not through a soluble factor. This 
however, was contrary to the findings of Shand who in 1976 demonstrated using a double 
chamber with a semi-permeable membrane that a soluble factor is a possible means by 
which allo-suppression occurs. However, they did not volunteer a possible candidate. 
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Studies were also undertaken that demonstrated that antigen specific molecules were 
instrumental in the suppression of the antibody response (Takemori and Tada; 1975) that 
were seemingly coded by the I-J region located between the I-A and I-E regions of the 
MHC (Taniguchi et al., 1976). Research soon emerged that made this particular mechanism 
unlikely (Kronenberg et al, 1983; Steinmetz, 1982). This ultimately led to a decline in 
research into the mechanism of the suppressor function of CD8 T cells. As the exact 
mechanism by which CD8 T cells exert their regulatory role remained undetermined, our 
intention was to revisit the mechanism by which CD8 T cells suppress the CD4 Th2         
(IL-4) immune response to allo-MHC. 
 
We proposed an alternate mechanism by which CD8 T cells inhibits the Th2 antibody 
response in the GVHD mouse model. The cytokine environment has been shown to be 
important in determining the type of T cell subset that is generated upon stimulation with 
an antigen (Gajewski and Fitch, 1988; Gajewski et al., 1989, Swain et al., 1990).  IFN-γ is 
considered to be the signature cytokine of the Th1 immune response (Mosmann et al., 
1986). Numerous studies have reported the presence of IFN-γ during the acute GVHR and 
its absence from chronic GVHD (Kataoka et al., 2001; Rus et al., 1995; Shustov et al., 
1998). IFN-γ has a stimulatory effect on macrophages, by increasing their microbicidal 
activity and upregulating MHC class I and II molecules on APCs. Moreover, IFN-γ has 
been shown to inhibit the production of IL-4 (Gajewski and Fitch, 1988; Gajewski et al., 
1989).   
 
While investigating the cytokine profile during the cell cycle of newly activated CD4 T 
cells in 1998, Bird and colleagues demonstrated that IFN-γ was produced within hours of 
the first cell division. However, the secretion of IL-4 was evident only after a minimum of 
three cell divisions. These findings are consistent with the much earlier findings of Salvin 
in 1958. He reported that a cell-mediated, DTH, response to an antigen such as diphtheria 
toxoid is initially present and over a period of time transitions into an antibody response. 
The rate of transition is dose dependent. Contrary to this, Rus and colleagues reported in 
1995, using a parent into F1 model in which both CD4 and CD8 T cells were present, that 
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the first cytokine produced in mice in which GVHR was induced was IL-4, irrespective of 
whether the mice eventually developed acute GVHR, characterized by IFN-γ, or chronic 
GVHD characterized by IL-4.  
 
In our model we propose that higher numbers of responding CD8 T cells at the initiation 
of the immune response would lead to increased IFN-γ production, that drives the 
differentiation of the naïve CD4 T cell towards a Th1 (IFN-γ) phenotype. Similarly, if few 
CD8 T cells are present, that is a high CD4:CD8 T cell ratio, with reduced IFN-γ 
production, the naïve CD4 T cell differentiates into a Th2 (IL-4) subset. We have 
determined that CD8 T cells produce IFN-γ upon stimulation with allo-MHC and do not 
produce IL-4 as illustrated in Figure 4.12. This is consistent with the findings of Fong and 
Mosmann in 1990, which demonstrated that murine CD8 T cells clones produce IFN-γ and 
not IL-4.  
 
The mechanism of suppression, which we propose is partly based on the current concept 
of immune class regulation. The Th1 and Th2 immune responses are reciprocally regulated 
by the antagonistic action of their signature cytokines, IFN-γ and IL-4, respectively.       
IFN-γ is known to have an inhibitory effect on the production of the Th2 cytokine, IL-4 
and to concomitantly enhance a Th1 immune response (Gajewski and Fitch, 1988; Snapper 
and Paul, 1987). We subsequently demonstrated using transwell-membrane plates that 
antigen-specific activated CD8 T cells in the upper chamber produce IFN-γ that is able to 
migrate across the membrane and suppresses the production of IL-4 by CD8 T cell depleted 
cultures stimulated with allo-MHC in the lower chamber (Figure 6.4). Notably, in both the 
BALB/c and C57BL/6 mice the spleen cells in the CD8 T cell depleted cultures generated 
a predominant Th1 (IFN-γ) immune response. The spleen cells of BALB/c mice initially 
generated a mixed Th1/Th2 immune response with the unprimed CD8 T cells (Figure          
4. 7). However, we assume that the primed CD8 T cells added in the above experiments 
(Figure 6.4) produced large amount of IFN-γ at the initiation of the immune response, 
which inhibited the production of IL-4. This is consistent with the findings of Snapper and 
Paul in 1987. Furthermore, to verify that IFN-γ was the soluble factor responsible for the 
switch from a Th2(IL-4) to a Th1(IFN-γ) immune response, we introduced a neutralising 
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anti-IFN-γ antibody (Figure 6.5). When anti-IFN-γ antibody was added to the upper 
chamber the switch from a Th2 (IL-4) to a Th1 (IFN-γ) immune response was inhibited in 
both BALB/c and C57BL/6 mouse strains. The fact that rIFN-γ alone can cause a switch 
in the immune resonse, we are thus able to conclude that IFN-γ was the soluble factor 
produced by the CD8 T cells that drives the CD4 T cell response towards a Th1 (IFN-γ) 
mode and concomitantly inhibits an antibody response to allo-MHC. 
 
7.4 Implications for Transplantation Immunity: Graft Rejection or Antibody-
Mediated Autoimmune Diseases 
The findings of our in vitro model demonstrate that CD8 T cells creates a specific cytokine 
milieu that drives the differentiation of naïve CD4 T cells towards a Th1 (IFN-γ) immune 
response with the concomitant inhibition of a Th2 (IL-4) immune response upon 
stimulation with allo-MHC. The CD8 T cells in our study produced IFN-γ, which is known 
to augment a Th1 cell-mediated immune response and inhibit a Th2 immune response 
(Gajewski and Fitch 1988). The Th1 immune response has been associated with an acute 
GVHR, which leads to the destruction of host tissue. Thus, in our system the presence of 
the CD8 T cells and their production of IFN-γ would result in the rejection of an allograft. 
In contrast, the absence of CD8 T cells or in the presence of reduced numbers of CD8 T 
cells the CD4 T cell would differentiate into a Th2 subset. A persistent Th2 antibody 
immune response would occur due to ineffective immune response to clear host cells. The 
high frequency of alloreactive CD4 T cells of the donor would activate the autoreactive B 
cells of the host in a cognate T-B interaction (Morris et al., 1990). This would result in 
generalised autoimmunity (Bretscher, 1973). Thus, the CD8 T cell plays an indirect role in 
inhibiting development of an antibody-mediated autoimmune disease such as lupus in the 
GVHD mouse model.  
 
7.5 Conclusion 
Distinct CD4:CD8 T cell ratios of the spleens of different strains of mice is associated with 
a Th1(IFN-γ), a Th2(IL-4) or a mixed Th1/Th2 type immunity when these cells are 
stimulated with spleen cells of mice differing at the MHC locus in an in vitro model of 
alloreactivity. Furthermore, we have demonstrated that this ratio is consistent between 
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spleens and inguinal lymph nodes. In the absence of CD8 T cells, CD4 T cells from the 
spleens of the different strains of mice differentiate into a predominantly Th2(IL-4) subset. 
Naïve and Effector CD8 T cells suppress the Th2(IL-4) development in an antigen specific 
manner by means of a secreted soluble factor. Effector CD8 T cells switch the Th2(IL-4) 
response to a Th1 phenotype by producing IFN-γ. Thus, the naturally occurring CD4:CD8 
T cell ratio promotes either Th1 immunity required for graft rejection, or Th2-type 
responses ineffective for attacking the graft. Thus, a persistent Th2 response by donor cells 
against host cells results in time in antibody-mediated generalised autoimmunity, 
resembling Systemic Lupus Erythematosus. Thus, in these studies we have revisited the 
mechanism by which CD8 T cells were known to act as “suppressors” of the antibody 
response. Our studies indicate that CD8 T cells inhibit in a cognate manner the CD4 
Th2(IL-4) differentiation, a CD4 subset required for antibody development. 
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